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Background: Type 1 diabetes (T1D) in children and young people is increasing worldwide with a particular
increase in children under the age of 5 years. Fewer than one in six children and young people achieve
glycosylated fraction of haemoglobin (HbA1c) values in the range identiﬁed as providing best future
outcomes. There is an urgent need for clinic-based pragmatic, feasible and effective interventions that
improve both glycaemic control and quality of life (QoL). The intervention offers both structured education,
to ensure young people know what they need to know, and a delivery model designed to motivate
self-management.
Objective: To assess the feasibility of providing a clinic-based structured educational group programme
incorporating psychological approaches to improve long-term glycaemic control, QoL and psychosocial
functioning in a diverse range of young people.
Design: The study was a pragmatic, cluster randomised control trial with integral process and
economic evaluation.
Setting: Twenty-eight paediatric diabetes services across London, south-east England and the Midlands.
Randomisation: Minimised by clinic size, age (paediatric or adolescent) and specialisation (district general
hospital clinic or teaching hospital/tertiary clinic).
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Allocation: Half of the sites were randomised to the intervention arm and half to the control arm.
Allocation was concealed until after clinics had consented and the ﬁrst participant was recruited.
Where possible, families were blind to allocation until recruitment ﬁnished.
Participants: Forty-three health-care practitioners (14 teams) were trained in the intervention. The study
recruited 362 children aged 8–16 years, diagnosed with T1D for > 12 months, with a mean 12-month
HbA1c level of ≥ 8.5%.
Intervention: Two 1-day workshops taught intervention delivery. A detailed manual and resources were
provided. The intervention consists of four group education sessions led by a paediatric diabetes specialist
nurse with another team member.
Outcomes: The primary outcome was glycaemic control, assessed at the individual level using venous
HbA1c values, measured at baseline, 12 and 24 months. Secondary outcomes were directly and indirectly
related to diabetes management, including hypoglycaemic episodes, hospital admissions, diabetes
regimen, knowledge, skills and responsibility for diabetes management, intervention compliance, clinic
utilisation, emotional and behavioural adjustment, and general and diabetes-speciﬁc QoL.
Process evaluation: Questionnaires, semistructured interviews, informal discussion following observation
sessions, ﬁeldwork notes and case note review were used to collect qualitative and quantitative data from
key stakeholder groups at speciﬁc time points in the trial.
Statistical analyses: Primary and secondary analyses were intention-to-treat comparisons of outcomes at
12 and 24 months, using analysis of covariance with a random effect for clinic. Prespeciﬁed subgroup
analyses based on age, gender, initial HbA1c value and socioeconomic status were estimated from models
that included an interaction term. The economic analysis compared long-term costs and predicted
quality-adjusted life-years (QALYs).
Results: The intervention did not improve HbA1c at 12 months [intervention effect 0.11; 95% conﬁdence
interval (CI) −0.28 to 0.50; p = 0.584] or 24 months (intervention effect 0.03; 95% CI −0.36 to 0.41;
p = 0.891). A total of 298/362 patients (82.3%) provided blood samples at 12-month follow-up, and
284/362 (78.5%) provided blood samples at 24-month follow-up. Follow-up questionnaires were
completed by 307 patients (85.3%) at 12 months and by 295 patients (81.5%) at 24 months. Intervention
group parents at 12 months (95% CI 0.74; 0.03 to 1.52) and young people at 24 months (0.85; 95% CI
0.03 to 1.61) had higher scores on the diabetes family responsibility questionnaire. Young people reported
reduced happiness with body weight at 12 months (−0.56; 95% CI −1.03 to −0.06). Only 68% of groups
were run. Of the 180 families recruited, 96 (53%) attended at least one module. Reasons for low uptake
included difﬁculties organising groups, and work and school commitments. Young people with higher
HbA1c levels were less likely to attend. Parents and young people who attended groups described
improved family relationships, improved knowledge and understanding, greater conﬁdence and increased
motivation to manage diabetes. Twenty-four months after the intervention, nearly half of the young
people reported that the groups had made them want to try harder and that they had carried on trying.
A high-quality, complex, pragmatic trial of structured education can be delivered alongside standard care
in NHS diabetes clinics. Health-care providers beneﬁted from behaviour change skill training and can
deliver pragmatic aspects of a National Institute for Health and Care Excellence (NICE)-compliant structured
education programme after relatively brief training. The process evaluation provides insight into aspects of
the model, and highlights strengths and aspects that may have contributed to the failure to inﬂuence
primary and secondary outcomes. Current NHS practice dominates CASCADE (Child and Adolescent
Structured Competencies Approach to Diabetes Education) in that it achieves the same number of QALYs
at a lower cost. The mean cost of providing the intervention was £5098 per site or £683 per child.
Members of paediatric diabetes services trained to deliver the CASCADE structured education package
using behaviour change techniques did not improve glycaemic control in patients compared with control
subjects 1 and 2 years after the intervention. The training workshops for practitioners were well evaluated;
however, more intensive training was needed. The intervention cost £683 per patient but was not
cost-effective because it did not improve metabolic control.
ABSTRACT
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Conclusions: A high-quality, complex, pragmatic trial of structured education can be successfully
conducted alongside standard care in NHS diabetes clinics. Pragmatic components of a NICE-compliant
structured education programme can be successfully delivered following a relatively brief 2-day training
while paediatric health-care professionals beneﬁt from training in behaviour change skills. The study
provides invaluable information on barriers and opportunities regarding future, similar interventions. A low
dropout rate and good attendance for the subgroup that attended the intervention suggests there might
be improved uptake if offered to young people with lower HbA1c. Testing whether this approach can be
more successful with a robust ongoing supervisory element should be a target of further research.
Trial registration: Current Controlled Trials ISRCTN52537669.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be
published in full in Health Technology Assessment; Vol. 18, No. 20. See the NIHR Journals Library website
for further project information.
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Scientiﬁc summary
Background
Type 1 diabetes (T1D) in children and young people is increasing worldwide, with a particular increase in
children aged < 5 years. Effective glycaemic control requires a careful balancing act between insulin, food
and physical activity. Intensive regimens offer the best possible control; however, they are oppressive for
children, young people and families. Fewer than one in six children and young people achieve glycosylated
fraction of haemoglobin (HbA1c) values in the range identiﬁed as providing best future outcomes.
One-third have a HbA1c value that puts them at signiﬁcant risk for development of long-term
complications. Moderate evidence supports the effectiveness of psychological interventions; however, only
20% of UK paediatric diabetes services have adequate access to psychological services.
There is an urgent need for clinic-based pragmatic, feasible and effective interventions that improve both
glycaemic control and quality of life (QoL). The intervention was designed to respond to policy goals and
addresses strengths and weaknesses of other approaches. The intervention offers both structured
education, to ensure young people know what they need to know, and a delivery model designed
to motivate self-management.
Objectives
To assess the:
1. feasibility of providing a structured psychoeducational programme in a standard clinic setting for
a diverse range of young people
2. effects on long-term glycaemic control
3. impact on diabetes-speciﬁc QoL using self-report and parental measures of QoL
4. impact on psychosocial functioning including (1) emotional and behavioural adjustment of children
and young people; (2) family functioning; and (3) self-management, decision-making and self-efﬁcacy
5. cost-effectiveness.
Methods
The study was a pragmatic, cluster randomised controlled trial (RCT) with integral process and economic
evaluation in 28 sites with paediatric/adolescent diabetes clinics across London, south-east (SE) England
and the Midlands.
Clinics that were eligible to participate were staffed by at least one paediatrician and paediatric nurse with
an interest in diabetes not running a group education programme at time of recruitment and had not
taken part in a similar paediatric diabetes trial within the last 12 months. The study recruited 362 children
aged 8–16 years, diagnosed with T1D for > 12 months, with a mean 12-month HbA1c value of
≥ 8.5 mmol/l who had not taken part in a similar paediatric diabetes trial within the last 12 months.
Children were excluded if they had a comorbid chronic illness that was likely to impact on HbA1c level,
were in receipt of ongoing psychiatric/psychological therapy, or had a signiﬁcant learning disability or
insufﬁcient command of English to enable participation.
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The intervention is a structured education programme using psychological approaches to increase
engagement and enhance behaviour change in children, young people and families. It was designed to
be delivered by diabetes multidisciplinary teams as part of routine care.
Randomisation
Allocation was based on clusters (paediatric diabetes services), with half randomised to the intervention
and half to the control arm. Randomisation was minimised by factors that were likely to inﬂuence clinic
mean HbA1c value, such as age of clinic population (paediatric or adolescent) and clinic specialisation
(district general hospital clinic or teaching hospital/tertiary clinic). Clinic size was added as a minimisation
factor to balance numbers between arms. Allocation was concealed until after clinics had consented and
a ﬁrst participant was recruited to minimise selection biases at entry of clusters to the trial. Where possible,
young people and families were blind to allocation until recruitment ﬁnished.
Outcomes
Primary outcome
The primary trial outcome was glycaemic control, assessed at the individual level using venous HbA1c level,
measured at baseline, 12 and 24 months. All samples were sent to a single UK laboratory for
measurement of HbA1c level, which was blind to participant allocation.
Secondary outcomes
Secondary outcomes were directly and indirectly related to diabetes management, including
hypoglycaemic episodes and hospital admissions, diabetes regimen, knowledge and skills associated with
diabetes management, responsibility for diabetes management, compliance with intervention and clinic
utilisation, emotional and behavioural adjustment, and general and diabetes-speciﬁc QoL. Service users
commented on the structure and content of questionnaires created for 8- to 12-year-olds, 13- to
16-year-olds, patients using injections, patients on pumps and carers.
Follow-up data were collected 12 and 24 months after the baseline blood sample.
Process evaluation
A mixed-methods approach was used in the integral process evaluation (PE). Speciﬁc aims of the PE were
to (1) report on the feasibility and acceptability of organising and delivering groups for both staff and
families; (2) assess quality and ﬁdelity of training workshops and satisfaction for trained staff; (3) describe
parent/carer and young people’s perceptions of impact of participation in the intervention on themselves
and their families, and views of staff regarding the impact on young people and their own practice; and
(4) describe NHS paediatric/adolescent diabetes service standard care delivered across control and
intervention sites. Questionnaires, semistructured interviews, informal discussion following observation
sessions, ﬁeldwork notes and case note review were used to collect qualitative and quantitative data from
key stakeholder groups (University College London Hospitals trainers, site staff, young people and parents)
at speciﬁc time points in the trial.
Statistical analyses
Primary and secondary analyses were intention-to-treat comparisons of outcomes at 12 and 24 months,
using analysis of covariance with a random effect for clinic to allow for clustering at that level. For skewed
data 95% conﬁdence intervals (CIs) were estimated using 2000 bootstrap samples. For binary outcomes,
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logistic regression was used to estimate the effect of the intervention. Prespeciﬁed subgroup analyses
based on age, gender, initial HbA1c value and socioeconomic status were estimated from models that
included an interaction term. A per-protocol analysis of all primary and secondary outcomes was carried
out with the same statistical analysis techniques used as for the intent-to-treat analysis.
Economic analysis
The economic analysis estimated the cost of the intervention, and compared long-term costs and
quality-adjusted life-years (QALYs) predicted for patients receiving routine NHS care with those for patients
receiving the educational intervention.
Intervention and training
The intervention consists of four modules led by a Paediatric Diabetes Specialist Nurse with an additional
member of the diabetes team. The intervention uses a group education approach, with three to four
families per group.
Two 1-day workshops taught delivery of the structured education programme. A detailed intervention
manual and resources were provided. It was anticipated that training would increase daily use of
behaviour change techniques and improve communication in health-care encounters with patients, as well
as greater consideration of emotional and physical needs of young people and the social constraints of
family life. The cost of the intervention included the cost of training the intervention teams.
Results
The intervention did not improve HbA1c at 12 months (intervention effect 0.11; 95% CI −0.28 to 0.50;
p = 0.584) or 24 months (intervention effect 0.03; 95% CI −0.36 to 0.41; p = 0.891). In total, 298 out of
362 patients (82.3%) provided blood samples at 12-month follow-up, and 284 out of 362 (78.5%) at
24-month follow-up. A total of 307 patients (85.3%) completed follow-up questionnaires at 12 months
and 295 (81.5%) at 24 months. Intervention group parents at 12 months (0.74; 95% CI 0.03 to 1.52) and
young people at 24 months (0.85; 95% CI 0.03 to 1.61) have higher scores on the diabetes family
responsibility questionnaire. Young people in the intervention group report reduced happiness in body
weight at 12 months (−0.56; 95% CI −1.03 to −0.06).
Only 68% of possible groups were run. Of the 180 families recruited, 96 (53%) attended at least one
module. Reasons for low uptake included difﬁculties organising groups and work and school
commitments. Young people with the highest HbA1c levels were less likely to attend. Parents and young
people who attended groups described improved family relationships, improved knowledge and
understanding, greater conﬁdence and increased motivation to manage diabetes. Twenty-four months
after the intervention nearly half of the young people reported that the groups had made them want to
try harder and that they had carried on trying.
A high-quality, complex, pragmatic trial of structured education can be delivered alongside standard
care in NHS diabetes clinics. Health-care providers beneﬁted from behaviour change skill training and can
deliver pragmatic aspects of a National Institute for Health and Care Excellence (NICE)-compliant structured
education programme after relatively brief training. The PE provides insight into aspects of the model
and highlights strengths and aspects that may have contributed to the failure to inﬂuence primary and
secondary outcomes. Current NHS practice dominates CASCADE (Child and Adolescent Structured
Competencies Approach to Diabetes Education), in that it achieves the same number of QALYs at a
lower cost. The mean cost of providing the intervention was £5098 per site or £683 per child.
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The CASCADE study shows that a high-quality, complex, pragmatic trial of structured education can be
successfully conducted alongside standard care in NHS diabetes clinics. We were able to recruit teams and
patients from clinical services reﬂecting a wide range of philosophies and research experience throughout
London, SE England and the Midlands. The pragmatic components of a NICE-compliant structured
education programme can be successfully delivered following a relatively brief two-day training workshop
whilst paediatric health-care professionals beneﬁt from training in behaviour change skills. The intervention
has been evaluated in ‘real-life’ and representative settings, and provides invaluable information on barriers
and opportunities regarding future, similar interventions. A low dropout rate and good attendance for the
subgroup that attended the intervention, as well as reported impact by this group, strengthens the
ﬁndings of the study, but, however, suggests there might be improved uptake if offered to young people
with lower HbA1c. Understanding why 37% chose not to attend is another important area. Testing
whether or not this approach can be more successful with a robust ongoing supervisory element should be
a target of further research.
Trial registration
This trial is registered as ISRCTN52537669.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction to CASCADE
Type 1 diabetes
Type 1 diabetes (T1D) is one of the most common chronic conditions of childhood and adolescence.
Treatment is a taxing regimen of daily insulin therapy, blood glucose (BG) self-monitoring, controlling and
calculating carbohydrate (CHO) intake and matching insulin to CHO, together with careful exercise
management. Insulin replacement therapy easily controls hyperglycaemia and ketoacidosis, but the main
treatment issue is supporting self-management by families and young people to maximise normality of BG
and quality of life (QoL), preventing long-term complications.
Epidemiology of type 1 diabetes
There is a signiﬁcant increase in the number of children and young people diagnosed with T1D and other
variants of diabetes. The current prevalence of T1D in the UK is 1 per 700–1000 children, yielding a total
population of over 29,000.1 Peak age for diagnosis is between 10 and 14 years of age.2
Diagnosis in the under-ﬁves has risen relentlessly over the last 10–15 years. The reason for this is not clear.
Changing incidence rates of childhood obesity have been suggested (‘The Accelerator Hypothesis’), with
little to support this other than observational studies.3 Young children have lower insulin needs and
unpredictable food intake, and are poorly served by conventional multiple injection therapies. The UK
National Institute for Health and Care Excellence (NICE) recommends insulin pump therapy at diagnosis for
management of this age group to avoid persistent hyperglycaemia and inadvertent hypoglycaemia, which
may be detrimental to the developing brain.4
Type 1 diabetes is a major health burden for the individual and society. Early onset in children is associated
with an increased risk of developing complications in their 30–40s, and the estimated cost of care and lost
earnings in the USA has been estimated to escalate from teenage years to 60 years of age. T1D is also
associated with a high mortality, both at diagnosis and especially in the critical period of transition to
adult services.
Monitoring of glycaemic control
Avoiding hyperglycaemia and hypoglycaemia requires BG monitoring using two modalities. The ﬁrst
is regular self-monitoring of current BG, ideally six or more times a day. Greater frequency of BG
self-monitoring is associated with better glycaemic control. Regular monitoring allows correction of high
or low BG into the normal range (4–7 mmol/l), and aids accurate dosing of insulin for CHO intake with
meals and snacks. Potentially painful ﬁnger-pricks needed for BG measurement are a signiﬁcant
disincentive to frequent testing for many and may impair QoL.
The second is assessment of long-term glycaemic exposure by measuring the glycosylated fraction of
haemoglobin (HbA1c). This estimates the exposure of red cells to glucose in the bloodstream over a 8- to
12-week period. The recommended target for prevention of long-term complications is a HbA1c value of
< 7.5% (< 58mmol/mol). In the UK National Paediatric Diabetes Audit (NPDA), < 16% of children and
adolescents reached this target.5
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Short-term complications
Diabetic ketoacidosis
In T1D, diabetic ketoacidosis (DKA) results from either insufﬁcient insulin or lack of insulin efﬁcacy
(e.g. during intercurrent illness). DKA carries a signiﬁcant mortality rate (0.2%), largely from cerebral
oedema and hypokalaemia. DKA is often present at diagnosis. Approximately 25% of all newly diagnosed
children are admitted in DKA at diagnosis (35% in those of < 5 years).6,7
Hypoglycaemia
The most common short-term complication of T1D is low BG (hypoglycaemia). Hypoglycaemia is a result
of an imbalance of insulin to both ingested CHO and the current BG level. Hypoglycaemia (BG level of
< 4.0 mmol/l) initially causes symptoms associated with activation of the sympathetic nervous system
(i.e. adrenaline release). Severe hypoglycaemia (BG level of < 2.5 mmol/l) results in insufﬁcient glucose for
neuronal activity (neuroglycopenia), resulting in impaired consciousness, bizarre behaviour, seizures,
coma and death. Persistent or frequent recurrent hypoglycaemia may impact on short- and long-term
neurocognitive functioning.8
Consequences of long-term hyperglycaemia
Microvascular and macrovascular disease due to persistent exposure to excess glycaemia reduces life
expectancy (on average by 23 years in people with T1D).9 Microvascular complications may present within
5–10 years post diagnosis and are frequently seen in adolescence and early adulthood, and include
signiﬁcant visual loss, chronic renal failure and dialysis, and autonomic symptoms that include impaired
peripheral sensation, pain, and gastrointestinal and genitourinary problems. The International Society for
Paediatric and Adolescent Diabetes (ISPAD) recommend screening for retinopathy (by retinal review) and
microalbuminuria (through urine albumin–creatinine ratio) at 11 years (with 2 years’ diabetes duration),
at 9 years (with 5 years’ duration) and after 2 years’ duration in adolescence.10
Macrovascular disease presents later in adult life with problems including heart attacks, strokes and lower
limb problems including ulcers and gangrenous extremities requiring amputation. High glucose variability,
i.e. rapid alternation of hyper-, normo- and hypoglycaemia, may independently increase risk of
cardiovascular end points, although this remains controversial.11
Suboptimal BG control through childhood and adolescence is a signiﬁcant risk factor for complications in
later adult life.12 Key outcome studies [e.g. Diabetes Control and Complications Trial (DCCT)] have
demonstrated improved diabetes control in childhood (or later improved control) can reduce the incidence
and progression of microvascular complications.13,14
The relationship between HbA1c and relative risk of developing eye, kidney and nerve problems is not
linear. Small changes from very poor to reasonable control (e.g. 12–9%) reduces risk ﬁvefold but does not
reduce it to the population background. Only moving towards near-normal values of HbA1c will effectively
reduce the risk in T1D to that of the general population.
Chronic hyperglycaemia leads to persistent glucose wasting in the urine, resulting in calorie insufﬁciency,
poor or absent weight gain, and thus poor growth and pubertal delay. Optimising adherence to insulin
therapy can reverse this.
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Common comorbid conditions
The most common conditions comorbid with T1D are autoimmune conditions. These include thyroid
disease (most commonly primary hypothyroidism), adrenal hypofunction (Addison’s disease) and coeliac
disease, although other autoimmune conditions, such as cystic ﬁbrosis, are described in association
with diabetes.
Management of type 1 diabetes in children and adolescents
The goals of diabetes management are adequate glycaemic control while maintaining high QoL. Studies
from the 1990s onwards have made it clear that tight glycaemic control is important to attain and
maintain from the point of diagnosis.14
The basic principle of insulin replacement therapy is to mimic the normal physiology of insulin secretion by:
1. Ensuring that there is always insulin around in the background throughout the 24-hour period. At night
this is essential to switch off hepatic glucose production.
2. Deliver a bolus of insulin in a dose-dependent manner for whatever amount of CHO is consumed.
3. Bring any BG that is high or low back into target range.
4. Insulin can be delivered through multiple daily injections (MDIs) or through constant subcutaneous
infusion of insulin. Intensive regimens are considered best practice and in many centres are commenced
at diagnosis.
5. As regimens become more ‘physiological’, so too do requirements for adherence to achieve the best
levels of glycaemic control.
Technological approaches
Advancing technologies such as the artiﬁcial pancreas are providing promising results in adults with
diabetes.15 Technological advances underpin increasingly sophisticated insulin delivery and self-monitoring
devices.15,16 Recent reviews report a wide range of current options.17–22 Individual and group
technology-based interventions include digital devices, video games, online chat rooms and social
networks designed to engage, motivate, support and inform young people, although effect on glycaemic
control remains modest.23–30
The multidisciplinary team
Safe and effective diabetes care for children and young people requires a well-resourced multidisciplinary
team (MDT) competent in integrating clinical, educational, dietetic, lifestyle, mental health and foot care
aspects of diabetes.31
Intensiﬁcation of treatment supported by the MDT can produce dramatic improvements in HbA1c. Poor
control is common when children are asked to take responsibility for self-care without sufﬁcient cognitive
and social maturity.32 Involving families,33 supporting parental monitoring34 and facilitating shared
responsibility for disease management contribute to good glycaemic control and adherence. The challenge
is to ﬁnd patient-centred models of care that can be implemented in clinics and create similar
improvements in HbA1c level to those achieved in the DCCT, with subsequent reductions in the
development of diabetes-related complications.
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Psychosocial aspects of diabetes
Adolescence disrupts the precarious balance managing diet, activity and insulin.35 There is an increased risk
of depression, anxiety, disordered eating, disrupted body image, adverse effects on behaviour and
increases in suicidal thoughts in this age group. Depression is associated with both poor glycaemic control
and low regimen adherence.36–44 Other outcomes include increased vigilance by parents and diabetes
teams and family conﬂict. Given the signiﬁcant number of young people who have unique needs as
a consequence of this particular developmental stage, training in adolescent health and medicine is
increasingly important.
Reactions to a diagnosis of diabetes
Initial reaction to a diagnosis of diabetes can be devastating. A loss of spontaneity and restrictions on
activities create a sense that things will never be the same.45 Adjustment improves with time after
diagnosis. However, parents were clear that they never fully ‘accept’ the diagnosis.46,47 Episodes of grief
are described 7 years post diagnosis triggered by regimen changes, injections, hospitalisation, discussions
about diabetes control and worry about complications, attending clinics and meeting new medical
teams – reminding them that their child is different.48
Parents worry over the long term, uncertainty about the future, medical procedures and ﬁnance. Loss of
pay and costs of travelling to appointments creates additional stress.45 For some, balancing a career and
managing the complexities and demands of a child’s treatment regimen becomes untenable.
Adherence to the treatment regimen
Adherence is a common problem in adolescents in general.49,50 Although adherence to different
components of the regimen may be unrelated to each other,51 insulin omission is common in adolescent
girls who are concerned with body weight issues.52–56 Failure to monitor BG or adjust insulin is also
common.57 Demographic, psychosocial and health-care system factors all inﬂuence adherence. Poorer
adherence is reported in children and adolescents with T1D from ethnic minority backgrounds, of low
socioeconomic status (SES) and from single-parent families.58 Adolescence is also a risk factor for low
adherence and poor glycaemic control. This is related to the effects of diabetes on major developmental
changes that occur in adolescence and include hormonal changes associated with puberty, resulting in
decreased insulin sensitivity negatively affecting BG metabolism, leading to increases in BG levels.59
Alongside these physical factors, self-management, increasing independence, emerging sexuality and
increased stress from peer and academic pressures are all associated with deteriorating glycaemic control
in adolescence.60
Healthier family functioning just after diagnosis and greater family support are associated with better
adherence over time.61–63 Good family communication patterns,64 low family conﬂict65,66 and good
problem-solving67 are also associated with better adherence. Frustration and guilt at failure to achieve
optimal outcomes can be exacerbated by existing psychological issues within families.
Psychosocial variables
High self-esteem, appropriate health beliefs (e.g. perceived threat of diabetes low and perceived beneﬁts
to cost ratio high)68–70 and the ability to cope with the stress of negative life events (ranging from a new
diagnosis to daily hassles) predict better adherence.58,71 Peer support is positively related to adherence,
particularly for dietary and exercise behaviours.72 However, pressure to conform to social situations and
be accepted by peers is related to decreased glucose monitoring.49,73,74 Young people who see themselves
as having little internal control over their health and who attribute negative events to external sources
(i.e. out of their control) have lower adherence.75
When young people identify other people’s reactions to their self-care as negative, they are also more
likely to have adherence difﬁculties.72,76,77 Maladaptive coping, such as risk behaviours or withdrawal from
family or peer interaction, is associated with poor adherence.78,79
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Psychological and psychoeducational interventions
Person-centred therapies, motivational interviewing (MI), positive reinforcement behavioural contracts,
negotiation of diabetes management goals and training in communication, coping and collaborative
problem-solving skills are potential approaches to decreasing psychological distress and improving
glycaemic control and QoL.
Managing the demands of a diabetes regimen
Stress management programmes using cognitive-restructuring and problem-solving strategies have limited
impact.80,81 In contrast, individual and group interventions focusing on peer group support,
problem-solving and coping skills impact on short-term glycaemic control, showing positive effects on
adherence including improved self-perception and increased knowledge about diabetes and decreases in
diabetes-related conﬂict.82,83 A problem-solving skills programme improved BG monitoring but failed to
show improvements in problem-solving or HbA1c level.84 In contrast, social problem-solving, social skills
training, cognitive–behaviour techniques and conﬂict resolution skills for children transferring to
intensive diabetes regimens reported improvement in glycaemic control and QoL, maintained at 1-year
follow-up.85–87 The groups did not affect adverse outcomes of hypoglycaemia, DKA or weight gain in
boys but decreased the incidence of weight gain and hypoglycaemia in girls.
Diabetes summer camps offering peer interaction, sports and recreational activities alongside diabetes
self-management training are highly evaluated; however, only show short-term changes in
self-management and knowledge and fail to demonstrate lasting improvements in HbA1c level without
ongoing support.88,89
Focusing on psychological therapies
The effectiveness of psychological and psychoeducational interventions to improve adherence, glycaemic
control, psychosocial functioning and QoL is debated, not only in T1D,90,91 but also in paediatric chronic
illness in general.92 Systematic reviews offer limited evidence that psychological interventions in children
and young people with diabetes improve adherence and glycaemic control, with small to medium effects
on physical and psychosocial outcomes.91,93 Interventions that result in modest improvements focus on
increasing knowledge/skills, addressing speciﬁc psychosocial issues and addressing self-management
behaviours, but are often not sustained. Continuous support delivered by a diabetes MDT may be equally
as important as short-term interventions. DeWit et al.94,95 reported that asking young people about QoL
during clinic visits improved QoL and satisfaction with care but had no effect on glycaemic control.
A recent meta-analysis of 15 randomised controlled trials (RCTs) of adherence interventions in 997
adolescents with T1D found a mean effect size of 0.11 (95% CI −0.01 to 0.23).96 Modest improvements
in glycaemic control were found in interventions that included emotional, social or family targets in
addition to speciﬁc behavioural goals.96 Interventions are most likely to be effective if they help the
adolescent connect the many different aspects of diabetes management with all aspects of daily living.97
Family interventions
Because of the complexity of diabetes management and the importance of family involvement and
support, most interventions include a family component. In a review of family interventions, a positive
effect was reported in 5 out of 19 studies, suggesting that family interventions may improve
diabetes-related knowledge and glycaemic control.98 A teamwork intervention increased family
involvement and prevented an expected deterioration in glycaemic control.98,99 However, the quality of
family relationships may not be causally related to adherence, therefore decreasing family conﬂict and
improving parent–child relationships alone may not result in improved adherence or glycaemic control.
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Multisystemic therapy and an intensive home and community family intervention, incorporating
developmentally appropriate negotiated responsibility,100 signiﬁcantly improved adherence to BG testing,
improved glycaemic control and decreased the number of inpatient admissions.101,102
Behavioural family systems therapy (BFST) was developed for families of adolescents with clinically
signiﬁcant conduct-related problems.103 The intervention includes cognitive restructuring of irrational
beliefs and targets problematic family characteristics, family communication and problem-solving. Initial
adaptations for children and families with diabetes addressed general developmental issues, such as
managing curfews, chores and focused less on diabetes treatment-related treatment adherence or
management.104–106 BFST enhanced family communication, improved parent–adolescent relations, reduced
behaviour problems and general and diabetes-related family conﬂict.104–108 The effects on psychological
adjustment depended on the adolescent’s age and gender but overall there was little effect on adjustment
to diabetes or diabetic control.104,105
A revised Behavioural Family Systems Therapy–Diabetes integrated empirically supported intervention
strategies focusing on speciﬁc behaviours, as well as the social context of diabetes
treatment-related behaviour including:
(a) targeting at least two or more diabetes problems
(b) behavioural contracting109
(c) self-monitoring BG82,110
(d) parental simulation of living with diabetes100
(e) involving peers, siblings, and teachers, and running sessions in different locations.
Family conﬂict decreased as well as improvements in adherence. HbA1c level was signiﬁcantly reduced,
particularly among adolescents with poor metabolic control. Change in treatment adherence correlated
signiﬁcantly with change in HbA1c level at each follow-up.105,106,111
These approaches show encouraging results; however, they are resource-intensive, requiring highly skilled
practitioners who are able to travel into the family home. Although effective, this strategy is unlikely to be
incorporated into UK clinical practice until shown to be clearly cost-effective.
Cognitive–behavioural therapy
Cognitive–behavioural therapy (CBT) can be delivered only by trained practitioners and usually requires
6–12 sessions. The client connects thoughts, feelings and behaviours. This requires a degree of
engagement and participation that is often missing in adolescents. Although effective, standardised
interventions for behaviour problems or depression in adolescents are available, no studies have targeted
speciﬁc psychological disorders in adolescents with diabetes. A review found that the majority of studies
used non-standardised approaches.112
Motivational interviewing
Motivational interviewing is a person-centred therapy that works to resolve ambivalence about behaviour
change. It creates a shared agenda, inviting the client to identify his/her goal (e.g. young people may say
they want to talk about problems at school, whereas parents may want to talk about blood tests). The
clinician negotiates how to explore these issues during the consultation. MI invites the client to be in
charge of making changes, and looks for statements about intention to change and optimism about the
future. The client identiﬁes importance of change, conﬁdence in their ability to change and when change
will be a priority.
Motivational interviewing in paediatric populations has been increasingly explored.113–115 Early work
demonstrated the potential of MI to decrease harm-reduction behaviours in relation to alcohol and
polysubstance use.113,114 A review of nine RCTs in health-related domains, including diabetes, reported
seven with positive ﬁndings on the effectiveness of MI. All RCTs that speciﬁcally addressed T1D related to
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the adolescent age group.113,114,116 Two studies using MI alone117,118 found a signiﬁcant reduction in HbA1c
level, reduced fear of hypoglycaemia, and improved QoL and positive well-being. MI combined with other
therapeutic approaches, such as dietary advice or CBT, has reported reductions in HbA1c level, a greater
sense of control, improved perceptions of diabetes and improved self-esteem.119–121
Attempts to incorporate MI into other formats, for example a six-session ‘personal trainer’ intervention
delivered by non-clinical practitioners,122 have shown promising results, lowering HbA1c levels in
older teenagers.
One response to the scarcity of mental health resources in the UK has been to ‘skill up’ staff and introduce
components of successful interventions into routine consultations. MI122,123 and other brief therapy
approaches have the potential to offer diabetes teams ways to communicate with young people and
encourage greater self-management.124,125 However, a recent study that attempted to deliver MI
components as part of routine consultations proved challenging to implement and had no impact
on either HbA1c level or psychosocial measures.123–125
Solution-focused brief therapy
Solution-focused brief therapy (SFBT) relies on the clinician noticing what works successfully during
conversations and doing more of this.124 SFBT assumes the clients are the expert in their own situation
and invites them to describe their preferred future and focus on what is already working. This creates
opportunities to notice small changes and identify what makes this possible.126 The clinician does not
attempt to ﬁnd the cause or ‘take the problem away’. The clinician and family work collaboratively to ﬁnd
already existing solutions to manage injections, ﬁnger-pricks or eating difﬁculties. They work together to
stop diabetes getting in the way of family communication and ﬁnd ways to manage sadness or anger.
The family takes the lead in relation to ‘non-adherence’, focusing on what is working for them.
Solution-focused brief therapy is an effective approach for most, including those with severe and
chronic problems.127 The latest outcome evaluation research128 reviewed 109 SFBT studies including
two meta-analyses and 19 RCTS. Nine RCTs found that SFBT has a greater effect than other approaches,
for example CBT. Of the comparison studies, 34 out of 43 favoured SFBT. Solution-focused practice
has been recommended within clinical practice guidelines.120,129,130 SFBT combined with MI has been
successfully integrated into diabetes clinical service,124 reducing HbA1c level in children and adolescents.121
Solution-focused conversations create a different experience for families. Young people who have been
blamed or criticised and described as non-adherent or manipulative ‘grow visibly taller in their chair’ given
the opportunity to talk about their strengths and abilities and describe positive steps they are already
taking to get their lives back on track.
This approach is increasingly relevant to the management of long-term chronic illness and models of
empowerment. Nurses trained in SFBT showed positive changes in their practice and improved
willingness to communicate with troubled people.124,131 Changes to practice centred on the rejection
of problem-orientated discourses and reduced feelings of inadequacy and emotional stress.
SFBT techniques may be relevant to nursing and a useful, cost-effective approach to the training of
communication skills . . . provides a framework and easily understood tool-kit that are harmonious
with nursing values.
Bowles, Mackintosh and Torn131
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Case management/educational approaches
Other interventions have focused on case management and/or diabetes education. Enhanced case
management increased the frequency of clinic visits, reduced hypoglycaemia and hospital admissions and
improved glycaemic control in ‘high-risk’ youths.132 Education and telephone case management has
improved adherence and self-efﬁcacy but with little inﬂuence on HbA1c level.133,134 The NICE Health
Technology Appraisal on patient education models (http://publications.nice.org.uk/guidance-on-the-use-of-
patient-education-models-for-diabetes-ta60) and National Diabetes Support Team (NDST) identiﬁed a lack
of nationally evaluated paediatric education programmes.135 Very few, if any, paediatric clinics in the UK
offer an evaluated structured education programme as part of routine clinical care.4
In the last 5 years, a number of studies were initiated to tackle this issue. Programmes vary in
methodology, style of intervention and number of patients recruited. Appendix 1 describes details of the
most recent nine trials. All have failed to show positive change in glycaemic control.136–138
The CASCADE study
The Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE)
intervention is a competency-driven, motivational, patient-centred structured intensive psychoeducational
programme designed to improve diabetic control, self-management and QoL in children and adolescents.
Intervention content and development are described in Chapter 2. CASCADE is a complex intervention
developed using the Medical Research Council (MRC) complex intervention evaluation framework.139
We have already conducted the Phase I study [Modelling – deﬁning components of the intervention and
Phase II study (Exploratory Trial Phase)]. The present study is a multicentre cluster RCT with integral process
and economic evaluation to investigate the effectiveness of CASCADE.
Research objectives
To:
1. assess the feasibility of the CASCADE intervention within a standard clinic setting for a diverse range of
young people
2. investigate the effects on long-term glycaemic control of diabetes
3. evaluate the impact of the intervention on QoL using well-validated and reliable self-report and
parental measures
4. investigate the impact on psychosocial functioning, including (1) emotional and behavioural adjustment
of children and young people; (2) family functioning; and (3) self-management, decision-making
and self-efﬁcacy
5. investigate cost-effectiveness.
Conclusions
Type 1 diabetes in children and young people is increasing worldwide, with a particular increase in those
of < 5 years. Effective glycaemic control requires a careful balancing act between insulin, food and physical
activity. Intensive regimens are best practice, and in many centres these are commenced at diagnosis.
Modern diabetes regimens can be oppressive for children, young people and families. Despite intensive
regimens offering the best possible control, fewer than one in six children and young people achieve
HbA1c values in the range identiﬁed as providing best future outcomes. One-third of all children with
T1D in the UK are at signiﬁcant risk for developing long-term complications. The challenge of how to
address non-adherence is signiﬁcant. Evidence to support one approach over another remains limited.
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Moderate evidence supports the effectiveness of psychological interventions in improving adherence.
However, only 20% of children and adolescent services in the UK report adequate access to
psychological services.140
There is an urgent need for pragmatic, feasible and effective structured education programmes that are
deliverable within clinics to targeted groups, which improve both glycaemic control and QoL. CASCADE
was designed to respond to policy goals addressing strengths and weaknesses of other approaches.
The aim was to reﬁne and test the effectiveness of a pragmatic intervention delivered by trained
educators. The intervention offers both structured education – to ensure that young people know what
they need to know – and a delivery model designed to motivate self-management through empowerment
techniques. The next chapter discusses the background to the development of structured education
approaches and the CASCADE intervention.
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Chapter 2 The development of the CASCADE
intervention
Introduction
The CASCADE intervention is a manual-based structured education programme incorporating
psychological approaches to increase engagement and enhance behaviour change in children, young
people and families. The intervention has four modules led by a paediatric diabetes specialist nurse (PDSN)
with a minimum of one additional member of the diabetes team.
This chapter outlines:
1. the background to structured education programmes
2. the CASCADE educational approach
3. the CASCADE underpinning philosophy
4. a summary of each CASCADE module
5. the educational theory and key components of the training workshops.
Structured education programmes
There are no effective structured education programmes for children and young people with diabetes in
the UK. Patient-centred care and timely access to specialist education and support form the central pillars
of the Diabetes National Service Framework,141 the NICE guidance for T1D4 and ‘Making Every Young
Person with Diabetes Matter’.142 The NICE Health Technology Appraisal on patient education models
(http://publications.nice.org.uk/guidance-on-the-use-of-patient-education-models-for-diabetes-ta60)
recommends that ‘structured patient education should be made available at the time of initial diagnosis
and then as required on an ongoing basis, based on formal, regular assessment of need’.
At a recent structured education conference only 4 of 38 local structured educational programmes were
paediatric. A number of programmes have recently been evaluated using different methodological
approaches. Each differs in hours of education per patient, time period of the course, number of trained
educators and number of patients taught per year (see Appendix 1).
International guidelines on how to establish, evaluate and improve diabetes education include the
American Diabetes Association143 and ISPAD Consensus Guidelines.144
The NDST guide to commissioning structured education identiﬁes criteria by which to evaluate the
effectiveness of patient education, including (1) quality assurance; (2) developmentally appropriate
educational approaches; (3) a structured curriculum incorporating audit; (4) an underpinning philosophy;
and (5) trained educators.135 Although nationally evaluated structured education programmes exist for
adults [Dose Adjustment For Normal Eating (DAFNE); Diabetes Education and Self Management for
Ongoing and Newly Diagnosed (DESMOND); and Xpert],145–147 no UK paediatric clinics offer structured
education that meets these standards.135
The CASCADE intervention was developed in response to the Health Technology Assessment (HTA) review
of psychoeducational interventions in childhood diabetes.91 The intervention is based on Phase 1 pilot
work and a non-randomised trial delivered by psychologists.121 CASCADE was designed with robust quality
assurance, developmentally appropriate educational approaches, a structured curriculum that incorporates
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an audit programme and most importantly an underpinning philosophy and trained educators. It uses
approaches important in predicting success in improving long-term diabetic control as well as simply
transferring knowledge.
Quality assurance
The programmes DAFNE and DESMOND have developed robust quality assurance processes;145,146
however, no standard template exists for paediatric and adolescent diabetes teams to assess patient
knowledge and skills. The structure of quality assurance is crucial to ensure a rigorous process, with clear,
written standards that can be monitored, regularly reviewed and updated. The quality assurance process
include three main elements:
l A deﬁned programme with clear content, structure, curriculum and underlying philosophy. The training
programme for educators should be included within the quality assurance process.
l Quality assurance tools based on the programme structure, and a set of observable behaviours
required to deliver the programme.
l Internal and external processes to assess delivery and programme organisation.
Educational approach
Developmental level and perceived learning needs
Children of < 12 years use concrete thinking to combine, separate, order and transform objects and
actions. An eight-year-old relies on parents to help test BG, supervise injections or manage hypoglycaemia
at school or out with friends. Educational material and conversations about health care need to be simple,
concrete and involve shared goals with the parent and child.
Adolescents start to develop a sense of identity, increasing their need for independence with a move from
parental to peer inﬂuence. Another change is the beginning of complex thinking processes (formal logical
operations), including abstract thinking (thinking about possibilities), reasoning from known principles
(form own new ideas or questions), the ability to consider many points of view according to varying
criteria (compare or debate ideas or opinions) and the ability to think about the process of thinking.
Adolescence is a transitional time with expectations of increasing responsibility for independent diabetes
self-management.
Age and developmental status are powerful contextual variables that inﬂuence diabetes self-management.
An evolutionary concept analysis identiﬁes three attributes of diabetes self-management in children and
adolescents.148 The ﬁrst is process, which is proactive, ﬂexible, and involves a shift of shared responsibility
between the child and family, and collaboration with health-care providers (HCPs). The second is
performance of simple to complex activities related to the adjustment of regimens, including self-adjustment
of insulin. The third is where children and parents engage in this process to accomplish certain goals.
Successful completion of process, performance and goals are developmentally inﬂuenced.
The CASCADE intervention was designed to be accessible for children and young people between 8 and
16 years. Four modules lasting approximately 120 minutes each are delivered to groups of three to
four families with children and young people aged 8–11 years or 12–16 years over 4 months. Everyone in
the group is included in all discussions, and encouraged to share ideas and thoughts and develop their
own solutions to their goals by evaluating decisions made in the past and think about possibilities
for the future.
Interventions that incorporate parents are generally associated with favourable outcomes.145,146,149–151
Young people are invited to bring parents or signiﬁcant family members to CASCADE unlike other current
structured education courses.137
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Learning methods
Families work in the large group or individual family or peer groups (young people and parents). Delivery
is non-didactic. Families are invited to discuss diabetes information from a position of their own knowledge
and expertise. Their right to choose different behaviours is acknowledged. The literacy level for written
material was age appropriate with additional visual and written information (handouts, charts, diagrams,
ﬂow charts). Children, young people and parents are invited to consider attitudes towards changing
self-care behaviours and complete exercises that look at the pros and cons of changing behaviour and
assess readiness to change. It is more important that the HCP ‘hear and understand what the child has to
say, than the child hears and understands what the healthcare worker is telling them’.152
The CASCADE structured curriculum
Modules were designed to develop conﬁdence managing different aspects of diabetes, including how
to adapt insulin dose, how to eat normally and how to manage exercise and illness. The curriculum
conformed to the agreed core content for education programmes set out by the Diabetes Education
network and Diabetes UK (DUK) (see Appendix 2).
Measuring change using a competencies framework
The aim of patient education is for people with diabetes (or their carers) to improve and put into practice
knowledge and skills with conﬁdence, enabling them to become experts at managing their (or their
child’s) diabetes on a day-to-day basis. HCPs need to collaborate with education specialists to formulate
appropriate and reliable evaluation methods that can be used in addition to measuring changes
in HbA1c.153
The CASCADE modules are informed by an eight-level competency system that assesses skills and
knowledge designed by Children’s Hospital in Los Angeles (Table 1).154
Families must demonstrate a minimum of competency level 5 to start on pump therapy. The assessment,
completed in a clinical interview, in conjunction with insulin pump therapy showed signiﬁcant and
sustained reductions in HbA1c level over a 2-year period.154
TABLE 1 Competency level scale (adapted from Kaufman et al.155)
Competency Level
Safety 1
Basics 2
CHO management 3
Correction doses 4
Daily changes 5
Base dose adjustment 6
Advanced management 7
Maximised control, basal and bolus therapy 8
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The manual
The manual provides a written curriculum. It includes Microsoft PowerPoint 2003, version 11 (Microsoft
Corporation, Redmond, WA, USA) slides from each training session with reading lists and copies of key
reading for each module.
Underpinning philosophy and delivery techniques
Psychological approaches used in CASCADE are MI and SFBT (see Chapter 1). Speciﬁc components
integrated into each module to enhance engagement, develop conﬁdence and motivation are
described below.
Key communication skills
Key skills in motivational conversations are asking open-ended questions, afﬁrming, reﬂective listening and
summarising. Educators use open questions to elicit information and broaden and deepen conversations.
Afﬁrming positive actions and intentions of young people and families focuses on positive outcomes.
Educators use reﬂective listening and simple summaries to show that they are listening.
Identifying skills abilities and strengths
Solution-focused brief therapy assumes that people possess the knowledge and resources they need to
tackle their problems.126 At the beginning of each module, educators invite descriptions of what has gone
well, listening out for examples of skills, abilities and resources. Children, young people and families note
positive change and identify what they are doing differently. The aim is for both educators and families to
have ‘determined curiosity and relentless optimism’.
‘How come?’ and ‘What else?’
Describing examples of when they have been in charge of diabetes since the last session orientates people
towards what is already working and acknowledges when their preferred future is happening. Educators
ask families what they had noticed had worked (‘What else?’) and ask what made the positive changes
possible (‘How come?’).
Focusing on the future
Families imagine themselves in the future having overcome difﬁculties or problems and describe this
problem-free preferred future. Families think about what they will be doing differently, or more, or less of,
and how this will have changed their relationships with friends and family. ‘Stepping into the future’
invites families to identify ‘their’ goal for change.
Scaling
Scaling helps families think about how close they currently are to their preferred future and break this into
small and achievable steps. Scaling reinforces positive change and prevents young people from feeling
stuck when change is difﬁcult to notice. Asking how someone had moved a half or a whole point towards
a goal reinforces a sense of personal agency having taken a step forward (or prevented themselves from
slipping backwards).
Considering the pros and cons of behaviour change
Motivational interviewing assumes that young people and families are, to a greater or lesser extent,
ambivalent about current self-management behaviours and the degree to which they put pre-existing
knowledge into action. The majority of young people with high HbA1c levels will have had many
conversations with diabetes consultants, nurses and dietitians, and possibly psychologists or counsellors.
Uncertainty about implementing change can be expressed across emotional, practical and behavioural
domains. In each module the young person and their parent/carer are invited to identify advantages and
disadvantages of behaviours related to diabetes self-management (e.g. BG monitoring, using different
insulin regimens, correcting for high or low BG) to help the educator understand the young person’s
position and clarify the ‘pros and cons’ of change for the young person.
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Establishing the importance and confidence of change
Importance and conﬁdence are central to exploring the young person’s ambivalence to change.156 Young
people and parents scale (between 0 and 10) importance of change, conﬁdence changing and how ready
they feel they are to do things differently after completing a pros and cons exercise. The family identify
what needs to be different for change to happen. If conﬁdence is low the young person can think how to
build conﬁdence before making changes. If importance is low the group can think about what would need
to happen for change to be more important.
Evocation not education: avoiding giving a choice or answer
The majority of young people with high HbA1c are aware of what they ‘need’ to do but are not willing,
able or ready to put this knowledge into practice. Educators ask if it is ‘OK’ to discuss information about
different topics and invite the group to talk about existing knowledge ﬁrst. These ‘scaffolding’ questions
help individuals discover further information for themselves, or ‘draw it out’.157 Additional learning is a
collaborative effort between individuals and trainers, reducing the sense of an expert imposing knowledge
and moving towards a shared venture. This active rather than passive approach has been shown to be
effective in eliciting behaviour change in other areas.158
The CASCADE modules
The teaching plan includes session activities, objectives, time guides and resources, including key
information essential for the educator, learning objective for the family and brief descriptions of each
activity. Young people and parents completed homework tasks including a post-module quiz, designed to
consolidate information, after each group. The educators encouraged the young person to complete the
quiz with parents who could not attend, facilitating communication of key messages delivered during the
module. The quiz and pre-prepared handouts could be sent to families if they missed a session.
Each module (apart from the ﬁrst) starts with a review of the previous module creating an opportunity to
highlight changes that have taken place and congratulate young people on successes. It also creates an
opportunity to review the previous module for any family who missed the session.
Module 1: the relationship between food, insulin and blood glucose
Readings: (1) educator notes about CHO foods, BG and a healthy diet and (2) ISPAD guidelines on
nutritional management in childhood and adolescent diabetes.159 The introduction identiﬁes strengths,
resources and abilities. Focusing on the future, identify how things will be in the future if families get
what they want from CASCADE. They scale how close they currently are to this. The session focuses on
understanding food groups, particularly CHO. It talks about the role of insulin and different insulin
regimens. Finally, families and young people consider the pros and cons of matching insulin to food to
attain better glycaemic control.
Module 2: blood glucose testing
Readings: Implications of the DCCT13 and assessment and management of hypoglycaemia in children
and adolescents.160
After reviewing module 1, educators discuss the recommended target HbA1c. The group identify factors
that cause BG to rise and fall and explore individual hypoglycaemia deﬁnitions, reviewing symptoms
according to severity. Families discuss ways to treat hypoglycaemia and assess the pros and cons of
BG testing.
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Module 3: adjusting insulin – pros and cons
Reading: insulin analogues in diabetes care,161 using CHO counting162 and guidelines on assessment and
monitoring of glycaemic control.163
Following the review families discuss symptoms of hyperglycaemia and ketones. A brainstorming session
considers when, how and who to contact for help with managing hyperglycaemia. The session focuses on
managing high BG using temporary insulin changes and explains how to correctly calculate correction
doses. The group explores the advantages of identifying trends in relation to permanent insulin dose
changes and considers the advantages and disadvantages of CHO counting as a way of improving
glycaemic control.
Module 4: living with diabetes
Reading: guidelines on exercise164 with a set of PowerPoint slides used in the workshop to explain the
principles of exercise and management of insulin and CHOs.
Following the review, families identify the effect that low and high BG has on performance and
concentration, and discuss effective strategies to bring BG into target range before starting exercise.
Participants work in family groups to identify how different activities affect BG and discuss the timing of
insulin injections in relation to exercise before considering the advantages of using CHO before, during
and after exercise (to keep their BG stable during different exercise).
At the end of module 4, young people and families complete a ‘blueprint for success’. This marks the end
of the sessions and acknowledges the steps into the future the young person has already made. It creates
an opportunity to review the programme and strengthens long-term motivation to change by reviewing
previous successful goals.
Trained educators
The Department of Health and DUK have both highlighted the importance of structured training for
educators involved in delivering patient education. Members of UK paediatric and adolescent diabetes
teams have a varying amount of training in relation to age-speciﬁc and developmental milestones for
children and adolescents with no current consensus regarding uniformity of roles and qualiﬁcations for
different members of teams delivering structured education.
Each diabetes team in the CASCADE intervention arm identiﬁed two primary site educators, one of whom
had to be a PDSN. The 2006 Royal College of Nursing (RCN) document on specialist nursing services for
children and young people with diabetes states that a PDSN based in hospital or community, working as
a member of the team specialising in the management of childhood diabetes, should be able to provide:
. . . a source of specialist advice for children, young people and families on the nursing care and
management of diabetes, including the provision of basic dietary advice and the management of
acute complications.
. . . individual specialist teaching for children, young people and families, facilitating the development
of self care skills and knowledge, at time of diagnosis and in planned, ongoing, age appropriate
education, both individually and in groups.
Royal College of Nursing165
The second trainer could be any HCP within the team. These two trainers were expected to deliver the
groups to families within their service. Teams were invited to bring along additional members to the
training if they so wished.
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Training and intervention
Pilot for intervention manual and training workshops
The intervention manual was piloted with a family known to the University College London Hospitals
(UCLH) team. Content, delivery and resources were discussed to ensure that the principles and messages
were clear and understandable. Training workshops were piloted with two UCLH PDSNs not involved in
the intervention development, and ﬁve local PDSNs from centres not recruited to CASCADE. Feedback on
the length of training (2 days), content and delivery was positive. Small changes were incorporated before
training of the intervention sites began.
Training workshops
Key messages, based on the fundamental principles of CASCADE ran through all of the workshops:
1. Assume basic diabetic knowledge already provided at, and subsequent to, diagnosis.
2. Non-didactic educational principles and psychological models underpin behaviour change.
3. Not additional work for staff but working differently.
4. No right or wrong ways of saying things – just more or less helpful ways of talking.
5. Builds on families’ knowledge, skills and abilities, and uses their experience and expertise.
6. Assumes families have knowledge about how to manage diabetes and want to change
their behaviours.
7. Use open questions; afﬁrm and positively connote behaviours.
8. Reﬂect on what is heard and summarise to show good listening skills.
9. Explore the advantages and disadvantages of changing.
10. Focus on advantages of change and disadvantages of the status quo.
11. Encourage staff to be interested in the person rather than the problem.
12. Identify ways that people are already doing what they want to do by focusing on what is going well
rather than what is not going well.
Training took place on two separate days with at least two intervention sites invited on each day.
The following basic principles were emphasised:
l Follow the manual as much as possible to maintain treatment ﬁdelity.
l Always have two people delivering each module.
l Divide the different components in the module in whatever way works best for site educators.
l Read key readings for each module to ensure knowledge of educational content.
Session 1 (morning of day 1)
The background to CASCADE was introduced with key delivery principles. These were to:
l Deliver the intervention to all recruited families in each intervention clinic.
l Offer four modules monthly to groups of three or four families with children in the same age group.
l Offer groups if only one or two families turn up for a module. If only one family turns up, reschedule
or complete the module on their own and then join another group for future modules.
l If families miss a module they can continue with the next module and, where possible, be helped to
catch up by discussing the module content with one of the site educators and/or being given the
handouts from the module they missed.
The session introduced the basic principles of SFBT and MI and provided opportunities to try out the
techniques embedded throughout the four modules.
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Session 2 (afternoon of day 1)
This session introduced modules 1 and 2. Delivery and communication style was modelled by the UCLH
trainers. Site educators participated in each exercise, giving answers or comments that they thought
children might offer or the information they thought correct. The UCLH trainers worked together; one
delivering the activities, while the second trainer commented on the process and performance, and invited
discussion of content and delivery style. The trainers highlighted SFBT and MI techniques used in
each activity.
Session 3 (morning of day 2)
Modules 3 and 4 were described using the same format as session 2.
Session 4 (afternoon of day 2): envisaging the future
Session 4 explored practicalities of running groups, organising sessions and how to engage and motivate
participants to attend. After a brief slide presentation on groups, educators then worked in their clinic
groups. They were asked to imagine themselves in 12 months’ time, having completed all of the
CASCADE groups, and consider:
l What made completing CASCADE possible?
l What aspects of the process had gone well?
l What had been possible challenges and barriers that they had overcome?
They were invited to identify their skills, abilities and knowledge that contributed to this ‘ideal outcome’
making the groups possible. As each ‘outcome’ was described, trainers asked questions to generate details
about solutions, such as ‘How did you achieve this?’ ‘Which days worked best for you?’ The shared ideas
from each clinic generated practical and achievable solutions to potential problems in advance to support
group organisation (e.g. in one training session good attendance was ‘achieved’ by staff phoning families
a week before the start as a reminder). Other ideas highlighted during this session included:
l Enthusiasm for the project, successful recruitment and practicing sessions in front of peers
for feedback.
l Resources in place for delivering the programme; ﬁnding an appropriate venue for running sessions
with staff and time to plan, organise and deliver sessions.
l Good communication between educators, supportive management and other team members who
would be receptive to the approaches and non-directive in communicating with young people.
l Sessions delivered at the right pace, working as a team with families with good attendance and age
groups that bonded well. Involving everyone in the group with good use of techniques and
listening skills.
l Positive feedback from young people and families. Families happy, more conﬁdent and accessing
services appropriately.
l All HbA1c levels of < 7.5%.
One-day refresher training
A 1-day refresher workshop was offered to all members of each intervention site when all workshops were
ﬁnished. The morning session provided the training in the delivery process with a description of the four
modules in the afternoon.
Ongoing support
Site educators could contact trainers at any time during the delivery of groups with queries or concern
about timing of the groups, clarity in relation to aspects of the manual or what to do if a family did not
turn up to training or composition of groups.
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Chapter 3 Methods
Trial design
The study was a pragmatic, cluster RCT with paediatric/or adolescent diabetes clinic as the unit of
randomisation. Integral process and economic evaluations were completed (Figure 1). The protocol was
published in BioMed Central trials.166 A list of all substantial amendments made to the ﬁnal protocol after
trial commencement is shown in Appendix 3.
Trial objectives
The primary trial objectives were to determine whether a structured, intensive educational programme
could be provided within a standard clinic setting for a diverse range of young people with T1D and to
assess whether the CASCADE intervention improved long-term clinical outcomes (HbA1c levels).
Secondary objectives included determining the impact of the intervention on other markers of diabetes
control, psychological wellbeing and costs (see Outcomes, below). The logic model which informed
evaluation of the intervention is shown in Figure 2.
Ethics committee approvals
The trial was performed in accordance with the recommendations of guiding physicians in biomedical
research involving human participants adopted by the 18th World Medical Assembly, Helsinki, Finland,
1964, amended at the 59th World Medical Association General Assembly, Seoul, October 2008. The study
was approved by the University College London (UCL)/UCLH REC reference number 07/HO714/112 (see
Appendix 4). Subsequent amendments to the original ethics approval are detailed below. Site-speciﬁc
approval was granted at each site.
Outcomes
Primary outcome
The primary trial outcome was glycaemic control, assessed at the individual level using venous HbA1c value.
Intravenous HbA1c samples for patients and questionnaires from patients and carers were collected at
baseline. The original protocol stated outcomes would be collected 12 and 24 months post intervention.
A substantial amendment to collect follow-up data 12 and 24 months after the date of baseline blood
sample was approved and reported in protocol v6 301010 (HTA progress report 5). Where possible, data
were collected within 3 months either side of the expected collection date.
Secondary outcomes
Secondary outcomes were outcomes directly and indirectly related to diabetes management, including
hypoglycaemic episodes and hospital admissions, choice of diabetes regimen, knowledge and skills
associated with diabetes management, responsibility for diabetes management, compliance with
intervention and clinic utilisation. Information about psychological functioning in terms of emotional and
behavioural adjustment and general and diabetes-speciﬁc QoL was measured using well-validated, reliable
self-report and parental measures.
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Trial stages
Data collection
methods
Site recruitment and randomisation
Patient recruitment
UCLH CASCADE training
(Intervention sites only)
1. Baseline blood samples and
    questionnaires
(Intervention sites only)
2. Researcher observation
3. Trainee evaluation forms
4. UCLH trainer interviews
(Intervention sites only)
5. Researcher observation
6. Site educator feedback forms
7. Fieldwork notes
8. 12- and 24-month follow-up
    blood samples and
    questionnaires (with process
    evaluation questions)
9. Interviews: site staff; young
    people; carers
10. Case note review (including
      economic evaluation data)
(Intervention sites only)
CASCADE groups delivered
Study end
FIGURE 1 Data collection timing and methods.
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Questionnaire development
Speciﬁc versions of questionnaires were created for 8- to 12-year-olds, 13- to 16-year-olds and carers
(questionnaires are available from the corresponding author). Those on pump therapy completed modiﬁed
questionnaires reﬂecting differences in regimen. Demographic information and clinical data included years
since diagnosis, insulin type dose, number of injections and time at current clinic. Carer outcomes included
demographic information [age, gender, ethnic origin, socioeconomic status (SES)]. Questionnaires
contained a number of validated instruments detailed below.
Psychosocial outcomes
Validated instruments appropriate for age were used wherever possible. Parental and self-report of
health-related QoL was measured using the Pediatric Quality of Life Inventory (PedsQL).167 The scale has
good internal consistency, reliability and validity for both the generic and diabetes modules. The physical
psychosocial health summary score produce an overall total score. The T1D module has four scales:
Treatment I and II, Worry, and Communication, which combine to produce a total diabetes score.
The ﬁve-item ‘Impact Supplement’ of the Strengths and Difﬁculties Questionnaire (SDQ) (parent and child
report versions) assessed the impact of identiﬁed emotional and behavioural difﬁculties on the young
person’s life.168
Young people were also asked to rate how happy they were with current weight and if they had skipped
insulin using two self-report questions designed speciﬁcally for the study.
Diabetes outcomes directly related to patient management (parental report
and case note review)
l Diabetes regimen (insulin dose/number of injections/insulin types).
l Hypoglycaemic episodes (frequency, severity) in last 6 months.
l Admissions to hospital in last 6 months and reason (e.g. episodes of ketoacidosis, hypoglycaemia).
Diabetes outcomes indirectly related to patient management
l Knowledge and skills associated with diabetes.155
l The Diabetes Family Responsibility Questionnaire (DFRQ)169 (parent and child report) reﬂects the sharing of
diabetes-related responsibilities (such as deciding what to eat at meals and snacks, rotating injection sites
and telling teachers about diabetes) within families. Parent and child versions of the questionnaire are
scored separately. Higher responses (on both) indicate greater responsibility taken by the young person for
their care. A dyadic score for the parent–child pair reﬂects agreement about who is taking responsibility.
High dyadic scores when neither reports taking responsibility is linked to poor health outcomes.
l The Diabetes Self-Efﬁcacy Scale assesses conﬁdence managing diabetes-related tasks.170
Compliance with intervention/control
l Attendance at intervention sessions.
l Service utilisation rate.
l Clinic attendance.
l Contacts with PDSNs and diabetes teams.
Data were collected through process evaluation (PE) and case note review (CNR).
Service user perspectives
Service user perspectives were sought on the structure and content of all the questionnaires. Initial
questionnaires were reviewed by a young woman with diabetes as part of the trial management group.
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One individual with research responsibilities for a diabetes charity and the mother of a girl with diabetes
who was also research trained provided comments about the length, general tone and speciﬁc items on
the questionnaire. Early data collection proved problematic as questionnaires were too long and were
often only partially completed. After consulting a patient organisation and a carer researcher, the
self-efﬁcacy scale was removed and questions assessing knowledge and skills about self-management
were removed from the 8- to 12-year-old child version.
Baseline data collection
Wherever possible, baseline data were collected at the point of consent. Otherwise it was collected at the
next possible opportunity. A substantial amendment to allow researchers to collect follow-up questionnaire
data by telephone was approved in June 2009 (progress report 3).
Primary outcome data collection
Arrangement for collection varied widely between and within sites. Research nurses or a member of the
local clinical team trained in venesection took the sample in the paediatric outpatient clinic or occasionally
at the patient’s home or GP surgery. Hospital phlebotomists also collected samples. Approximately 4 ml of
blood was collected and stored in a tube preﬁlled with diluent and preservative. The samples were sent to
a single UK laboratory (UCLH Special Biochemistry, London) for measurement of HbA1c concentrations.
This ensured direct comparability of results from all clinics. Current legislation requires that non-infectious
diagnostic specimens are transported in accordance with guidelines UN 3373 and need to conform to
secure packing instructions P650 (The European Agreement concerning the International Carriage of
Dangerous Goods by Road; Regulations concerning the International Carriage of Dangerous Goods by Rail;
the International Air Transport Association). The research team provided the appropriate packaging.
Samples were transported using a courier or more often delivered by hand by researchers or via the Royal
Mail (identiﬁed as a biological substance, category B). HbA1c assays were carried out on a Tosoh G8
instrument (Tosoh Bioscience, Tessenderlo, Belgium) with International Federation of Clinical Chemistry
aligned calibrators and results reported directly to the data manager following adjustment against the
DCCT international standard.
When a sample was lost or spoiled in transit, the research team used their discretion with regard to
requesting a repeat sample. A small number of young people were recruited in whom it was subsequently
found they had variant haemoglobin, meaning that HbA1c levels could not be accurately measured.
This issue came to light when the UCLH laboratory reported abnormal results for baseline blood samples.
The clinic principal investigator (PI) was informed. These patients remained in the study and provided
completed questionnaires but their HbA1c data were not used and no further study blood samples taken.
Secondary outcome data collection
For collection of secondary outcome data the researcher provided patients and carers with a copy of the
appropriate questionnaire. Participants were encouraged to self-complete the questionnaires
independently (i.e. parents and children were asked not to confer). The researcher provided help when
required. If a young person and/or their carer was not able to complete the questionnaire in the clinic,
either owing to insufﬁcient time or the parent not being present, the researcher would go through the
questionnaire with the young person/parent on the telephone. Patients recruited by site staff or research
network nurses were contacted by telephone to complete the questionnaire.
The PI from each clinic ensured appropriate access to advice and psychological support should any
participant express any concerns or worries with regard to taking part in research activities. In exceptional
circumstances, for example disclosures of signiﬁcant risk (to self or others), feedback to the family/carer
and clinical team would be made by the research team. Participants were reminded that DUK provides an
independent voice of support, through ‘Careline’, a dedicated helpline for all people with diabetes, friends,
family, carers and HCPs.
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Follow-up data collection
The process for collecting data at 12 and 24 months was the same as for baseline. A letter was sent to the
young person and their parent/carer a few weeks prior to their clinic appointment, approximately 1 year
after the baseline blood sample and 1 year later for the second-year follow-up. Families were asked to
come to clinic early if possible to meet with the researcher and advised that a £10 high street gift voucher
would be offered as a thank you for their participation. A substantial amendment to the protocol was
submitted and approved (progress report 5, protocol v6) allowing the team to offer an additional £10 high
street gift voucher at the second follow-up.
There was ongoing support from research nurses from networks that had capacity to continue to support
the study at one or both follow-up time points. National Institute for Health Research (NIHR) ﬂexibility and
sustainability funding supported a part-time researcher from June 2010 to June 2011 to assist with
follow-up data collection where research network nurses were not available.
During the ﬁrst- and second-year follow-up, some patients transitioned to adult services. The risk of data
loss was minimised by requesting that, wherever possible, clinics delayed transition. If this was not possible
the research team wrote to the adult consultant to introduce the study and reassure him/her that the
research team would take responsibility for overseeing data collection.
Trial Steering Committee and Data and Ethics
Monitoring Committee
The NIHR-HTA appointed a Trial Steering Committee (TSC) and independent Data and Ethics Monitoring
Committee (DMEC). The TSC met with the trial management group every 6 months. The DMEC reviewed,
in strict conﬁdence, data from the trial approximately halfway through the recruitment period. The Chair
of the DMEC could also request additional meeting/analyses. In the light of these data and other evidence
from relevant studies, the DMEC would inform the TSC if in their view:
l There was proof that data indicated any part of the protocol under investigation was either clearly
indicated or contra-indicated, either for all patients or a particular subgroup of patients, using the Peto
and Haybittle stopping rule.171,172
l There were major ethical or safety concerns.
Details of committee membership are provided in Appendix 5.
Centre recruitment and consent
A database of potential diabetes clinics was created from a list of hospitals and consultant paediatricians
identiﬁed from the Royal College of Paediatrics and Child Health (RCPCH) handbook. The Chief Investigator
e-mailed the clinical lead for each potential clinic on behalf of the UCLH team to invite them to participate.
Clinical teams in a few sites, hearing about the study, approached the study team to request inclusion.
Clinical teams that expressed an interest were contacted by the research team to discuss the study in
more detail and ensure that they met inclusion criteria. Consent to randomisation was obtained from the
responsible clinician who agreed to act as PI (Figure 3). Research and development (R&D) approval was then
arranged with the participating acute trusts.
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Eligibility criteria for clusters
l NHS paediatric diabetes service – clinic had to be staffed by at least one paediatrician and paediatric
nurse with an interest in diabetes.
l Located within London, the south-east (SE) and the Midlands (maximum train journey time 2 hours).
l Not running a group education programme at time of recruitment or during trial.
l Not taken part in a similar paediatric diabetes trial within the last 12 months.
l At least 40 eligible patients on current patient list.
Patient recruitment and consent
Prior to randomisation, clinics were asked to review patient lists to identify patients eligible to participate in
the study. Guidance regarding patient eligibility was provided in writing, over the phone and sometimes
face to face. The following criteria were used to determine eligibility.
Inclusion criteria for patients
l Diagnosis of T1D with duration ≥ 12 months.
l Aged 8–16 years.
l Mean 12-month HbA1c value ≥ 8.5 mmol/l.
l Under the care of a paediatric and/or adolescent diabetes clinic conducted by a specialist, or general
paediatrician with an interest in diabetes.
Exclusion criteria for patients
l Signiﬁcant mental health problems unrelated to diabetes requiring speciﬁc mental health treatment.
l Signiﬁcant other chronic illness in addition to diabetes that may confound the results of the
intervention. Patients with coeliac disease or hyperthyroidism were included.
Step 1. Consultant paediatricians were  identified
from the latest RCPCH handbook 
Step 2. Invitations sent from CI’s e-mail address signed
by all members of UCLH clinical team
Clinic interest in
project. Arrange
meeting
Clinic cannot
participate No answer in
reasonable
time frame
Different contact
identified
Reminder e-mail sent with invitation and
short protocol attached
Clinic visit by research team
member
Clinic participation agreement – signed site-specific information form received
and R&D approval secured.
FIGURE 3 Centre recruitment and consent process. R&D, research and development.
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l Signiﬁcant learning disability or insufﬁcient command of English to enable full participation in the
planned intervention. Young people with good command of English but whose parents have poor
command of English would be eligible to attend by themselves if they wished as long as parents had
given informed consent. Another relative who was one of the primary diabetes carers (e.g. sibling,
aunt or uncle) who had good command of English could participate instead of the parents.
l Participated in diabetes treatment trials in the 12 months prior to collection of baseline data.
Sample size
Based on NPDA ﬁgures, we calculated the average number of eligible patients would be 80–100 patients
per site. A recruitment rate of 25% was predicted based on a previous study by the Chief Investigator.121
The standard deviation (SD) of HbA1c in the target population is approximately 1.5%. The proposal was
to recruit sufﬁcient young people to allow the trial to detect a difference between groups of 0.5 SD,
i.e. 0.75%, with 90% power at a signiﬁcance level of 0.05 (two tailed), considered to represent a moderate
size of effect. Power calculations were based upon an intracluster correlation coefﬁcient (ICC) (the variability
in outcome between clinics divided by the sum of the within-cluster and between-cluster variances) of 0.1.
In the absence of reliable data on which to calculate an ICC for the clinic population, this was chosen
to be compatible with databases of ICCs such as www.abdn.ac.uk/hsru/epp/cluster.shtml. With these
assumptions, 13 clinics in each arm with an average of 20 young people in each would be required to
detect a difference of half a SD (0.75) with > 90% statistical power at 5% signiﬁcance. Given the possible
loss to follow-up of approximately 10%, the target recruitment was inﬂated to 22 young people from each
clinic. The original target sample size was therefore 572 children and young people recruited from 26 sites.
Early in the trial, the average number of eligible patients per clinic reported was 48 patients, with a range
of 19–97 patients. This was considerably fewer than the 80–100 patients per clinic originally estimated.
Given the lower than expected number of eligible patients per clinic, the predicted recruitment rate of
25% would mean an average of only 11 patients per clinic was likely to be available (a total possible
sample size of 286). Maintaining the original predicted effect size of 0.5 SD the reduced sample size would
have power of only 80%.
A preliminary exploration of baseline data suggested that the ICC was 0.01, which was signiﬁcantly lower
than the original assumption of 0.1. Using this revised ICC and increasing the number of recruited clinics
to 28, a minimum of 11 patients per clinic provided 87% power to detect the proposed effect size with
5% level of signiﬁcance. This created a revised patient recruitment target of 308. The rationale for this was
sent to the DMEC, TSC and NIHR-HTA and was approved on 21 December 2009.
In order to meet this overall target, the target recruitment rate per clinic was also raised from 25% to
33%. In clinics where eligible lists were particularly small, or patient recruitment began late, 33% was felt
to be unrealistic and a minimum of seven recruits was set in these clinics. Where eligible patient numbers
were felt to be particularly small, clinical teams were asked to review patient lists to identify any additional
eligible patients who may have been inadvertently missed. Where requested, the research team visited
clinical teams to help with this process.
Recruitment process
The research team provided electronic templates of letters and pre-printed information leaﬂets. Invitation
packs were posted by clinics to the parent/guardian of all eligible patients and included:
l an invitation letter (printed on trust headed paper) to parent/guardian
l participant information leaﬂet for parent/guardian explaining the study
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l a separate non-sealed envelope containing an age appropriate invitation letter for the young person
(printed on trust headed paper) and an age-appropriate information leaﬂet
l separate invitation letters and participant information leaﬂets for 8- to 10-year-olds and 11- to
16-year-olds.
Administrative support to send out invitation packs was provided by the research team if requested by
the site. The team liaised with site staff and travelled to outpatient clinics when eligible patients were attending
routine appointments. Initial recruitment was carried out by two full-time members of the research team.
Eligible children, young people and carers were approached in clinic and asked if they had received the
invitation pack in the post. If not a duplicate pack was provided and patients were then approached at the
next convenient opportunity. The trial was described as a comparison of different ways of helping young
people to manage their diabetes. Participants were told that if they were in the intervention arm they would, in
addition to standard care, be invited to a series of four 2-hour group sessions. If they were in the control arm
they would continue with standard care only. It was made clear that all approaches had potential advantages
and disadvantages. They were informed that the children and young people were required to give a venous
blood sample and complete a questionnaire at three time points, and that the parent/carer would be required
to complete a questionnaire at the same time points. Eligible patients that asked for more time to think about
the study before consenting were followed up (by phone, letter or at subsequent clinic appointments).
Informed written consent or assent was obtained from both the young person and one parent/carer. The
right of a child or parent to refuse participation without giving reasons was respected. The child/young
person or their parent remained free to withdraw at any time from the study without giving reasons and
without prejudicing further treatment. If a participant withdrew consent from further trial participation
their data remained on ﬁle and was included in the ﬁnal study analysis. If a participant withdrew consent
for their data to be used, the data were destroyed immediately.173,174
Additional strategies to support recruitment process
Five additional sessional workers were used to support recruitment on an ‘as required’ basis to increase
capacity and maximize ﬂexibility within the team.
Where possible clinics were asked to cluster eligible patients into speciﬁc clinics to minimise the number of
trips researchers had to make. Reimbursement was offered to families for any expenses incurred through
travel for research purposes.
The study was accepted as part of the NIHR portfolio and adopted by The Medicines for Children Research
Network (MCRN) and the Diabetes Research Network (DRN). Research nurses from MCRN Trent and
MCRN West Midlands Local Research Networks supported recruitment in clinics that fell within their
geographical localities. Nurses connected to the London South East, North Central and East Research
Network supported recruitment in a number of London clinics.
Protocol amendments were approved to allow local clinicians to recruit and take consent from young
people and their families. For example, £100 was paid to the trust for each patient recruited. Baseline
questionnaires were distributed and subsequent data collected over the telephone for patients recruited by
local clinicians (progress report 1, 30 October 2008). Research nurses and site staff were trained in study
procedures particularly with regard to minimising risk with respect to allocation. All patient recruitment
took place on hospital sites with the exception of one site where a member of the clinical team
recruited a patient at home. Ongoing support for staff assisting with the recruitment was provided by
e-mail, phone and face-to-face contact. A DVD was made to support recruitment in clinics. A copy of the
DVD was provided to each clinic and the ﬁle was also uploaded to YouTube (www.youtube.com/
watch?v = XFgVKBYdCbU). A substantial amendment was submitted to allow the DVD to be used by site
staff to support recruitment (progress report 2, 30 April 2009).
A regular newsletter was sent to clinics to maintain motivation to recruit.
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Site randomisation
Clinics were randomly allocated to intervention or control. The randomisation schedule was drawn up at
the London School of Hygiene and Tropical Medicine (LSHTM) and allocation concealed until after clinics
had consented and a ﬁrst participant recruited to minimise selection biases at entry of clusters to the trial.
Randomisation was in a 1 : 1 ratio and minimised by factors likely to inﬂuence clinic mean HbA1c, such as
age of target population of the clinic (paediatric or adolescent) and degree of clinic specialisation (district
general hospital clinic or teaching hospital/tertiary clinic) and ﬁnally size of clinic to ensure balance in
numbers of eligible children between the two arms of the trial. This information was provided by the site
PI who completed a minimisation criteria form shortly after site recruitment. Allocation (i.e. whether the
site was in the intervention or control arm) was conveyed to sites by the trial Chief Investigator. Staff were
requested not to inform young people and families about randomisation status until recruitment had
ﬁnished. Site staff then sent a letter informing them which arm the site had been randomised to (or told
them in clinic). The research team sent the patients’ GP a letter informing them their patient was taking
part in a trial and informing them which arm the hospital had been randomised to. The central laboratory
assessing the primary outcome (HbA1c value, see below) remained blind to participant allocation.
Statistical analysis
The primary analysis was an intention-to-treat comparison of HbA1c values between the two groups of
patients at 12 months and 24 months, using analysis of covariance with a random effect for clinic to allow
for clustering at that level.
Psychological outcome measures were derived from baseline and follow-up questionnaires and analysed
using analysis of covariance with a random effect for clinic to allow for clustering. As most of the
psychological outcome measures were highly skewed, 95% conﬁdence intervals (CIs) for these measures
were estimated using 2000 bootstrap samples. For binary outcomes, logistic regression was used to
estimate the effect of the intervention. Again, a random effect was included at the clinic level to allow for
clustering and baseline values were adjusted for, where available.
Prespeciﬁed subgroup analyses based on age (paediatric/adolescent), gender, high/low (< 10.4 vs.
≥ 10.4 mmol/l) initial HbA1c levels and socioeconomic status (SES) (as measured by the multiple deprivation
score) were carried out, and effect sizes and 95% CIs estimated from models that included an
interaction term.
A per-protocol analysis of all primary and secondary outcomes was carried out with adherence to the
protocol being deﬁned as attending three or more of the four CASCADE sessions. The same statistical
analysis techniques were used as for the intent-to-treat analysis.
Serious adverse event reporting procedures at site level
A member of the clinical team at each site was asked to take responsibility for overseeing the reporting of
serious adverse events (SAEs) at that site.
This person was asked to ensure that all SAEs experienced by trial participants, from the time of consent to
take part in the trial to the trial ending, were reported via a secure fax number to the research team within
24 hours of staff learning of the event. Assessment of seriousness, causality and expectedness relating to
the CASCADE intervention of a reported event was carried out by a clinically trained member of the
research team blind to allocation. The form was then signed by the study Chief Investigator and forwarded
within 15 days to the Research Ethics Committee (REC).
All standard operating procedures (SOPs) are available on request.
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Health-economic evaluation
The economic evaluation compares the CASCADE intervention with current NHS practice. It is assumed
current diabetes education (dietary education, physical exercise and psychological support) is given in a
non-standard, irregular way by health-care providers during clinic and home visits. Assessment of
CASCADE cost-effectiveness with respect to current NHS practice focuses on the relative success
controlling HbA1c level and the predicted impact on diabetic complications over time. Good BG control
(HbA1c level of < 7.5%) is associated with a reduction in the risk of diabetic complications.175
The cost-effectiveness model considered long-term cost and beneﬁt implications of delaying onset of
microvascular and macrovascular diabetic complications by comparing HbA1c levels in the intervention and
control groups. A series of Markov chain Monte Carlo (MCMC) submodels simulated the progression of
microvascular complications (kidney diseases, neuropathy – foot ulcer and risk of amputation, and
retinopathy) and cardiovascular complication (infarction) were used to predict future treatment cost of
patients receiving the CASCADE intervention or standard care. This is a similar approach to that adopted
in the DAFNE study145,176–178 (DAFNE Study Group. 2002, unpublished). A detailed description of the
methodology used in the economic analysis is provided in Chapter 7.
Process evaluation
Aim
The PE was designed to assess the feasibility and acceptability of delivering CASCADE groups as part of
standard care within an NHS setting. Should the CASCADE intervention fail to be effective, the PE was
also designed to assess the extent to which theory or implementation was responsible.
Speciﬁc aims of the PE were to:
1. compare and contrast standard NHS paediatric/adolescent diabetes service across control and
intervention sites
2. describe the UCLH training workshops for the CASCADE intervention and assess quality, ﬁdelity
and satisfaction
3. report on feasibility and acceptability for staff organising and delivering CASCADE groups in the sites
4. review feasibility and acceptability of the CASCADE intervention for families
5. describe parent/carer and young people’s perceptions of impact of participation in CASCADE on
themselves and their families and views of staff regarding the impact on young people and on their
own practice.
Design of the process evaluation
A mixed-methods approach to data collection was used. Data were collected from key stakeholder groups
(UCLH trainers, site staff, young people and parents) at speciﬁc time points in the trial. Questionnaires,
observation and CNR were used to collect qualitative and quantitative data. Qualitative data were collected
through semistructured interviews, informal discussion following observation sessions and ﬁeldwork notes.
Participants were informed that all information would be conﬁdential with only the research team able to
access individual data. All data used would be anonymised. Permission to record interviews was sought.
Interviews were transcribed verbatim. If permission to record was not granted then notes were taken by
the interviewer during or immediately after the interview. All PE instruments used for data collection are
available on request.
DOI: 10.3310/hta18200 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 20
29
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Christie et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
Process evaluation methods
University College London Hospitals training workshops
Observations
The aim of the researcher observation was to assess quality and ﬁdelity across the workshops and describe
delivery of training in terms of methodology, content, engagement and satisfaction (as perceived by the
observer). Three each of workshops 1 and 2 were observed by researchers (between August 2009 and
May 2010). A researcher observed the 1-day refresher workshop (June 2010) offered for members of
the intervention clinics who were interested in learning more about the background to the intervention.
Observers were introduced by the UCLH trainers at the start of the training sessions but observed from
the back of the room as non-participants. Brief notes made during sessions were written up in more detail
immediately afterwards. Details of number of attendees, professional background and role in CASCADE,
and which hospital/clinic site they were from were also recorded.
Evaluation forms and questionnaires
A one-page anonymous evaluation form was completed by attendees immediately after each workshop
session. Forms designed by the UCLH trainers captured immediate feedback on what participants most
liked about the session, what they had not understood and what they would do differently as a result
of being in the session. Trainers administered the forms and used the feedback to modify subsequent
sessions if needed. For the purposes of the PE these data were used to support themes arising from other
data sources.
After completing the second training workshop (and before the CASCADE groups started) a short
questionnaire was sent to attendees. This collected further demographic data and evaluated the UCLH
training workshops with the beneﬁt of distance from the training.
Interviews with the University College London Hospitals trainers
A semistructured interview schedule was designed to gather views of the UCLH trainers on the process of
intervention development and delivery of the training workshops. Perceptions of progress with group
delivery in the sites were also captured. One interview was carried out soon after all training workshops
had been conducted and before many sites started delivering groups. The second interview was conducted
once the delivery in the sites was well under way.
CASCADE groups
Observation
Non-participant observation by a researcher of one complete group of four modules delivered by the
trained site educators occurred in each of the 13 intervention clinics that ran any modules. The observation
collected data on timings, setting, attendance, observers’ and staff views on what worked well and what
worked less well, and recorded the extent to which the intervention was delivered as intended and noted
problems that arose ‘in the real world’.
Groups in each site were purposively selected to ensure a mix of ﬁrst, middle and last groups, based on
the premise that trainers would gain conﬁdence and expertise the more groups they ran.
A semistructured observation pro forma was used to enable a description of delivery of the intervention
comparable across all sites, with unstructured observations to provide context and meaning to the
observations. The pro forma was developed by the research team using the intervention manual and initial
observations by researchers of sessions in four sites. Four researchers who had attended at least one UCLH
training workshop carried out observations. The observer sat away from the group to be as unobtrusive as
possible but near enough to be able to observe effectively. Observers were introduced to the group as a
member of the research team by the site educators. Notes were used to complete the pro forma as soon
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as possible after the group had ﬁnished to maximise recall accuracy. Observers referred to the intervention
manual throughout to be able to ‘score’ completion of each activity. Activity content in each module was
rated on a scale of 1 (not completed) to 7 (completed). Observers also rated use of psychological
techniques on a scale from 1 (not at all) to 5 (extensively) for each module. These two scales were
designed to ensure high levels of validity and reliability. More intervals were used on the content than the
technique scale because of an expectation that there would be more discernible difference with content
than with technique. When developing the pro forma the research team discussed what each scale point
meant to ensure a common view about amount of content and technique.
Site educator feedback
Site educators completed a short pro forma after every module to record information about young person
and/or parent carer demographics, together with details of non-attendees. Staff rated the extent to which
they felt they had delivered the required content on a scale of 1–7 and the extent to which they had used
the key techniques on a scale of 1–5.
Interviews with site staff
Researchers interviewed one site educator from each intervention site and a key member of staff who had
contact with young people in the control clinics (usually the lead nurse), as well as other key stakeholders
working within the clinics. A purposive sampling approach ensured that those expected to have key
information were included. Interviews were conducted either in person or over the telephone with the
exception of the structured questions at the beginning, which could be e-mailed and completed in
advance of the main interview. Interviews were conducted after all groups had been completed in the
intervention sites. Control site interviews lasted about 30 minutes, and about 60 minutes for intervention
sites. The schedule included structured and semistructured questions about service structure, current
challenges regarding diabetes care, and current training/education. For the intervention sites
semistructured questions were asked about the training and delivery of the CASCADE intervention.
Interviews with young people and parents
The main aim was to gather in-depth information on how young people and their families look after their
diabetes, and the education they had been offered and/or received about diabetes. Control site interviews
focused on standard practice, whereas in the intervention sites they included experience of the
CASCADE modules.
The original protocol stated that these data would be collected from focus groups. Given the challenges
experienced in the study with accessing young people at time points additional to routine clinic
appointments, a decision was made to use individual interviews with young people and their carers instead.
This minimised inconvenience for all stakeholders as interviews could be conducted in the clinic setting at
the same time as follow-up data were collected or, alternatively, over the telephone. Interviews with up to
four young people in each intervention site and two in each control site (plus parents) were planned.
Saturation point (the point at which no new information was given) was reached after 30 intervention and
18 control site interviews were completed therefore target numbers were reduced to two and one per site
respectively. To ensure a range of key characteristics within the sample, interviewees in each site were
purposively selected using a sampling grid constructed for each site (Box 1). The aim was to achieve
diversity across as many characteristics as possible in each site and across the two arms of the trial.
Individuals were invited to take part in an interview by a member of the research team, with parents/carers
invited to take part once the young person consented. Young people were interviewed even if parents/
carers declined.
Semistructured interview schedules used learning from data collected in the study and lasted
approximately 20 minutes. They were piloted with a few young people and then further reﬁned. All
children and young people were asked about their experience and management of diabetes. Intervention
site informants were also asked about their experience of CASCADE and any perceived impact. Those who
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had opted out of sessions were asked about their reasons for opting out. Carers were asked about views
of their child’s management of diabetes, and, in the intervention sites, experience of CASCADE.
In control sites, interviews were completed at the time of ﬁrst follow-up data collection. In intervention
sites, interviews were carried out within 3 months of the young person completing groups. Most
participants were invited to take part by letter that explained the main aim of the interview, and informed
that they would receive a £10 voucher as a ‘thank you’ and compensation for their time.
Five researchers carried out most interviews face to face. Parent and young person interviews were
designed to be conducted separately but a request to do the interview together was acceptable. Some
were carried out over the phone when a face-to-face encounter was difﬁcult to arrange. If a selected
participant declined to be interviewed then a replacement participant was selected from the sampling grid.
Questions in secondary outcome measure questionnaires
A small number of PE questions were incorporated in the follow-up questionnaires for intervention
families. This allowed data capture from the whole intervention sample (as opposed to just those
interviewed). In the 12-month follow-up questionnaires the focus was on experience and perceived impact
of the CASCADE groups. Those who had declined to take up the groups were asked to give reasons for
this. In the 24-month follow-up questionnaires, questions were based on interview data from young
people and carers focusing particularly on views of sustained perceived impact.
Field notes
Detailed ﬁeld notes were kept during the 4 years of data collection.
Case note review
A CNR was conducted at each site around the time of the participants’ 24-month follow-up appointment.
CNR for withdrawn patients was completed up to when they last provided data for the study. The same
data were collected for participants at both control and intervention sites and entered on to a secure
database with controlled access and no patient identiﬁable information. Data were used to describe
standard care, speciﬁcally the level of nursing contacts in both control and intervention sites. Data were
compared using Microsoft Excel version 2003, version 11 (Microsoft Corporation, Redmond, WA, USA).
BOX 1 Characteristics of young people used for purposive sampling for interviews
Girl < 12 years.
Girl ≥ 12 years.
Boy < 12 years.
Boys ≥ 12 years.
At least one missed clinic appointment in previous year.
No missed clinic appointments in previous year.
The grids for the intervention sites had, in addition, attendance at:
l all CASCADE sessions
l some CASCADE sessions
l no CASCADE sessions.
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Analysis
For large quantities of qualitative data analysis was supported by the use of NVivo software version 9
(QSR International, Southport, UK). Where the quantity was small, it was done by hand. Qualitative
analysis of the interview transcripts identiﬁed key topics and issues that emerged from the data through
familiarisation with transcripts.179 Pertinent excerpts were coded and memos written to summarise and
synthesise emerging themes. Researchers reﬁned their analysis ensuring that themes were crosschecked
with other data, ﬁrst within and then between transcripts so that the validity of emerging explanations
were tested and improved so themes were ordered within an analytical framework based on the data.
To maximise the validity of the ﬁndings, a sample of the qualitative data were separately analysed and
reviewed to agree a framework for full analysis of all data.
Quantitative data were analysed using an Excel spreadsheet and the Statistical Package for the Social
Sciences (SPSS) version 19 software (SPSS Inc., Chicago, IL, USA) for statistical tests.
Composite ﬁdelity delivery scores from individual observer and self-rated scores were created for each pro
forma for content and for technique. This allowed the range and median score for content and technique
to be calculated. A further composite variable was then calculated, which summed the content and
technique scores for each site across all four modules. If any scores were missing for a module the total
scores would be divided by the number of completed modules. This allowed comparison across sites and
modules, as well as comparing the individual inﬂuence of content and techniques.
Analysis of the UCLH training workshops observation was carried out by a separate researcher reading
through the notes made by the observers and identifying key themes and ﬁdelity issues emerging from
the data.
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Chapter 4 Results
Clinic recruitment
Twenty-eight paediatric diabetes clinics in London, SE England and the Midlands were recruited between
May 2008 and January 2010 with local research governance processes completed by March 2010
(Figure 4). One clinic withdrew before randomisation owing to the departure of the PI. An additional clinic
was recruited to replace it. A large number of clinics were ineligible because of involvement in three other
large paediatric diabetes research studies [Development and Evaluation of a Psychosocial Intervention for
Children and Teenagers Experiencing Diabetes (DEPICTED), Kids in Control of Food (KICk-OFF), and Family
and Adolescent Communication and Teamwork Study (FACTS)].136,180,181 Concern about staff capacity was
the most common reason for declining to participate.
Characteristics of the clinics
Clinic-level characteristics clinics are shown in Table 2. The two groups were similar at trial entry, with all
clinics mixed with regards to age – 86% in each arm were general hospitals with similar numbers of
eligible patients in each arm.
Patient recruitment
Three hundred and sixty-ﬁve patients were recruited between February 2009 and September 2010. A total
of 1340 eligible patients were identiﬁed and sent information about the study. Attempts were made to
approach all eligible patients; however, some failed to attend multiple clinic appointments. Overall, 1177
were approached and invited to take part, representing a recruitment rate of 31% of those approached,
27% of eligible. Main reasons for declining to participate included lack of time and dislike of giving
venous blood samples. Three patients were recruited with ineligible HbA1c levels and were therefore
excluded from further analysis. The ﬁnal recruitment ﬁgure was 362. Figure 5 shows the ﬂow of clinics
and young people through the trial.
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TABLE 2 Clinic-level characteristics
Characteristic Intervention (N = 14) Control (N = 14)
Age profile of patients (years)a
Paediatric (0–12), n (%) – –
Adolescent (13–18), n (%) – –
Mixed, n (%) 14 (100) 14 (100)
Type of clinica
General hospital, n (%) 12 (86) 12 (86)
Specialist/tertiary, n (%) 2 (14) 2 (14)
No. of eligible patientsb
≤ 32, n (%) 6 (43) 4 (28)
32–50, n (%) 5 (36) 5 (36)
> 50, n (%) 3 (21) 5 (36)
Clinic size
No. attending clinic, mean (SD) 122 (45.8) 140 (51.3)
More than 50 young people registered, n (%) 14 (100) 14 (100)
More than 100 young people registered, n (%) 11 (79) 9 (64)
a Minimisation factors.
b Minimisation factor added after ﬁrst 16 randomisations.
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Baseline characteristics of the participants
Demographic information on 327 children and young people and 324 parents who completed the
baseline questionnaire are shown in Tables 3 and 4. Groups were similar at baseline, with a mean (child)
age of 13 years (SD 2.1 years), and time since diagnosis of diabetes of 5.1 years in the intervention arm
and 5.6 years in the control arm.
Table 5 shows the numbers providing data at each point of the analysis. Main reasons for loss to follow-up
included an inability to contact participants at follow-up points (attempted directly and with assistance of
clinic staff), and withdrawal (1) as moving away, (2) for reported reasons including needle phobia or
pressure of GCSEs, and (3) for unexplained reasons. Some participants unavailable at follow-up 1, were
re-engaged for data collection at follow-up 2. Table 5 shows some participants provided one type of
follow-up data (blood sample or questionnaire) but not the other. Participants in the intervention arm who
changed their mind about taking part in the CASCADE groups were informed that they were welcome
to remain in the study despite choosing to opt out of the intervention.
TABLE 3 Demographic characteristics of young people who completed the baseline questionnaire
Characteristic Intervention (N = 159) Control (N = 168)
Gender
Female, n (%) 91 (57.2) 90 (53.6)
Male, n (%) 68 (42.8) 78 (46.4)
Age (years), mean (SD) 13.1 (2.1) 13.2 (2.1)
1 missing 3 missing
Ethnicity
White British, n (%) 133 (83.7) 129 (76.8)
White other, n (%) 5 (3.1) 5 (3.0)
Mixed, n (%) 7 (4.4) 4 (2.4)
Asian/Asian British, n (%) 5 (3.1) 14 (8.3)
Black/black British, n (%) 5 (3.1) 6 (3.6)
Chinese, n (%) 0 0
Other, n (%) 4 (2.5) 9 (5.4)
Time since diagnosis (years), mean (SD) 5.7 (3.2) 6.1 (3.3)
27 missing 32 missing
Time since enrolled at participating clinic (years), mean (SD) 5.1 (2.9) 5.6 (3.2)
32 missing 32 missing
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TABLE 4 Demographic characteristics of parent (parent most involved in management at diabetes and attends
clinic with child) who completed the baseline questionnaire
Characteristic Intervention (N = 159) Control (N = 168)
Gender
Female, n (%) 137 (87.8) 151 (89.4)
Male, n (%) 19 (12.2) 17 (10.1)
1 missing
Relationship to young person with diabetes
Mother, n (%) 136 (87.2) 153 (90.5)
Father, n (%) 17 (10.9) 13 (7.7)
Female guardian, n (%) 0 1 (0.6)
Male guardian, n (%) 0 0
Other, n (%) 2 (1.3) 0
1 missing 2 missing
Partnership status
Married, n (%) 89 (57.1) 113 (66.9)
Cohabiting, n (%) 18 (11.5) 18 (10.7)
Single parent, n (%) 45 (28.9) 36 (21.3)
4 missing 2 missing
Ethnicity
White British, n (%) 135 (86.5) 132 (78.1)
White other, n (%) 7 (4.5) 5 (3.0)
Mixed, n (%) 0 2 (1.2)
Asian/Asian British, n (%) 6 (3.9) 15 (8.9)
Black/black British, n (%) 4 (2.6) 5 (3.0)
Chinese, n (%) 1 (0.6) 1 (0.6)
Other, n (%) 3 (1.9) 8 (4.7
1 missing
Tenure 135 (86.5) 132 (78.1)
Privately owned, n (%) 106 (68.0) 98 (58.0)
Council/rented, n (%) 48 (30.8) 68 (40.2)
2 missing 3 missing
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Missing data
As there was no differential attrition by arm and no reason to believe the data were missing not at
random, an intention-to-treat analysis based on randomised participants who provided primary outcome
data was undertaken for all outcomes.
Baseline data
Values of the primary outcome at baseline are shown in Table 6.
Baseline young people measures for secondary outcomes are shown in Table 7, with baseline carer
measures in Table 8. The two groups appear well balanced at baseline both as reported by the young
person and as reported by the carer.
The DMEC conﬁdentially reviewed unblinded interim analyses on three occasions and did not recommend
stopping the trial early.
TABLE 6 Primary outcome measure at baseline
Primary outcome
Intervention group Control group
n Mean (SD) n Mean (SD)
HbA1c (venepuncture) at baseline 157 9.9 (1.5) 158 10.0 (1.5)
TABLE 5 Participants providing blood and questionnaire data at each time point
Type of follow-up Intervention, n (%) Control, n (%) Total, n (%)
Eligible and randomised 180 182 362
Baseline
Both blood and questionnaires 142 (78.9) 146 (80.2) 288 (79.6)
Blood only 15 (8.3) 12 (6.6) 27 (7.5)
Questionnaires only 17 (9.4) 22 (12.1) 39 (10.8)
Neither 6 (3.3) 2 (1.1) 8 (2.2)
12-month follow-up
Both blood and questionnaires 138 (76.7) 152 (83.5) 290 (80.1)
Blood only 5 (2.8) 3 (1.6) 8 (2.2)
Questionnaires only 10 (5.6) 7 (3.8) 17 (4.7)
Neither 27 (15.0) 20 (11.0) 47 (13.0)
24-month follow-up
Both blood and questionnaires 130 (72.2) 141 (77.5) 271 (74.9)
Blood only 5 (2.8) 8 (4.4) 13 (3.6)
Questionnaires only 14 (7.8) 10 (5.5) 24 (6.6)
Neither 31 (17.2) 23 (12.6) 54 (14.9)
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TABLE 7 Secondary outcome measures at baseline (young people)
Secondary
outcomes
Intervention group (N = 159) Control group (N = 168)
Missing Mean (SD)
Median (IQR)/
n (%) Missing Mean (SD)
Median (IQR)/
n (%)
PedsQL: generala
Physical health
summary score
46 87.6 (12.0) 90.6 (84.4–96.9) 15 87.4 (11.8) 90.6 (81.3–96.9)
Psychosocial health
summary score
46 81.3 (13.5) 83.9 (75.0–91.7) 15 79.5 (13.8) 81.7 (70.0–90.0)
Total score 46 83.5 (12.1) 87.0 (76.1–92.4) 15 82.3 (11.7) 84.8 (75.0–91.3)
PedsQL: diabetes module
Diabetes score 1 63.3 (17.0) 62.5 (50.0–77.3) 1 62.1 (16.8) 61.4 (50.0–72.7)
Treatment 1 score 4 73.6 (20.1) 75.0 (62.5–87.5) 1 76.6 (20.5) 81.3 (62.5–93.8)
Treatment 2 score 2 82.5 (15.3) 85.7 (75.0–92.9) 1 83.7 (15.1) 87.5 (71.4–96.4)
Worry score 1 70.0 (25.2) 75.0 (50.0–91.7) 1 72.4 (23.2) 75.0 (58.3–91.7)
Communication score 1 70.5 (26.2) 75.0 (50.0–91.7) 1 77.5 (23.0) 83.3 (66.7–100.0)
DFRQ
Family responsibility
total score – young person
24 34.8 (5.1) 35.0 (31.0–39.0) 20 35.5 (4.3) 36.0 (32.5–39.0)
Family responsibility total
score – young person
(weightedb)
2 34.9 (5.1) 35.0 (31.0–38.3) 1 35.3 (4.6) 36.0 (32.0–39.0)
SDQ
Strengths and difﬁculties
total average impact
score
3 0.38 (1.30) 0.0 (0.0–0.0) 5 0.31 (0.94) 0.0 (0.0–0.0)
Normal 3 – 139 (89.1) 5 – 145 (89.0)
Borderline – 2 (1.3) – 3 (1.8)
Abnormal – 15 (9.6) – 15 (9.2)
Body weight and insulin
Happiness with body
weight
4 6.9 (2.7) 8.0 (5.0–9.0) 7 6.6 (2.8) 7.0 (4.0–9.0)
No. of times skipped
insulin in last month
4 – 0 (0 to 2) 6 – 0 (0 to 2)
Ever skipped insulin to
lose weight
0 – 8 (5.0) 0 – 9 (5.4)
IQR, interquartile range.
a The missing data in the baseline measures of three secondary outcomes arose because a question was inadvertently left
out of some of the initial baseline questionnaires at an early stage of the study. Although there is no reason to believe
that there was any bias in which participants received this version of the questionnaire, more clinics in the intervention
arm were supplied with the incorrect version, resulting in a larger quantity of missing data in the intervention than the
control arm of the study. Additional analyses that incorporated imputed values for the missing PedsQL data at baseline
produced summary statistics very similar to those we report in the baseline tables with no suggestion of any imbalance
between the two study arms at baseline. Impact analyses, which included the imputed values of the missing baseline
PedsQL measures, were likewise consistent with the results of the complete case analysis.
b Weighted to allow for non-response.
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TABLE 8 Baseline characteristics of carers’ diabetes knowledge, conﬁdence and management
Baseline
outcomes
Intervention group (N = 156) Control group (N = 169)
Missing Mean (SD)
Median (IQR)/
n (%) Missing Mean (SD)
Median (IQR)/
n (%)
Management
No. of severe hypoglycaemic episodes in last month
1 – – 12 (7.6) – – 13 (7.8)
2 – 2 (1.3) – 2 (1.2)
3 – 1 (0.6) – 1 (0.6)
12 – 1 (0.6) – 0
No. of times admitted in last 6 months
1 – – 23 (14.7) – – 16 (9.5)
2 – 0 – 2 (1.2)
3 – 1 (0.6) – 1 (0.6)
10 – 1 (0.6) – 0
No. of times
attended diabetes
clinic in last year
7 3.7 (0.9) 4.0 (3.5–4.0) 13 3.9 (1.5) 4.0 (3.5–4.0)
Visit hospital doctor
most/every visit
10 – 130 (89.0) 9 – 142 (88.8)
Visit diabetes nurse
most/every visit
5 – 139 (92.1) 4 – 158 (95.8)
Visit dietitian
occasionally or more
often
16 – 129 (92.1) 17 – 129 (84.9)
Visit psychologist
occasionally or more
often
47 – 16 (14.7) 46 – 19 (15.5)
PedsQL: general
Physical health
summary score
44 85.4 (14.2) 89.1 (78.6–93.8) 15 83.8 (17.6) 87.5 (78.1–96.9)
Psychosocial health
summary score
44 74.6 (15.6) 76.7 (63.8–86.7) 15 71.9 (18.7) 75.0 (61.7–85.0)
Total score 44 78.4 (13.2) 79.3 (70.1–89.1) 15 76.0 (17.1) 80.4 (68.5–88.0)
PedsQL: diabetes module
Diabetes score 1 57.7 (15.8) 56.8 (45.5–68.2) 1 55.5 (17.3) 54.5 (43.2–65.9)
Treatment 1 score 1 60.9 (22.4) 62.5 (43.8–75.0) 1 61.6 (21.8) 62.5 (50.0–75.0)
Treatment 2 score 1 76.9 (16.3) 78.6 (65.0–89.3) 0 75.9 (18.2) 75.0 (64.3–91.7)
Worry score 1 64.8 (25.6) 66.7 (50.0–83.3) 1 65.5 (25.2) 66.7 (50.0–83.3)
Communication score 1 68.2 (28.0) 66.7 (50.0–100.0) 1 68.9 (29.6) 75.0 (50.0–100.0)
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TABLE 8 Baseline characteristics of carers’ diabetes knowledge, conﬁdence and management (continued )
Baseline
outcomes
Intervention group (N = 156) Control group (N = 169)
Missing Mean (SD)
Median (IQR)/
n (%) Missing Mean (SD)
Median (IQR)/
n (%)
DFRQ
Family responsibility
total score – parent
26 30.9 (4.6) 31.0 (27.0–35.0) 28 31.9 (5.0) 32.0 (29.0–35.0)
Family responsibility
total score – parent
(weighteda)
0 31.1 (4.7) 31.0 (27.5–35.0) 1 31.6 (5.4) 31.8 (28.0–35.0)
Dyadic parent–child
responsibility pattern
44 0.82 (1.23) 0 (0–1) 40 0.72 (0.97) 0 (0–1)
SDQ
Strengths and difﬁculties
total average impact
score
2 0.57 (1.40) 0.0 (0.0–0.0) 1 0.79 (2.07) 0.0 (0.0–0.0)
Normal 2 – 126 (81.8) 1 – 138 (82.1)
Borderline – 4 (2.6) – 5 (3.0)
Abnormal – 24 (15.6) – 25 (14.9)
IQR, interquartile range.
a Weighted to allow for non-response.
Note: ﬁve of the young person questionnaires have no corresponding parent questionnaire and three of the parent
questionnaires have no corresponding young person questionnaire.
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Primary outcomes
Results for the primary outcomes at 12 and 24 months are shown in Tables 9 and 10.
The mean HbA1c value at 12 months was 10.2 mmol/l in the intervention group and 10.1 mmol/l in the
control group [mean difference 0.11 (95% CI –0.28 to 0.50)]. The ICC for the primary outcome at
12 months was 0.134.
The mean HbA1c value at 24 months was 10.1 mmol/l in the intervention group and 10.0 mmol/l in the
control group [mean difference 0.03 (95% CI –0.36 to 0.41)]. The ICC for the primary outcome at
24 months was 0.060. There was no impact of the intervention on the primary outcome.
TABLE 9 Primary outcome measure at 12 months
Primary outcome
Intervention group Control group
Adjusted difference in
meansa (95% CI)n
Mean (SD)
(mmol/l) n
Mean (SD)
(mmol/l)
HbA1c (venepuncture) at
12 months
143 10.2 (2.0) 155 10.1 (1.6) 0.11 (–0.28 to 0.50), p = 0.584
Change in HbA1c
(venepuncture) at
12 months from baseline
137 0.38 (1.34) 144 0.28 (1.27)
6 missing 11 missing
a Adjusted for baseline and accounting for clustering within clinic.
TABLE 10 Primary outcome measures at 24 months
Primary outcome
Intervention group Control group
Adjusted difference in
meansa (95% CI)n
Mean (SD)
(mmol/l) n
Mean (SD)
(mmol/l)
HbA1c (venepuncture) at
24 months
135 10.1 (1.9) 149 10.0 (1.7) 0.03 (–0.36 to 0.41), p = 0.891
Change in HbA1c
(venepuncture) at
24 months from baseline
129 0.10 (1.52) 138 0.07 (1.53)
6 missing 11 missing
a Adjusted for baseline and accounting for clustering within clinic.
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Secondary outcomes
Secondary young person outcomes
The secondary outcomes as reported by the participants at 12 months and 24 months are shown in
Tables 11 and 12. They are similar between the two arms of the trial. At 24 months the intervention group
has a higher DFRQ scores, which indicates that child/young person is taking more responsibility for
self-management. There is also reduced self-reported happiness in body weight. However, it should be
noted that with a 5% level of signiﬁcance this number of signiﬁcant ﬁndings is consistent with chance.
Changes in knowledge and diabetes regimen were additional secondary outcomes. These data
proved difﬁcult to collect with accuracy. We present the results here (Table 13), but these data should be
interpreted with caution, as they are unadjusted for baseline and have a large number of missing
participants. Young people showed no increase in knowledge at either follow-up.
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Secondary parent/carer outcomes
Secondary outcomes reported by the parent/carer are shown in Tables 14 and 15. They are similar
between the two arms of the trial. At 12 months, the carer reports an increase in the family responsibility
score, which indicates the child/young person is taking more responsibility for self-management of
diabetes. As stated this signiﬁcant ﬁnding is consistent with chance.
Comparison of per-protocol and intention-to-treat analyses
A per-protocol analysis was completed using participants who had attended three or four modules.
In general the results from the per-protocol analysis support the ﬁndings from the intention-to-treat
analysis of no effect of the intervention on any of the primary or secondary outcomes. The per-protocol
analysis tables are in Appendix 6.
Subgroup analyses
A number of prespeciﬁed subgroup analyses were carried out. The results from these are given in
Table 16. The subgroup analysis suggested that those with higher baseline HbA1c levels experienced a
small rise in HbA1c that was signiﬁcant at 12 months but not at 24 months, suggesting that those with
higher HbA1c levels responded poorly to the CASCADE intervention. Given the number of statistical tests
completed this result is consistent with chance.
Serious adverse events
Serious adverse events were reported through clinics using a standardised reporting form following a SOP.
Table 17 provides the number of SAEs reported by site staff.
Despite procedures in place and review of these procedures during the trial, it was recognised that fewer
than expected SAEs were being reported. Therefore, the CNR data were used to ascertain a clearer picture
of the number of SAEs that occurred during the trial. Tables 18 and 19 show the number of SAEs
identiﬁed through the CNR.
Table 19 shows that there is no evidence of any difference in the number of patients experiencing SAEs
between the two arms of the trial.
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TABLE 16 Primary outcome (HbA1c)
Primary
outcome
Follow-up
12 months 24 months
n
Adjusted difference in
meansa (95% CI)
Interaction
p-value n
Adjusted
difference in
meansa (95% CI)
Interaction
p-value
Age group
≤ 12 years 129 0.17 (–0.34 to 0.68) 0.639 118 –0.20 (–0.75 to 0.36) 0.268
> 12 years 149 0.02 (–0.45 to 0.50) 146 0.20 (–0.30 to 0.71)
Sex
Males 128 0.11 (–0.40 to 0.62) 0.914 122 0.18 (–0.36 to 0.73) 0.398
Females 153 0.08 (–0.40 to 0.56) 145 –0.12 (–0.62 to 0.39)
Baseline HbA1c level
< 10.4mmol/l 191 –0.15 (–0.59 to 0.28) 0.015 179 –0.20 (–0.64 to 0.24) 0.106
≥ 10.4mmol/l 90 0.63 (0.05 to 1.20) 88 0.40 (–0.21 to 1.01)
SES (index of multiple deprivation)
Least
deprived
80%
204 0.09 (–0.32 to 0.50) 0.201 189 0.11 (–0.34 to 0.57) 0.895
Most
deprived
20%
48 0.63 (–0.15 to 1.40) 50 0.18 (–0.71 to 1.06)
a Adjusted for baseline and accounting for clustering within clinic.
TABLE 17 Serious adverse events reported by site staff
SAE Intervention Control
Severe hypoglycaemia 0 2
DKA (when pH < 7.1) 2 6
Death (as a result of DKA)a 1
Less severe DKA (not meeting the criteria above) 5 3
Other (monitoring and advice) 0 1
a This SAE was notiﬁed by a member of the research team – not by the clinic.
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TABLE 18 Serious adverse events identiﬁed through CNR by event type (from hospitalisations recorded in
case notes)a
Adverse event type
Intervention, n
(N = 163)
Control, n
(N = 180)
Overall, n
(N = 343)
DKA 58 67 125
Hyperglycaemia with or without ketones 29 19 48
Hypoglycaemia 8 7 15
Severe hypoglycaemia 2 4 6
Uncontrolled diabetes/monitoring or insulin adjustment 9 8 17
Admission for general illness, for which T1D was a
factor – includes gastric issues and pump problems
19 27 46
Accident or other problem (T1D not a complication) 17 26 43
Reason for admission not recorded 3 29 32
Total SAEs 145 187 332
a Includes hospitalisations from point of study consent until CNR carried out (approximately at 24-month follow-up).
TABLE 19 Number of SAEs per participant (from hospitalisations recorded in case notes)
No. of SAEs recorded Intervention, n (%) Control, n (%) Overall, n (%)
0 95 (58.3) 106 (58.9) 201 (58.6)
1 34 (20.9) 37 (20.6) 71 (20.7)
2 17 (10.4) 14 (7.8) 31(8.6)
3 7 (4.3) 5 (2.8) 12 (3.5)
4 2 (1.2) 6 (3.3) 8 (2.3)
5 3 (1.8) 4 (2.2) 7 (2.0)
6 3 (1.8) 3 (1.7) 6 (1.7)
7 2 (1.2) 1 (0.6) 3 (0.8)
8 0 (0.0) 1 (0.6) 1 (0.3)
9 0 (0.0) 1 (0.6) 1 (0.3)
12 0 (0.0) 2 (1.1) 2 (0.6)
Total no. of participants 163 (100.0) 180 (100.0) 343 (100.0)
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Chapter 5 Process evaluation results
This chapter reports on:
1. views of clinic staff participating in CASCADE
2. attendance, quality, ﬁdelity and acceptability of the UCLH training workshops for the UCLH trainers and
site educators
3. feasibility and acceptability for sites organising the intervention
4. feasibility and acceptability for sites delivering the intervention
5. feasibility and acceptability for families engaging with the intervention
6. parents’ and young people’s perceptions of impact of participation in CASCADE and views of staff
regarding the impact on young people and their own practice.
Data sources and respondents
Sources of data used for these PE ﬁndings are listed below. Site codes given after each quote indicate if
the respondent is from an intervention site (I) or a control site (C).
1. observation of the UCLH training
2. training workshop attendance data (provided by UCLH)
3. site educator CASCADE training evaluation forms for modules 1–4: 170 (99%) evaluation forms
received immediately after 12 UCLH workshop sessions
4. site educator CASCADE training questionnaires: 27 (63%) received a few weeks after the UCLH
training from 18 nurses, eight dietitians and one doctor
5. interviews with the two UCLH trainers
6. researcher observation of CASCADE modules delivery: 47 modules observed across 13 intervention
sites (12 each of modules 1, 2 and 4 and 11 of module 3, between November 2009 and March
2011); observations were made in the ﬁrst set of CASCADE groups run; in ﬁve sites they were in the
second set and in three sites they were the third set; site educator views were obtained after each
observed module
7. site educator pro formas completed following delivery of each module: 125 pro formas (94%)
returned following completion of 131 modules
8. interviews with site staff: 30 staff interviewed (15 in each trial arm), after CASCADE groups delivered;
28 of the interviewees were nurses (of whom 14 were site educators)
9. interviews with young people and parents/carers: 53 young people (21 control/32 intervention) and
52 parents were interviewed; of the young people, 31 were female, 17 were 10–11 years old and
36 were 12–18 years old
10. young people and parent questionnaires at 12 and 24 months: PE questions were completed by
135 young people and 121 parents at 12 months and by 121 young people and 114 parents at 24 months.
Staff perspectives on taking part in the CASCADE trial
The decision to take part in the trial
Staff interviewed were mainly nurses. They had become involved in CASCADE mainly because of a
consultant’s interest in being part of the study. About half of them remembered it being a collaborative
team decision to take part:
Dr X said ‘I think we should do this, what do you think?’ And I remember two ladies coming down
[presentation from the research team]. It sounded interesting, so we agreed to do it.
Nurse I11
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For a signiﬁcant minority, involvement was not something they had actively chosen, either because the
current consultant, with little or no discussion, had instigated it or a previous consultant or other member
of staff who was no longer part of the diabetes team had agreed to take part:
By that point I knew [my predecessor] wasn’t gonna come back but I felt that I couldn’t stop the
process because it had gone too far and I’d sort of inherited it all and I just thought, ‘oh my
goodness, how am I gonna cope with all of this?’
Nurse I4
Views on becoming involved in CASCADE
Becoming involved in CASCADE was an exciting prospect for many. They saw it as an opportunity to
develop aspects of their service they wanted and would be expected to offer in the future.
I was quite keen because we’d had to stop giving the diet sessions because we hadn’t got . . . enough
dietetic time and I just thought it would be great to have some structured education . . . and I
thought it was something that we could be involved in and hopefully give something to benefit
the kids.
Nurse I13
Many, however, including those who were generally enthusiastic about being involved, expressed concern
they might not have the time or resources to do what would be required. Nurses were unsure whether
consultants who had agreed to be part of the study were aware of the extent of the work involved.
I was a bit anxious at the time because I felt that the consultant didn’t truly understand who did what
[in CASCADE] and I think she believed that everybody [from the central team] was gonna come in
and deliver the sessions which wasn’t the thing so that made me a little bit anxious.
Nurse I1
Feelings about the outcome of the site randomisation process
Staff had varied reactions to which arm their site was randomised to. About half in the intervention arm
were pleased. An equal number were anxious and concerned often owing to the delay that resulted from
the extended patient recruitment process, which meant that the timing was no longer good for their site
primarily because of lack of resources or staff shortages.
Horrified, well, because of the time delay and by the time we were starting it was just not a good
time for me, so yes, I was horrified.
Nurse I1
Well, initially I think we were a little anxious because at the time we were having staff shortages and
we think from a practical point of view it would have been better to have been in the other arm but
it didn’t matter . . . we were excited to be in it anyway.
Nurse I5
Those randomised to the control arm were also evenly split between relief and disappointment at
the zoutcome.
I was quite relieved because having to do the education [would have been] really difficult for me . . .
actually carrying that out without any support [would have been] very difficult.
Nurse C2
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We’d have liked to have been in the intervention arm partly because we were hoping that people
would like to see what we could do to change our practice to improve the teenagers, particularly 12
and upwards [when they] start to get more independent and not wanting to comply.
C8
University College London Hospitals CASCADE training
Attendance at the training
Workshops 1 and 2 were run on six occasions each between 18 August 2009 and 21 May 2010 at UCLH.
The UCLH trainers also travelled to deliver training to eight staff from two hospitals (in one site) over
2 days. The remaining workshops 1 and 2 were run between 1 and 7 weeks apart, with the majority
≤ 2 weeks apart. Each site sent the required minimum of two staff, with some sites sending more than
two. A total of 43 staff attended. A few sites found it challenging to ‘free up’ staff to attend. Seven
additional staff from intervention sites attended the 1-day refresher workshop. The numbers of participants
at each workshop ranged from two to eleven. The number of clinics at workshops ranged from one to
four (Table 20).
The majority attending were PDSNs. Dietitians from 10 intervention sites attended, eight of whom were
intending to be the second educator. One site, unable to release a second member of the diabetes team
for training, sent a research nurse based at the site. One consultant attended both workshops. Three
consultants attended one workshop or the 1-day refresher. Two nurses who attended the initial
workshops also attended the 1-day workshop.
Fidelity across training workshops
Observation data demonstrated a high degree of ﬁdelity across both workshops. The same trainers
delivered all workshops and maintained a high degree of consistency in both content and style. The
training approach was highly interactive with regular opportunities to clarify concerns in question and
answer sessions.
Satisfaction and acceptability of training
Attendance
The majority of staff who completed the questionnaire (21/27) indicated they had been ‘extremely’ or
‘very’ keen to participate in the training. The remainder were ‘quite’ keen. Any reticence was generally the
result of anxiety about lack of knowledge and experience, lack of control over the decision to take part, or
lack of time to take on the delivery of the groups.
TABLE 20 Numbers of site educators and clinics attending each UCLH CASCADE training workshop
Workshop 1 Workshop 2
No. of individuals No. of clinics No. of individuals No. of clinics
5 3 7 3
7 3 9 4
11 4 2 1
8 3 7 2
5 2 6 3
6 3 6 3
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The UCLH trainers noted during workshop 1 that some attendees appeared to ‘not want to be there’.
Approaches were used to change this resistance into a more relaxed position.
For some it was much more aggressive than that . . . ‘I haven’t got time for this, I shouldn’t be here’
. . . Anger actually, and so we had that conversation and then also started at the beginning . . . I guess
the other side of that was how involved some of these people got, some of these people who came
in clearly feeling a little bit bamboozled into it and not of their own choice, who actually went off
really enthusiastic and positive and that was lovely.
UCLH trainer
Venue and timing
Ten workshops were run in London (at UCLH). Travelling to London was not generally a problem for
intervention clinic staff, as long as they had enough notice. Two workshops were provided locally which
had the advantage of reaching more members of the site team and made attendance easier.
Initially we thought we might have had to go down south and [a staff member] was going off and all
those things . . . ‘oh, what have we done?’, but no, I mean [northern training location] was fine.
Nurse I10
Spreading the remaining workshops out (a few weeks apart) was acceptable to the majority, who said a
2-day block would have been more difﬁcult to attend because of other commitments. Staff and trainers
commented that 2 days of training felt the right amount.
A 45-minute lunch break was provided in every workshop. Breaks in the morning and afternoon depended
on how well training was proceeding. When there were no additional breaks there was feedback that
a break would have been an improvement in view of the high information load and opportunities
to network.
Content and training style
Most staff thought the training was very good, motivating and comprehensive.
I thought it was excellent. I thought it was really good, we were quite motivated when we left,
weren’t we . . . excited . . . I thought it was very well run.
Nurse I5
The primary focus of the workshops was to train site educators to use the speciﬁc techniques of the
programme rather than teach specialist diabetes management. Site educators enjoyed learning about
MI/SFBT techniques. Many found it refreshing to learn a communication style that was non-didactic,
focused on positives and drew on the skills and knowledge of patients and families. They reported this
approach might be useful in their practice.
I think it’s a really clever way of delivering your education. It’s very different to the way I’m used to. I
tend to talk at people and teach that way . . . old fashioned teaching, and I liked seeing the different
style how you actually get them to do the talking and draw it out of them.
Nurse I14
Not all trainees were positive about the approaches and their applicability in the ‘real world’. One trainee
doubted the usability of the approach.
I can see that it would work for some patients, I don’t know it would work for all of them.
Nurse I4
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For another trainee, the approaches were confusing until she put them into practice.
It didn’t make sense at all . . . when it was just talking about MI it kind of lost me a bit. I guess I’m
not so much into psychology . . . but having said that, when you do try and put it into practice
yourself it makes sense.
Nurse I13
Observation and evaluation form data showed variability in understanding by some site educators of some
specialist diabetes management topics. These included food groups, matching food and insulin, CHO
counting, insulin sensitivity ratios and exercise management.
I was shocked at the low level of knowledge for some of them to the point that some of it was
ending up teaching them the content as opposed to teaching them the style of delivery. I hadn’t
expected to be teaching content.
UCLH trainer
One secondary site educator commented
At the time I’d got very little diabetes knowledge so, for me, I was actually learning from it and I
know that’s not really what it was about but a lot of it was that . . . I found it quite intimidating
because of my lack of knowledge.
Nurse I3
The training modelled the approach to be used in module delivery. Witnessing examples of how to run
modules in practice, including the integral group exercises, was considered to be a really useful training
approach by the participants.
It was nice to see them actually do the session as they would anticipate us doing it so that was really
helpful to see how . . . instead of just being talked about it and then left with it.
Nurse I6
The manual and resources
Site educators were positive about the manual and the resources. They found the manual easy to follow
with useful prompts to promote wider discussion.
Preparedness to deliver CASCADE after training
The majority of the 27 participants who completed questionnaires rated their readiness to run sessions (on
a scale of 1–10 with 10 being the highest) at 8 (range 6–9). Despite the majority saying that the 2 days’
training was adequate, there was concern at the scale of the task ahead considering the relative briefness
of the training.
I remember thinking . . . gosh, they’ve thrown a lot of information at me and if and when we did ever
get this running, I don’t know that I’m going to be able to remember all the things I’ve been taught.
Nurse I4
It was a lot in the few days. Teaching people theories and expecting them to suddenly change their
behaviour I think is very difficult . . . cause some things are so set in your approach to leading things.
I’ve taught student nurses before and to try and completely change how you do less talking
[isn’t easy].
Nurse I1
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The time gap between the training workshops and setting up the groups meant that some site educators
said that they had lost focus and conﬁdence.
I came away really buzzing inside to get going, but the downside for me was that we didn’t start
then for probably another 3 months and I felt like I’d lost my confidence a bit.
Nurse I14
The 1-day refresher workshop was offered to all site educators to address this but only two site educators
chose to attend. The UCLH trainers made it clear that they were available to give additional support to the
site educators by phone or by e-mail.
Organising the CASCADE groups
Numbers of groups
A total of 30 groups were run across 14 intervention sites. The modal number of completed groups was
two, with a range of zero to six groups offered by clinics (Table 21). Twelve sites delivered at least one
complete group of four modules. One site only offered the ﬁrst session and one site failed to offer
any groups.
Sites were not given a formal target number of groups but were aware that all recruited participants
should be offered the opportunity to attend a group. A post hoc calculation suggested that 44 groups
should have been run across the 14 intervention sites. Only three clinics completed the maximum number
of groups possible (Table 22).
Size of groups
The aim was to deliver a group to three to four young people of a similar age. This was not achieved in
most modules (Table 23). The attendance ranged from one to ﬁve young people with a mode of two.
TABLE 22 Number of actual groups vs. ideal
No. of groups No. of sites
Completed ideal number of groups 3
One group fewer than ideal number
completed
8
Two groups fewer than ideal number
completed
3
TABLE 21 Number of complete CASCADE groups run
No. of complete groups run No. of sites
0 2
1 2
2 5a
3 4
6 1
a One site ran only three modules in one of their groups.
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Time between modules
The average interval between modules was slightly greater than 1 month (Table 24) though the average
length across all groups (from start to ﬁnish) was approximately 4 months. The main reason for delays was
problems organising dates, as well as site educators being on sick leave or study leave.
Time between training and delivery
As soon as site educators completed the UCLH training they were free to start preparing the groups. On
average, sites ran the ﬁrst CASCADE module 3 months after completing the UCLH training (Table 25) with
module 4 completed 7 months after training.
The training was very good, the only criticism is between training and then actually getting up and
running was about 6 months which is . . . I think the training needs to be done a month before you
go and launch your site.
Site educator I12
A key reason for delay setting up the ﬁrst groups was delay in patient recruitment. Training began in
August 2009; however, patient recruitment was not completed until September 2010. Earlier trained
clinics often had to wait several months before they could start to organise and deliver groups. Many site
educators cleared their diaries in anticipation of delivering groups; however, the delay meant that they
were unable to sustain this with other commitments encroaching on the time required for the project.
Where there were enough patients to make up a group, organising and delivering groups started before
TABLE 23 Average number of young people attending CASCADE modules
Module Total completed
No. of young people attending each module
Range Mean Mode
1 38 1–5 2.6 2
2 32 1–4 2.4 2
3 33 1–4 2.3 2
4 30 1–4 2.2 3
TABLE 24 Days between delivery in individual modules
Intervals between modules: Mean (days) Range (days)
1 and 2 38 7–98
2 and 3 43 14–111
3 and 4 43 14–91
Total between 1 and 4 124 55–238
TABLE 25 Timing between being trained in CASCADE and actually running groups
Intervals Mean (days) Range (days)
Completing CASCADE training and running module 1 of ﬁrst group 101 (n = 13 sites) 42–176
Completing CASCADE training and running module 4 of ﬁrst group 213 (n = 12 sites) 140–280
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patient recruitment was completed. For sites with a low number of recruited patients this strategy
prevented groups being organised by age.
Time between sets of groups
Where sites had sufﬁcient participants groups were mostly run concurrently, organised by age, at different
times to suit particular families. One site had a very long gap between running their ﬁrst set of groups
and their second owing to a site educator being on sick leave.
Days and time of CASCADE modules
Groups were run on a full range of weekdays. They were offered within school time (morning or
afternoon), immediately after school (e.g. 1600), and evening (e.g. 1800). The most frequent time for
running modules was the early afternoon (Table 26). Saturdays and holidays did not appear to appeal to
participants more than weekdays. One attempt at running a module on a Saturday ended when no
participants arrived.
Preparation for running groups
In the majority of sites a single site educator did the bulk of the preparatory work particularly when the
second trainer had limited time allocated to paediatric diabetes (e.g. dietitians and mental health
practitioners). Preparation involved deciding which participants should be grouped together, setting dates
and times and booking rooms. This was felt to be particularly burdensome in sites where there was just
one PDSN.
Initial decisions on how to group participants were considered straightforward, except in sites with small
numbers of recruited patients. Where numbers were small, compromises were made about grouping by
age. For sites with larger recruited numbers this compromise was usually made as they reached the last
groups and the remaining pool of participants was small.
Setting dates and times was the most challenging aspect reported. The initial challenge was anticipating
and/or determining time preferences for participants. Approaches used included contacting families to ask
for individual timing preferences and offering a range of different days. Some staff were prepared to work
outside normal working hours – including evenings and weekends; others were not.
The first one I think we held at about six in the evening having spoken to the families first and that
was the preferred time for them and then we negotiated it as we went along. The first group was
more flexible and were prepared to come in . . . let’s say less outside hours time. The second group
was a nightmare because . . . there was no [flexibility]. ‘We want it at this time and I’m giving up this
to get here’ and there was no concession at all that [my colleague] and I were giving up our
[personal activities].
Nurse I11
TABLE 26 Time of day of delivered CASCADE modules
Time of session n (%) [N = 105a]
Morning 20 (19)
Early afternoon 42 (40)
Late afternoon 26 (25)
Evening 17 (16)
a Timing data were not available for all sessions.
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Other sites made calculated guesses about the best times for holding the modules.
We did the sessions in the morning and I think the reason for that was really I didn’t feel they’d want
to, or be able to, take on that after school when they’re tired.
Nurse I2
I think we did 6.30 to 8.30 [pm] for all our sessions, we thought it was a good choice because we
didn’t want the young people to be missing school.
Nurse I8
The process of trying to reach an acceptable date was considered to be laborious and time-consuming.
Site educators communicated via a combination of letter, telephone, and (occasionally) text. No site used
e-mail or web-based diary systems to help organise dates. For most sites agreeing a date involved a series
of negotiations to ensure that the greatest number of potential participants could attend.
We tried, we sent out an initial letter with a date like say, for example, the 8th of July as so those that
didn’t respond I rang them again and said ‘We haven’t heard from you’ and they’d say ‘I’m on
holiday that day’. So then I offered them an alternative date the following week and some of them
were offered three or four opportunities to come before we abandoned them. So everybody was
offered a selection of dates. It wasn’t through want of trying, it was a shame really.
Nurse I14
Group 2 was the problem. We probably offered something like August, October, November and
December . . . really the people couldn’t make any of those dates.
Nurse I13
Following the setting of the date and time, most sites sent out a standard conﬁrmation letter (provided by
UCLH). Some sent a reminder letter (or made a reminder telephone call) prior to the date, which improved
attendance. Teams that did not send a reminder expressed regret that they had not, thought it should not
have been required or did so after early groups failed.
A common challenge was participants not attending agreed dates. When attendance was poor, site
educators either cancelled or rescheduled to achieve better take-up or ran the session with one family who
were then invited to join remaining modules of a different group. One of the sites that ran three complete
groups offered seven module 1, ﬁve module 2, four module 3 and three module 4. Only one of the
three groups ran with the same participants in (or at least invited to) all four sessions.
The majority of site educators began with great enthusiasm and goodwill trying to accommodate everyone
but became more pragmatic about what was achievable over time. Additional administrative support
would have made the task considerably easier for many sites, especially where site educators had little
administrative experience and had to do this work in addition to normal work responsibilities. No site had
any signiﬁcant level of administrative support for organisation and running of groups.
Oh, it would have been very useful, to have somebody else running around making sure people could
make certain dates . . . reminding them, cause one of the issues we had was that people claimed the
letters had never gone out so I then started reminding everybody a week before.
Nurse I11
Staffing constraints
Staff turnover, absence and lack of ﬂexibility around work hours also inﬂuenced the number of groups
organised. In two sites a site educator left while groups were being delivered. One site found a
replacement who had attended the refresher workshop and the groups recommenced relatively smoothly.
The other site was unable to ﬁnd a replacement and completed only one group (with the original
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educators), cancelling the second planned group. One site did not run any modules. The lead trainer went
on extended sick leave and on return was deployed into a different role. In another site, educators ran
module 1, twice in the morning, on a speciﬁc day of the week – inviting the same four families on each
occasion. On the ﬁrst date only one young person and parent turned up, on the second the previous
attendee and parent returned along with one other participant and parent. Neither returned for module 2.
No further groups were offered owing to the small number of recruited patients in this site.
The added burden of the research context
Problems setting up groups were exacerbated by CASCADE being a research project, not just an
educational intervention. Staff felt pressured by additional trial-related tasks, such as organising research
blood samples and liaison with research staff.
Restricting groups to a subset of recruited patients, instead of offering groups to the entire clinic list was
perceived as making the organisation of the groups more challenging. This was particularly the case in
sites with a small number of recruits and/or where a hospital served a large geographical area making
travel arrangements complex. It also meant that natural groupings of patients (by age, or geographical
area, etc.) were more difﬁcult (and at times not possible). Site educators were aware that they would be
observed delivering some of the modules which added to their concern about achieving reasonable
group numbers.
Use of time
The theory behind use of time was explained in the training workshops:
Site educator: How do we find the time to organise and run the sessions?
Trainer: CASCADE is about organising time differently, not taking more time. For example, a home
visit might take an hour and nothing changes afterwards. But, if you run a CASCADE session, you can
say something to a group of children that you otherwise might have to say on an individual basis.
However, a great deal of frustration was expressed about the time required to organise CASCADE.
In many sites complications around organising the modules took up any time that site educators had
allocated to practice and preparation of the programme.
It suddenly hit me about how much commitment and organisation it was going to take and I do
remember saying to [a colleague] ‘Gosh, I don’t know how we’re going to fit this in with all the other
things that we’ve got!’.
Nurse I4
Staff perceptions were that so much time was spent on organisation it was unlikely to be outweighed by
time saved.
I didn’t notice that it saved me any time because I was constantly chasing them [families] up
to be there.
Nurse I1
The UCLH trainers were aware that organisation would be challenging and allocated time to discussing
this in the training. The extent to which it was to emerge as a barrier had not been anticipated.
There have been no email, telephone requests back to [the trainers] . . . about the content of the
manual, how to teach a particular element or uncertainty about ‘could you go through this again?’
I’ve had nothing. Nothing. The main one has been . . . ‘I can’t get people to come to this group, but
also the admin organising side of it’.
UCLH trainer
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Teamwork
Sites that were the most successful organising and running groups were similar. Two exemplary sites had
dedicated MDTs who were ﬂexible and willing to modify schedules in order to provide additional tailored
care for the young people in their clinics. These sites had shown greater whole team dedication to the
CASCADE project than some of the other sites, for example with greater consultant involvement.
Delivery of the CASCADE education sessions
Site educators
All four CASCADE modules should have been delivered by at least two trained site educators with the
recommended level of diabetes knowledge.165 Delivery in most sites was carried out by two trained
educators (range 1–3). Staff delivering the modules were primarily PDSNs. In some sites the second
(or third) site educator was a dietitian who shared the training equally at some sites, whereas in others
covered only dietary topics. In one site an educator was a Child and Adolescent Mental Health Service
(CAMHS) practitioner (Table 27).The majority of site educators reported that they worked well together.
All sites had continuity with at least one trained site educator. Difﬁculties with second educators were
experienced in a number of sites where they deviated from recommended CASCADE principles. In one site
a dietitian who had not attended any of the CASCADE training assisted with the delivery of a module 4
session. In another site two members of staff who had only attended workshop 1 provided a support role
in some modules. The rationale behind including untrained or partly trained staff was that site educators
felt they did not have speciﬁc expertise that the untrained site educator had (e.g. dietetics or psychology).
In a third site, two groups were delivered predominantly single-handed as the second site educator was
sick. The site educator who ran these solo sessions said the lack of a second educator made delivering the
modules very challenging.
Venues
Staff often had limited choice over venues. All groups, bar one, were held on hospital premises, usually in
a seminar/training room. Most rooms had tables and chairs suitable for a teaching environment. The
groups ran most smoothly when venues were comfortable, light and airy, and the set-up was conducive
to interactive small group activities and discussion. One site held evening sessions in a pavilion in the
community, creating a relaxed and informal environment away from the hospital setting.
Some sites managed with less suitable venues such as hospital wards and consulting rooms. One site held
a module in an open waiting room area of children’s outpatients, with hospital staff passing through while
the group was in progress. In another outpatient setting, there were no tables and the telephone in the
background rang continuously. Distractions such as these disrupted module delivery.
TABLE 27 Number of site educators delivering the intervention per clinic
No. of trained educators delivering modules No. of sites Specialist roles of educators
1a 1 One PDSN
2 8 PDSN, paediatric nurse (one site)
Two PDSNs (three sites)
PDSN and dietitian (three sites)b
PDSN and CAMHS practitioner (one site)
3 3 Two PDSNs and dietitian
a In module 1 there were two site educators but in other modules there was one.
b In the two sites where no complete groups were run (not included in this table), two members of staff (PDSN and
dietitian) had attended the training.
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Measuring fidelity of delivery
Activity completion was measured through site educator self-report and observer ratings. Self-report for each
activity in all four modules had a median score of 7 (out of 7) for every activity (see Appendix 7, Table 52).
Observers scored activity completion lower than site educators, although still generally quite high. When
observers rated an activity as being incomplete, the reasons given were mainly not using techniques enough
or appropriately, rushing, missing a part of the activity or deviating from the protocol.
Time spent on activities
The manual recommends a guide time for each activity within each module. Modules were supposed to
last between 90 and 110 minutes. Most lasted between 75 and 120 minutes (range 55–150 minutes).
Educators could be ﬂexible with timing, depending on numbers in the group, group dynamics, family
knowledge and interest in different topics. Although there was variation between sites, there were no
activities that were either consistently truncated or that over ran excessively (see Appendix 7, Table 53).
A key factor affecting timing was the size of the group. Smaller groups took less time to complete
an activity.
Very few observed modules incorporated a planned break. Observers noted modules ﬂowed better when
there was a scheduled short break to prevent children becoming restless and bored. Offering refreshments
also appeared to help group mood and improved focus.
Content
CASCADE content was consistent with the recommended level of knowledge and skill of a PDSN.165
However, there were areas of the curriculum that some site educators reported were beyond their
expertise, for example use of CHO for exercise management. The educators spent less time than intended
on these sections when delivering the modules. Educators were also more comfortable with activities
where they felt families were engaged and/or knowledgeable.
The one thing that had a real impact on all of them was there was a chart that showed your HbA1c
and the rise. The graph . . . and how when your HbA1c was 14, how much more at risk you were with
your eyes and . . . they all sort of took a sharp intake of breath when they saw that and they’ve all
said since, so it really makes you sort of think. We definitely would love to use that in the future.
Nurse I14
Site educators were less able to encourage discussion when there was initial hesitation from families or the
family found the topic difﬁcult to understand – e.g. matching food and insulin. When this happened some
educators struggled to keep families engaged or interested.
The group introductions and reviews at the start of the modules were particularly challenging. The aim of
introductions in module 1 was to help group members connect with each other, to increase engagement
and encourage attendance. Despite the importance of this activity some site educators spent only a few
minutes on it (see Appendix 7, Table 53). This was particularly the case if they felt they knew the families
well. Managing this activity was also difﬁcult when groups were very small.
Module 1 . . . I thought the beginning of it where you’re trying to identify people’s strengths and
weaknesses is a very difficult starting position.
I13
Educators also did not ﬁnd it easy to facilitate reviews at the start of modules 2, 3 and 4. They struggled to
‘bring forth’ positive events and activities during the reviews speciﬁcally designed to build participants’
sense of knowledge, skills and abilities.
PROCESS EVALUATION RESULTS
70
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Reviewing the previous session, people couldn’t remember, it was too far away and I think some of
that maybe because we’d have to re-schedule our sessions so it might have been longer than the
month but still I do think a month is too long, you’ve forgotten . . . I couldn’t tell you what I did a
month ago . . .
Nurse I13
Content: module 1
Module 1 was reported as the hardest module to deliver owing to ‘dry’ content. Others thought it was
too long, especially for younger children. Activities that they reported most difﬁcult to complete were
(1) focusing on the future and (2) matching insulin to food. Many site educators found it difﬁcult to deliver
the ‘looking to future’ activity at the start of module 1 and thought it should be done later when people
had warmed to the CASCADE process. They struggled to deliver speciﬁc activities when the content
conﬂicted with their standard practice or knowledge of the topic, for example the testing of urine
(vs. blood) for ketones. Variation in levels of knowledge about CHO counting also made this module
particularly difﬁcult for some site educators. The weakest activities reported by observers were
(1) ‘identifying how insulin works’ and (2) ‘what is CHO?’.
Site educator: The only thing that perhaps didn’t work from my point of view and [the other site
educator]’s . . . It’s like a blood stream, how the sugar moves across into the cell, a lot of them didn’t
really understand that . . . We had to spend longer on that . . . lots of blank looks.
Nurse I14
Content: module 2
Site educators reported few difﬁculties with activities in module 2 although observers found that
(1) identifying hypoglycaemia and (2) the pros and cons of BG testing were areas of weakness.
It was pros and cons of BG testing, actually getting them to identify the category, extremely difficult
and I don’t think they all got those words. They may have said them in the list, but it was really hard
for them to actually come out with those words . . . detect, confirm, managing and adjusting. That
was really hard to do that, to put that together.
Nurse I6
Content: module 3 and module 4
In modules 3 and 4 reviews of the previous session were rated as the hardest activity to complete.
Observers rated the weakest activities in module 3 as (1) when to seek help and (2) permanent insulin
changes. In module 4 the weakest were (1) review activity and (2) using CHO to keep BG stable.
Module 4 . . . It’s something we haven’t used before, the way they talk about the exercise and putting
it into (blocks) . . . Found that very useful . . . I think had more children been able to come to that
session, we would have had quite good results cause we’ve got a lot of kids that do a lot of sport and
if they were able to receive that information it would have been good. And even those that maybe
don’t have a high HbA1c that were recruited into CASCADE, if they could be delivered that
information I think it would benefit a lot of people. I think that was probably the best session out of
all of them cause that’s . . . something I don’t think we all cover in clinics very well. We tend to talk
about hypos, talk about ketones, talk about illness . . . little bits here and there and I don’t think
exercise is covered particularly very well at all.
Nurse I1
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Use of techniques
Self-report from the site educators suggested that they felt they had used the SFBT and MI techniques ‘quite
a bit’ on average, but less than had been hoped. ‘Asking open questions’ and ‘focusing on positive solutions’
were rated by site educators and observers as being used the most consistently (see Appendix 7, Table 54).
They were less conﬁdent in ‘avoiding giving choices’ and asking ‘how come?’ and ‘what else?’, which were
designed to evoke responses from families. Observers rated these techniques as only ‘somewhat used’.
Overall completion of activities and use of techniques
An alternative way to calculate ﬁdelity was derived to explore the degree to which individual site educators
delivered the four modules as intended. From each observer activity score overall activity completion and
technique ﬁdelity scores were calculated. The scores only reﬂect observed modules and do not provide
data about changes in ﬁdelity over time for sites that ran more than one group.
The composite activity score was based on all 24 activities delivered in the modules (as listed in Table 28).
With possible ratings of ‘1’ (not completed) to ‘7’ (completed) the highest possible composite score was
168. The range of composite activity scores achieved by the 12 sites that completed at least one full group
of the four CASCADE modules was from 116 to 161 (or 69–96% of the possible maximum score). This
indicates that there was a high level of activity completion in eight of the twelve sites.
The techniques ﬁdelity composite score was based on the six techniques used over four modules. With
possible ratings of ‘1’ (not used at all) to ‘5’ (used extensively) the highest possible composite score was
120. Sites scored between 65 (54%) and 113 (94%). Half of the sites were able to use the techniques to
an acceptable extent (> 70%) in delivery of the intervention (Table 29).
TABLE 29 Composite technique scores
Average composite scoresa No. of sitesb
Range of scores
(% of possible 120 score)
Above 108 (use of techniques ‘extensively’ across all modules) 1 108–113 (94)
84–107 (use of techniques ‘quite a bit’ across all modules) 5 88–108 (73–88)
60–83 (use of techniques ‘somewhat’ across all modules) 6 65–83 (54–69)
a These scores required the imputing of missing data, in some cases.
b Observer techniques scores scale:1 = techniques not at all used, 2 = a bit used, 3 = somewhat used, 4 = used quite a bit,
5 = used extensively.
TABLE 28 Composite activity scores
Average composite activity scoresa No. of sitesb
Range of scores
(% of possible 168 score)
> 144 (average ‘completed’ or ‘not quite completed’ across activities) 3 147–161 (88–96)
132–143 (average ‘not quite completed’ or ‘just more than partly
completed’ across activities)
5 134–140 (80–87)
108–131 (average ‘partly completed’ or ‘just more than partly
completed’ across activities
4 116–129 (69–79)
a These scores required the imputing of missing data, in some cases.
b Observer scores scale:1 = not completed, 2 = between not completed and partly completed, 3 = nearly partly completed,
4 = partly completed, 5 = just more than partly completed, 6 = not quite completed, 7 = completed.
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There appeared to be relationship between technique ﬁdelity and activity delivery ﬁdelity scores – with
sites having similar high, medium or low scores for both. However, there were a few anomalies – one of
the sites that scored lowest in the activity completion rated high on use of techniques, whereas, in
contrast, one of the most successful sites in terms of activity completion rated lower on the use of
techniques. Both these sites took time to use the manual and plan the sessions.
Barriers and facilitators to delivery
Facilitators
Site educators liked the manual and found it easy to use when delivering the modules.
Sites with high delivery ﬁdelity composite scores shared certain features. First, they were relatively
well-resourced teams in terms of stafﬁng. Site educators in these sites spent time preparing by completing
the reading and familiarising themselves with the content and plan of activity before the modules were
run, as emphasised during training. Site educators reported modules worked best when they read though
the module in advance and agreed which educator would be delivering which activity. Modules that were
most successful had two (or three) trained and enthusiastic educators who worked out their module plan
in advance.
Successful sites also had site educators who had experience delivering groups, worked together for many
years in the clinic and good knowledge of the participants. Highest ﬁdelity ratings for individual modules
were obtained where site educators were (1) knowledgeable about diabetes, (2) conﬁdent clear presenters
and (3) persisted in encouraging reluctant participants to complete activities (e.g. breaking into small
groups). These site educators were, in the main, very enthusiastic about CASCADE.
As site educators became more familiar with delivery and the group got to know each other there was
improvement in the ﬁdelity technique composite scores across the four modules. Early challenges were
often overcome through increased conﬁdence gained from running initial modules and increased
familiarity with content and less need to check the manual during delivery. Site educators said they had
started to use the approaches in every day clinical practice and felt better able to deal with silences and
more able to facilitate discussion. Some said that when delivering a module they frequently referred to
what a previous group had said. This worked well as a technique to help generate discussion in smaller
quiet groups. Two sites started with relatively high scores in the ﬁrst two modules dropped off in
modules 3 and 4. These sites swapped site educators across the modules.
The modules ran well when site educators adapted to difﬁcult circumstances (e.g. only one family
attending, difﬁcult family dynamics), ran the sessions at a good pace and ﬁnished on time.
Modules ran most smoothly when site educators had a strong grasp of the MI and SFBT techniques
underpinning the CASCADE philosophy. Consistent and effective use of the techniques created a sense
of inclusion and helped to engage less responsive participants. What worked well:
l A friendly and non-judgemental manner that created a relaxed, informal atmosphere conducive to
positive interaction within and between families.
l Site educators working hard to ‘draw out’ quiet participants through asking open questions,
encourage a thicker description of situations by asking ‘what else?’ and using afﬁrmation and
positive connotation.
l Site educators actively listening to participants, explaining that there were no ‘right or wrong’ answers,
as well as exploring issues and questions raised by asking the group for their views and ideas rather
than ‘providing expert advice’.
An example of a well-run session is provided in Appendix 8.
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Barriers
The four sites rated as having the lowest composite scores had difﬁculty organising the modules, which
took up much of the time and lowered their enthusiasm for delivering CASCADE. There was illness or
disruption in the continuity of the educators with reported time conﬂicts and heavy workloads that meant
the educators were often unprepared for the modules. When there was no preparation observers reported
either less adherence to the manual or a stilted delivery needing to refer repeatedly to the manual. These
groups were also held in problematic venues.
When there was a long gap between the UCLH training and starting the groups site educators said it was
hard to remember what they had been taught and felt ‘very rusty’ delivering the modules.
Despite enthusiasm to use the approaches some found it a challenge to adopt the methods consistently
and found it difﬁcult to maintain the approach in larger or small groups or where there were difﬁcult to
manage group dynamics. Educators sometimes found it difﬁcult to keep mixed age groups focused on
activities and to engage the entire group at once. This resulted in boredom in some mixed aged groups.
One site educator thought that the modules worked better with the adolescents because their knowledge
was better.
Too far apart in age it doesn’t work, you use different methods for each age group even though the
content is the same you do use different teaching methods for a 9-year-old than you do for a
14-year-old.
Nurse I5
Modules ran less smoothly when the site educator appeared confused, lacking in conﬁdence or actively
unhappy about participation in CASCADE. Some site educators fell back into didactic teaching, telling
people what to do rather than using the approaches taught in CASCADE (e.g. asking open questions) to
elicit knowledge. Reasons for reverting to telling and giving advice were because site educators wanted
young people to understand, were trying to keep to time, or participants weren’t giving expected answers.
One educator said she found it difﬁcult asking questions and found it easier to ‘teach’ and tell people
what to do, which was part of her nursing training. Some found it difﬁcult to keep the young people
focused when more challenging topics were introduced. Educators also found it challenging at times to
work with parents and children and keep both of them focused on the task. Lively participants tended to
dominate at the expense of quieter, less conﬁdent ones. Observers noticed that site educators often failed
to engage quieter children whose contributions often went unnoticed. Many agreed that this had been
a key challenge and did not have the conﬁdence to use the approaches enough to address this.
In one group a father was described as ‘very negative’, to which the site educators had found it
difﬁcult to respond.
Young people and families uptake and views on
the intervention
Number of young people attending any CASCADE modules
Ninety-six of the 180 young people recruited to the intervention arm (53%) attended at least one
module. Signiﬁcantly more children (8–12 years) attended at least one module compared with teenagers
(13–16 years) (64% vs. 44%, p < 0.01). Those who attended had signiﬁcantly lower mean baseline HbA1c
levels than those who did not attend (9.52 mmol/l vs. 10.33 mmol/l, p < 0.01). There were no signiﬁcant
differences in attendance by gender, length of time since diagnosis of diabetes, ethnicity or level of
deprivation in the area in which they lived.
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Non-attendance
Eighty-four young people failed to attend any module. There were three main categories for
non-attendance at any CASCADE modules.
1. Seven (4%) dropped out of the study before the CASCADE workshops were offered across six sites.
2. Eleven (6%) were never offered modules to attend by their site either because the site did not run any
modules or had stopped offering modules.
3. Sixty-six (37%) were offered the opportunity to attend the modules but opted not to do so.
4. All sites, bar the one that failed to offer any modules to anyone, had young people who chose
to opt out.
There was no signiﬁcant difference by intervention site when all three reasons for complete
non-attendance were included. However, when the seven who withdrew from the study were removed,
attendance compared with non-attendance was signiﬁcantly different across the intervention sites
(p < 0.04). Table 30 shows that only two sites kept non-attendance at less than one-quarter of the
recruited young people from their site.
The two sites with the lowest non-attendance rate had the lowest mean baseline HbA1c levels for their
recruited patients and completed the target number of groups for their site based on number of recruited
families. The six sites with the highest number of non-attendance struggled with the organisation of
groups, had high proportions of teens (vs. children) and relatively high baseline HbA1c means. There was a
signiﬁcant difference in mean baseline HbA1c level for the young people in the site with the highest level of
non-attendance (75% non-attendance, mean 10.38 mmol/l) compared with the site with the lowest
non-attendance (10% non-attendance, mean 8.75mmol/l, p < 0.03).
Reasons for opting out of the CASCADE education sessions
Young people were asked at follow-up for reasons for non-attendance of CASCADE modules. For the
36 non-attenders that returned the questionnaire the most frequently cited reason was not wanting to
miss school (n = 10). This was especially the case for teenagers, many of whom were preparing for GCSEs.
Eight young people said they were not interested or did not think it would help. Other reasons are
detailed in Appendix 7, Table 55.
I couldn’t be bothered. I just wanted to do the blood tests they asked me for.
Teenager I1
Parents provided very similar responses. Some explained work constraints hindered attendance, which
made it more difﬁcult for their child to as well. Only two parents suggested that they thought that
CASCADE would not help their child.
[My daughter] does not understand diabetes. I hoped that she could attend to learn. I regret her
not going.
Parent who had work conflicts I13
TABLE 30 Categorisation of non-attendance of CASCADE modules by site
Non-attendance (no. of modules attended by recruited young people)a (%) No. of sites (n = 14)
10–25 2
26–49 6
50–100 6
a Following removal of recruits who withdrew before the offer of the education sessions.
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Site educators also commented on parents’ work being a barrier.
I think the child would have liked to have come but it’s more to do with one of parents, it was her
dad. He was a very busy dad, making a lot of money I think, had a lot on his plate really.
Nurse I6
A few parents mentioned their child didn’t want to attend. One said her son was at a stage where he did
not want to talk about his diabetes all the time. Some parents tried to persuade their children to go,
others let this be their decision.
I tried to encourage my son to attend, so did the diabetes nurse. He just didn’t want to go. He said
that if sessions had been during school time, he would definitely have attended so he could miss
some school time!
Parent of teenager I14
When it came to the actual crunch, she goes ‘I don’t wanna do it’ and I was thinking ‘Okay, if you
don’t wanna, don’t want to force you, don’t do it then’. So I wasn’t that bothered about it either.
Parent of child I12
Staff commonly cited lack of motivation when discussing the challenges of trying to encourage attendance
by the most difﬁcult to engage young people.
I would say the people that opted out I would have thought at the beginning wouldn’t have done it
anyway so I was probably very surprised that they agreed to do the CASCADE study in the first place . . .
Nurse I6
I don’t think they were motivated enough, it’s just classic, isn’t it? That’s why they were invited in the
first place, they were not motivated enough and they weren’t motivated enough to come.
Nurse I5
This view is consistent with the higher HbA1c levels among non-attenders.
Some staff also commented they thought attendance at CASCADE would be better for those who were
closer to their diagnosis of diabetes, as these families tended to prioritise health needs over any other
needs (including school work), thus facilitating uptake.
I think when you’re newly diagnosed, they tend to attend better, if you say you need to come to clinic
because you’ve just been diagnosed, they’ll find the time to come that very first Monday whereas
when they’ve been diagnosed 2 or 3 years, they’ll phone up and say . . . ‘I can’t get out of work’ or
something, ‘can’t get out of school so I can’t come to clinic’. They’re a bit sort of more ‘do as they’re
told’ for the first 12 months, they’re more likely to attend and perhaps take it on board, it gets them
in the right frame of mind early.
Nurse I14
Attendance at modules
Attending the ﬁrst module increased the likelihood of attending three or four modules. Of the
96 attendees, 57% attended the full intervention of four CASCADE modules (Table 31) and 78 (82%)
attended three or four modules. There were no signiﬁcant differences by gender, age group, ethnicity,
deprivation score, mean baseline HbA1c levels or length of time since diagnosis between those who
attended one or two modules and those who attended three or four modules.
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Regular attendance did not signiﬁcantly vary by site. Seventy-ﬁve per cent or more participants attended
three or four sessions in 10 of the 12 sites that offered all the modules. The remaining two achieved 67%
retention. Delivery ﬁdelity by the site educators did not inﬂuence attendance.
The main reasons given by young people for missing modules were not wanting to miss school, illness,
having no one to accompany them, snow and forgetting. Only three young people said that they had
stopped attending because they were not interested or did not want to go. Parents’ responses were similar
citing speciﬁc reasons why individual modules had to be missed, and disappointment that they were.
A few parents suggested that attendance was a struggle. One parent commented:
We attended all the sessions but (my daughter) didn’t want to go but I insisted she went.
Parent of teenager I6
Staff agreed most participants seemed engaged and lack of attendance did not indicate a dislike of
the programme.
I think it was personal issues really, one teenager had an exam on the last session, it was
circumstantial rather than not wanting to come I think.
Nurse I6
Number of parents/others attending
The CASCADE intervention was designed for young people and family members to attend together.
Young people were accompanied at 297 of the 327 modules (90%). The majority were accompanied by
at least one parent (mostly mothers); however, other signiﬁcant family members and one girlfriend also
attended (see Appendix 7, Table 56). In 50 modules (17%) more than one member of the young person’s
family attended the session with them. One young man attended three modules on his own. Three
modules were attended by family members but not by the young person.
Acceptability of CASCADE to young people and parents who attended
At 12 months, young people and parents who had attended modules were asked if they would
recommend the CASCADE intervention to a friend in their situation. Overwhelmingly parents and young
people said they would. Only one parent (out of 85) and two young people (out of 94) said that they
would not make this recommendation.
I felt they were of little use to me as I already knew everything however this kind of session would be
useful to someone who had just been diagnosed.
Teenager I9
I think they were very helpful and informative. The atmosphere at the sessions was very nice and
friendly and I would definitely recommend it to friends.
Teenager I10
TABLE 31 Number of modules attended
Module(s) n (%) [N = 96]
1 11 (11)
2 7 (7)
3 24 (25)
4 54 (57)
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In general, responses were positive to speciﬁc questions about module content, group dynamics and the
structure and length of sessions (Table 32).
Group dynamics
Most young people and parents liked being together in the same groups. In the questionnaires two-thirds
said that they’d learned something from other people in their group with positive endorsement for group
work from the interviews. Very small group sizes were criticised by parents and young people with mixed
age groups described as problematic by some young people.
I quite liked the fact that there were other kids with the parents there, I think it takes the pressure off
the individual child so for them to be with other kids that have the same problem and bringing it up
there . . . their issues.
Parent of teenager I8
If more children and parents had turned up, then it might have been [easier to come]. It would be
different; you needed more [participation]. Just one or two doesn’t make it beneficial, you need
feedback from more, at least a good half dozen would’ve been good, I think.
Parent of child I5
[Being in a mixed age group] kind of restricted the things to talk about but if you make CASCADE
each have a different age group, it would be better, bit more open.
Researcher: What else did you want to discuss?
Sort of sexual matters and drinking matters and sort of drugs and stuff like.
Teenager I11
Good [things about CASCADE] – meet other [people with] diabetes your age, with same probs and
how they deal with it; Bad [things about CASCADE]- time consuming (coursework, homework . . .)
and aimed at a younger age group.
Teenager I8
Teaching styles and length
Nearly all parents were positive about the length of sessions and methods used by trainers. In contrast
nearly one-quarter of the young people were critical about the length of the sessions and said they would
have preferred more sessions that were shorter.
TABLE 32 Acceptability of CASCADE (responses from those attending at least one CASCADE module)
Aspects of the group
Answered ‘quite a lot’ or ‘a great deal’: n/N (%)
Young people Parents/carers
Group dynamic
Liked parents/young people being together in modules 81/90 (90) 81/84 (96)
Felt learnt something from other people in the group 64/93 (69) 60/85 (71)
Teaching style and length
Liked the way the trainers taught 74/93 (81) 81/86 (94)
Felt the sessions were too long 22/94 (23) 7/85 (8)
Content
Felt that some of the things covered were too complicated 7/92 (8) 8/85 (9)
Felt that some of the things covered they knew before 48/91 (53) 42/86 (49)
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I would have said . . . cause sometimes with like a concentration lapse, maybe [the sessions could be]
a bit shorter . . . Yeah, cause like say if [the module] started at 3, they did then carry on till 5, all of us
are just thinking about our stomachs.
Child I1
I thought it was OK, but I was a little bored, but my mum thought it was good.
Child I3
It was well planned . . . yeah, it was like humour as well . . . They gave us activities to do and then like
we’d all go through it which helped like to get a good understanding . . . They stood out the front
and did their bit and then they like handed it down to us, to let us like discuss our views on what like
we thought about it.
Researcher: Is that a good way of doing it?
Yeah . . . I think so, like we would all have different methods of like different things, so . . . yeah,
it made the sessions better that we could all like discuss our views in the middle of the sessions.
Child I1
Most young people thought it was a good thing to know the site educator in advance of the modules.
A few were critical of this, however, because they felt the nurse had preconceived ideas about them.
I think it makes it more personal [if you already know the site educator] . . . I think I would have felt
less comfortable [if I hadn’t know them] cause I was meeting new people in the group and I would
have had to have met new nurses as well, it could have been quite awkward cause we all knew
[the site educators], it was all quite mutual.
Teenager I9
Content
About half the parents and young people thought the CASCADE content covered things they already
knew, but many commented positively about having an opportunity to revisit this information.
Quite a lot was a reminder of what we might have known but it was still very helpful. I enjoyed
it a lot
Teenager I6
I thought it was really useful – right balance between sciency and everyday terms and it
was applicable.
Teenager I11
Well I didn’t enjoy it that much because they’re basically saying things like I already kind of knew and
when I got diagnosed I got taught about all the things that they were doing.
Child I5
Perceived impact of CASCADE: young people, parents and staff
These data complement the quantitative data on the primary and secondary outcomes of the trial. They
provide additional information in relation to the feasibility of using the selected trial outcomes to measure
programme changes.
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Perceived impact of CASCADE
Nearly all parents who completed follow-up questionnaires (95%) and/or took part in interviews perceived
CASCADE to have had some positive impact. When parents reported no real changes, this was sometimes
because they said they had always felt conﬁdent about managing the diabetes, and/or encouraging their
son/daughter to participate in sports and other activities. During interviews, a few described some change
since attending the groups but were unsure whether or not this should be attributed to CASCADE rather
than other factors, such as increasing maturity or other life experiences of their child. One parent reported
that although useful at the time, attendance at the sessions had no continuing impact. Another parent
expressed disappointment that it hadn’t helped as she had hoped.
Like the parents, almost all young people identiﬁed some impact of the CASCADE sessions. Many
indicated that changes had been both positive and sustained but often perceived as modest.
Researcher: Has CASCADE changed the way you look after your diabetes?
A little bit.
Researcher: How has it changed?
Cause like if it’s too high I give myself a few units and then I go and do like take the dog for a walk
or something like that.
Researcher: So is there anything you can do now you couldn’t do before CASCADE?
No.
Researcher: So you haven’t learnt anything new?
I have, just like little bits? . . . Um, matching my food to insulin.
Teenager I1
Speciﬁc themes of how CASCADE was perceived to have had an impact are detailed below.
Improved knowledge and understanding
Ninety per cent of parents who attended the CASCADE sessions reported a greater understanding of the
need for CHO counting with others reporting increased knowledge relating to insulin and CHO (Table 33).
In the interviews many parents reported increased knowledge as a result of CASCADE, either for speciﬁc
topics or it had reinforced or supported their existing knowledge base.
At 12-month follow-up approximately three-quarters of young people identiﬁed increased knowledge
and improved understanding in diabetes management as a positive outcome of attending CASCADE
(see Table 33). CHO counting, matching insulin to food and exercise were most commonly cited as areas
of increased knowledge and many young people gave examples of applying this knowledge to
daily management.
I still eat but now I’m starting to inject the right amount.
Researcher: And you weren’t doing that before?
[before CASCADE] I’d sometimes miss the injections.
Researcher: So it’s made you want to do your injections?
Yeah, cause I understand a bit more.
Teenager I14
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Many examples were given of how the young person had applied this knowledge and understanding to
the management of their illness with subsequent outcomes.
Well I’ve learnt new things . . . yeah, I could do some things but it’s just like improved the way that I
do it . . . I’d probably say like carb counting, and yeah, I used to have like a rough idea, now I know
like things that are already in my head, like how much a piece of bread . . .
Child I1
Another young person was now able to make their own adjustments to match insulin to foods and
explained the nurses had ‘shown her different ways’.
At 24-month follow-up 84% of parents who attended the modules continued to report that CASCADE
had increased their knowledge (Table 34).
I found the sessions very informative, especially where growth hormones and ketones were
concerned. I thought I was quite clued up on diabetes until I attended these sessions.
Parent I9, 24-month questionnaire
Greater confidence in managing diabetes and making decisions
At 12 months, over two-thirds of parents who attended any CASCADE module reported greater
conﬁdence in making decisions in the day-to-day management of their child’s condition; 78% felt that
they were better able to control their child’s BG levels (see Table 33). Parents who attended the groups
commonly reported anxiety and worry had decreased. Greater conﬁdence was frequently attributed to an
improved understanding of diabetes and its management, and a belief that their child’s diabetes was
being managed more effectively. In a few instances parents identiﬁed a particular component of
TABLE 33 Parents’ and young people’s perceptions of inﬂuence of CASCADE: 12-month questionnaire
After attending some or all of the CASCADE diabetes education
sessions, how much did your child/you:
Answered ‘quite a lot’/’a great deal’
Parent: n (%)
[N = 90]
Young person: n (%)
[N = 97]
Knowledge
Understand better how insulin works 66 (74)a 70 (73)a
Understand better which foods contain CHO 73 (81) 68 (70)
See why counting the CHO in the food your child/you eat(s) can be helpful 80 (90)a 73 (75)
Intention to change
Want to stop your child’s/your glucose levels from going too low or high 85 (94) 85 (87.5)a
Want to test your child’s/your BG levels more often 56 (43)a 40 (42)b
Control
Feel more in charge of your child’s/your diabetes 61 (69)a 65 (68)b
Feel able to change your child’s/your insulin dose when they are exercising 68 (77)b 66 (69)a
Feel you are able to control your child’s/your BG levels better 70 (78) 64 (67)b
Access to care
Feel more able to ring/contact your diabetes nurse/GP/hospital if your child/
you need(s) help
72 (82)b 52 (54)a
Family dynamic
Feel you had a better understanding of how diabetes affects your family 67 (75)a 69 (72)a
a One missing.
b Two missing.
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CASCADE which they had found helpful, for example a log book as a tool for assessing foods. Young
people also reported greater conﬁdence making decisions about insulin needs and application of this
knowledge in day-to-day management of diabetes.
At 24 months, 61% of parents who had attended still reported more conﬁdence managing their child’s
diabetes. Over half said they were happier about how their child felt about their diabetes and just under
one-third said they worried less now about their child’s diabetes as a result of CASCADE (see Table 34).
Ambivalence in relation to putting knowledge into action was highlighted by nearly all the parents (93%)
reported a greater desire to stop their child’s BG going too high or low; however, less than half (43%) said
they wanted to test their child’s BG level more often.
Reported impacts on disease management and lifestyle
Improved management of diabetes was described by a number of interviewed parents. In one instance, a
parent identiﬁed CASCADE as the reason for their daughter not having had an admission to hospital since
the sessions. Improved BG levels were also reported in a number of cases.
Additionally some of the interviewed parents suggested practical and lifestyle impacts of attendance at
CASCADE modules. Speciﬁc points made by parents included changes in shopping habits, closer reading
of food labels, understanding of CHO counting, and managing sugars with exercise. In one instance, the
parent reported that as a consequence of the participation in CASCADE, she was now able to leave the
home for a day or two without worrying.
TABLE 34 Parents’ and young peoples’ perceptions of impact of CASCADE: 24 months’ questionnaire
After attending some or all of the CASCADE diabetes education
sessions, how much did your child/you:
Answered ‘quite a lot’/’a great deal’
Parents: n (%)
[N = 80]
Young people: n (%)
[N = 91]
Knowledge
I/they learnt new things about diabetes 67 (84) 73 (80)
The sessions helped me understand things I already knew in relation to my
child’s/my diabetes
49 (61) 51 (56)
Confidence
I felt more conﬁdent afterwards in regard to managing my child’s/
my diabetes
49 (61) 55 (60)
I worry less now about my child’s/my diabetes 23 (29) 39 (43)
I am happier about how my child/I feel(s) about their/my diabetes now 39 (49) 27 (30)
Access to care
I liked spending time talking to the diabetes team without being in a rush 48 (60) 36 (40)
Family dynamic
It was helpful being with other parents and young people dealing with
diabetes
67 (84) 41 (45)
Being with my child/parent at the sessions was helpful 57 (71) 53 (58)
I get on better with my child/parents with regard to their/my diabetes now 29 (36) 14 (15)
No impact
CASCADE did not help me/my child 4 (5) 8 (9)
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Changes observed in the young person by parents
Young people were described in interviews by parents as having greater awareness and understanding of
their condition, and being more conﬁdent and comfortable with managing their condition. Examples given
to illustrate this were changes to regimens and taking more responsibility.
Especially in school time, he is more responsible.
Parent of teenager I12
One parent described how her daughter, previously, apparently disinterested, was now motivated to
manage her condition effectively and took responsibility for many tasks with which she had been
previously less co-operative.
Social impacts were also reported. One parent observed that her daughter now felt able to discuss
diabetes with friends and participate in social activities she had previously avoided. Another parent
reported how her son had become more accepting of his condition and was more open with his friends.
Young people’s observations of self-change
Greater understanding of long-term complications of disease motivated one young person to change
eating habits. This young person also reported
Keeping a lot more close eye on my BG . . . I think it made me realise . . . keep it under control now
so I’ll be healthy when I’m older.
Teenager I3
Closer attention to, and/or more frequent testing of, BG levels was reported by many young people as well
as the belief that they could make more appropriate adjustments particularly in relation to food and sport.
I suppose I’m taking it more seriously . . . I’m looking at more sort of how I should be eating and how
like exercise and other things, how it all affects . . . you know . . . I change my units up and down
based on what I’m eating and what I’m doing.
Teenager I11
Young people becoming more proactive in the management of their condition was common, for example
one young person reported doing her own research:
[Regarding different foods] I noticed that they’re not good for me and I also got a list of things that
were good and bad for me off the Internet.
Child I12
Changes of attitude and emotional factors
Sessions came along at the right time for this young person:
I had to finally accept and think that it was enough of actually going into hospital and getting into a
lot of trouble.
Teenager I14
At 12 months young people felt more in control (68%). At 24 months they described a change in attitude,
including ‘greater acceptance’ of the condition and the need for injections. Forty per cent reported that
they were happier with their diabetes as a result of attending CASCADE and more conﬁdent (43%)
and comfortable in the management of their condition (see Table 34).
[After CASCADE] I look after it much more than I used to. I feel good, just to know that I know.
Teenager, I5
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I’ve been more happier . . . yeah, like around the house I’ve been more happier. Not so many strops
. . . Cause my readings are better and we’ve been given a lot more information about the ketones and
how to treat it . . . I found it really good . . . like useful the way they presented it.
Child, I13
In some cases young people also reported that they could take more responsibility:
I can do more things now, like by myself.
Child, I11
. . . if I’m in a low I don’t have to . . . nobody else has to worry about it that much cause I can
handle it.
Teenager, I5
Partnership between parents and young people
At 12 months, three-quarters of parents said they had a better understanding of how diabetes affected
their family following CASCADE. Participation had a positive inﬂuence on parents’ relationship with their
son/daughter and their interaction managing diabetes.
Attending modules with their son/daughter was identiﬁed as beneﬁcial by a number of parents. They
described a shared understanding of the condition, which made communication at home easier. Parents
also described how after sessions both parents and young people had a greater appreciation of each
other’s perspectives and concerns. One parent also reported how they enjoyed spending this dedicated
time, including the travel time and attending the sessions, with their son/daughter.
She’s not thinking ‘shut up’, she knows why I’m saying it, she understands . . . why I was saying it.
Parent of child I6
I think we’ve both been told the same . . . we’re both more on an even keel.
Parent of teenager I12
A number of parents reported they learnt more about their son/daughter by attending CASCADE with
them. For example, they discovered that their son/daughter had greater knowledge and understanding of
their diabetes than they previously thought, or gained more insight into how their son/daughter felt about
having diabetes.
At 24 months, 71% of parents still reported it was helpful to have been at the sessions with their child
and just over one-third said they get on better with their child regarding their diabetes now, as a result of
CASCADE (see Table 34).
Young people also reported better co-operation with parents in managing diabetes, as a consequence of
having a better understanding of the need for good management.
I just like, my relationship . . .
Researcher: Your relationship with your mum?
Like I can become less angry and stuff and like less agitated and stuff.
Teenager I14
. . . my mum used to say inject and I always did it like an hour later cause I was feeling it won’t affect
me, but they showed me the graph and whenever mum told me to inject, I did it like seconds after.
Child I14
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. . . she [mother] probably worries less because she knows I know a lot more about it.
Teenager, I12
One young person said his father now “paid more attention” and would engage in discussions to help
achieve appropriate sugar levels.
Communication with diabetes team
Pre-existing relationships and accessibility were generally felt to be very good, therefore, the majority of
parents and young people reported no change in the way they might contact or relate to clinic staff.
However, at 12 months parents (82%) reported they were more able to contact health services in regards
to their child’s diabetes after CASCADE. At 24 months, over half (60%) said that they liked spending time
talking to the diabetes team without being in a rush. Reported changes were always in a positive direction,
for example feeling more able to ask for help, or being more prepared to ask for explanations or to
‘challenge’ answers to questions. Positive changes for young people were that they found staff more
approachable, were more conﬁdent raising issues for discussion and prepared to disclose their feelings:
I used to never tell the truth about my bloods because I was scared they would shout at me . . . But
now . . . if I’m like high I’ll tell them . . . and they sort it out.
Child, I14
I wouldn’t say changed it [feelings about talking to nurses and other staff], but like I say, I have
become more confident with knowing what I’m actually talking about.
Teenager, I11
Combined impact scores (12 months)
The scores for the nine factors in Table 33 (all except nursing contact) were combined to form a composite
measure of the perceived impact of CASCADE at 12 months for parents and for young people. Scores
could range between 0 and 27. Parents had a mean score of 19 with 85% rating CASCADE as having
helped them ‘quite a lot’ or a ‘great deal’ (Table 35). Young people who had a mean score of 17
with 78% rating CASCADE as having helped them ‘quite a lot’ or a ‘great deal’ with (see Table 35).
For the parents composite perceived impact score there were no signiﬁcant differences by age or gender
of children or by the number of sessions attended. Children reported a signiﬁcantly higher impact than
teenagers (mean 19.9 vs. 15.6, p < 0.01); however, there was no difference by gender or number of
sessions attended.
Long-term impact on blood glucose control
Over half of parents reported that CASCADE had a long-term impact on motivating their child to keep
trying to keep their BG well controlled. Just under half of young people reported some long-term impact
on how hard they tried (Table 36).
TABLE 35 Parents and young person composite perceived impact of CASCADE at 12 months
Scores
Parents: n (%) Young person: n (%)
Mean score 19 (IQR 16–23): N = 84 Mean score 17 (IQR 14–21.5): N = 89
0–4 (‘no impact’) 2 (2) 4 (5)
5–13 (‘only a little’ impact) 11 (13) 16 (18)
14–22 (‘quite a lot) 47 (56) 55 (62)
23–27 (‘a great deal’) 24 (29) 14 (16)
IQR, interquartile range.
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Why CASCADE might have had less impact
A couple of parents said the information covered was known already. A few felt that group dynamics
(differing characteristics of participants – e.g. ages, regimen, small group size) reduced the potential
impact. Several parents acknowledged the difﬁculties of trying to change behaviour in young people.
I think being a ‘teenager’ has interfered with her understanding. She knows what she should do but
doesn’t always do it. Hopefully this is something that she will grow out of and get back on track.
Site I2, 24-month questionnaire
Useful to have time to talk through issues surrounding management, but my child is at an age now
where she will not always listen to advice.
Site I1, 24-month questionnaire
Two parents also suggested that although they liked CASCADE, the intervention did not seem enough on
its own to overcome entrenched problems.
I will always worry about my child’s diabetes. My child is very angry about having diabetes and I don’t
think the amount of lessons about diabetes will stop my child from asking ‘why me?’! . . . My child
tries hard but feels disappointed when goes to clinic and the results aren’t what she expects. Then
leaves feeling low and not wanting to do anything including blood readings.
Site I6, 24-month questionnaire
The most frequently mentioned reason for CASCADE failing to have an impact for young people was that
they already knew the information covered. Some said they were bored or the sessions were too long or
the content was boring. Young people also said that mixed groups with different ages and genders and
varied regimens made the groups less helpful for them.
Staff perceptions of impact
At the point of delivering sessions staff were generally positive about the potential for impact and the level
of involvement of families who attended. Several site educators noted some children were opening up
more in the sessions and were committed to attending. These staff were generally positive about the
impact that the activities were having on the knowledge and engagement of young people who attended.
I think it’s made them more aware of how important it is looking at the future and complications.
Nurse I14
Staff were aware of young people who they believed as a consequence of CASCADE tested their BG more
often, had better clinic attendance, were more conﬁdent and relaxed, which, in a few cases, had
improved relationships with staff and might have better HbA1c levels.
TABLE 36 Parents’ and young people’s view of long-term impact on BG control (24 months)
Views of long-term impact on BG control
Parents: n (%)
[N = 75]
Young people: n (%)
[N = 86]
The sessions made my child/me want to try harder and he/she has/
I have carried on trying hard
42 (56) 43 (50)
My child/I tried harder for a while after the sessions but has/I have not
been able to keep this up
24 (32) 27 (31)
The sessions made no difference to how hard my child tries/I try 9 (12) 16 (19)
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I have seen some changes and at least a better understanding in all of the others. One of the young
men from the first session . . . is a little less frightened of controlling his diabetes and used to be very
reticent to put doses up cause he would be frightened of hypos and things like that, so it’s improved
that. As to HbA1cs and things, I haven’t seen a huge difference so far . . . I would say a slight
improvement in parents and child relationships and slightly better base knowledge but I’ll wait and
see whether it’s implemented fully.
Nurse I11
One of the people who came to . . . all four sessions, they’ve turned theirself around and I think if it’s
only helped one out of 8 . . . then it’s done its job. Yes, they’ve changed and the parents have
commented how much it’s changed them.
Nurse I12
In follow-up interviews, often several months after all groups had been delivered, site educators expressed
disappointment that the intervention did not seem to be having a more measurable impact, although they
did feel that some young people had beneﬁted.
A variety of reasons were given by staff for this potential lack of impact including entrenched
behaviour, lack of engagement, individual personality, lack of motivation to change and insufﬁcient
parental involvement.
Some people aren’t comfortable in a group setting, you will always get that, some will do fine and
engage and get things out of it, others will always sit back and not engage.
Nurse I5
I’ve spoken to a parent of one of the young ladies who was saying that she’s very good at interacting
in the session and she’s very knowledgeable and all that involved . . . given information willingly but
then the mum has said to me that behind the scenes that they’re still very much at loggerheads at
times over the diabetes and she doesn’t feel necessarily that behind the scenes much has changed
with that individual.
Nurse I8
Well, it’s only going to benefit the ones that actually want to make a change I think really or want to
consider making a change let’s say but there’s obviously those who just wouldn’t be interested
regardless of what you offered, so . . . yeah, it’s going to benefit some more than others.
Nurse I3
No comments suggesting a negative impact of attending the groups CASCADE were received.
Having taken part, many staff valued the experience of participating in the intervention arm of the trial
and felt that the CASCADE approach was a very positive one. Some suggested they would like to carry on
running CASCADE groups but were concerned about the resources required in terms of staff time and
capacity. Some staff having being trained in CASCADE reported an impact on their own practice beyond
the education groups themselves. In particular, they were, and expected to continue, using MI techniques,
for example employing them in consultations with young people.
Biggest thing for me was the MI and that way of doing things and I consistently pick myself up in
clinic when I find myself slipping into the whole ‘you should do this, you should do that’. Well, I like
to think I use it all the time.
Nurse I11
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There were examples where staff explained that they had actively chosen not to continue with
such techniques.
We’d met with mum 2 weeks ago and said we’ll try the motivational approach with [your daughter]
and see if we can get her to reach her own outcomes . . . goals, and she said ‘Oh no, don’t try that
with [my daughter], she knows what you’re up to and she doesn’t like it, just talk to her straight’.
So we were very straight with her recently and her HbA1cs improved by us using the old-fashioned
method. Well, we weren’t too harsh on her but we did have to say ‘ if you don’t follow the rules
to keep yourself safe we’ll have to consider you stop using the pump’ and she actually liked that.
Nurse I5
Conclusions
The mixed-methods PE demonstrated that the CASCADE intervention had promise but faced some
challenges in implementation.
It proved possible to train site educators in every site and the intervention was delivered with relatively
high levels of ﬁdelity to some families in most of the sites. Young people and parents who attended
and staff who delivered it were enthusiastic about CASCADE’s relevance and members of all stakeholder
groups perceived that it had some impact.
The PE illuminated key contextual factors that affected implementation. Not all the site educators had the
level of expertise expected. Setting up groups proved frustrating and time consuming and used site
educator time that might otherwise have been devoted to practising delivery of the intervention groups.
Approximately half of the families that were offered the groups attended; take-up was particularly low for
those young people with the highest HbA1c levels. Fewer groups than expected were run, and those that
did were smaller in size and more mixed in terms of ages of participants than considered ideal. Delivering
the intervention to these non-ideal groups was sometimes very challenging.
The PE ﬁndings suggested that some aspects of the CASCADE model contributed to the failure of the
intervention to achieve expected outcomes. In particular, the expectation that the site educators could
organise and deliver the intervention with high ﬁdelity but minimal ongoing support. The theory that
young people with the worst glycaemic control would voluntarily attend a group intervention outside
of normal clinic appointments also was shown to be problematic as was the expectation that CASCADE
would not add signiﬁcantly to the workload of site educators.
These implementation and model factors were compounded by trial factors, including the small numbers
of recruits in some sites, an extended time lapse between training and delivery caused by delays in trial
patient recruitment, and workload related to supporting data collection. We would recommend that the
site educators carry out some practice runs delivering modules before actual delivery in the trial and be
assessed for ﬁdelity of delivery and constructive feedback in any future such interventions.
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Chapter 6 Standard care in NHS clinics
Introduction
The recommended core paediatric diabetes team should include a consultant paediatrician (or
diabetologist) with specialist expertise in diabetes; a PDSN; a registered dietitian and clinical psychologist
(or mental health professional).4 The most recent survey in the UK showed that stafﬁng had improved,
with 98% of consultants having a special interest in diabetes; a PDSN working solely in diabetes in 88%
of services; 93% having a paediatric dietitian in clinic; and 21% having a psychologist as an integrated
member of the team.182,183 The NPDA collected data on 23,676 children and young people aged
< 25 years diagnosed with diabetes.5 Fewer than 16% achieved the recommended target glycaemic
control of < 7.5%.
Although the aim of any diabetes team is to provide expert practical guidance and skill training, until
recently there has been no national curriculum for either HCP training or a nationally agreed curriculum.184
The SWEET project (better control in paediatric and adolescent diabetes in the EU: working to create
centres of reference) identiﬁes different levels of knowledge expected from each core HCP.185
This chapter describes the type of diabetes care that children, young people and families currently receive
and explores the context in which CASCADE was delivered within NHS clinics. It describes clinical teams
and patient numbers, outpatient services, education at time of diagnosis and any ongoing structured
education including group work. Key challenges to delivery are also detailed.
Data sources
l Staff interviews after the CASCADE groups were completed.
l Parent/carer and young people’s interviews.
l Detailed ﬁeldwork notes.
l Data collected for the minimisation criteria.
l CNR.
Patient numbers and stafﬁng
Patient numbers
The number of registered patients per clinic ranged from 78 to 220 (control) and 90 to 280 (intervention)
at the start of the study, increasing slightly across both arms during the study.
Consultants
The majority of sites had one paediatric consultant. Six had two consultants and one had three. In 27 sites
the ratio of consultants (including staff grade) to patients ranged between 1 : 80 and 1 : 120. In one site
(intervention) it was 1 : 170. In one intervention site the consultant was on long-term sick leave for the
majority of the period from patient recruitment to completion of delivery of the intervention.
Nursing
Approximately half of the 28 sites had one PDSN, one (control) had four, with the remainder having two or
three (Table 37). Nurse to patient ratio ranged from 1 : 51 to 1 : 170, with seven having a ratio of ≥ 1 : 100.
The RCN recommends a ratio of 1 : 70.165 The majority worked part time. At the start of the trial there
were 29 nurses in the control clinics [22.4 whole-time equivalents (WTE)] and 24 in the intervention
clinics (17.9 WTE). In control sites there was little change in nursing time over the course of the study.
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Two intervention sites had a 100% increase in nursing WTE. All control clinic nurses and over 90% of the
intervention clinic nurses described themselves as being employed as PDSNs, with the majority having at
least one nurse who had worked at the site, in their current role, for over 5 years.
Dietetic support
In control sites, 13 out of 14 received approximately 0.1 WTE dietetic support compared with 0.2 WTE in
intervention sites. The dietitian was not always a paediatric dietitian. The majority of dietetic time was
used to cover routine paediatric diabetes outpatient clinics and newly diagnosed patients.
Psychological support
Very few sites had any integrated psychology provision in the early stages of the study. Lack of
psychological support was a major concern for many staff. In general, referrals go to local CAMHSs. This
was almost unanimously considered to be very unsatisfactory with long waiting lists and the threshold for
accepting young people often too high for most referrals from the diabetic team.
Unless it’s a suicide attempt it’s difficult to get anyone to see children.
Site educator I12
Two intervention sites appointed a psychologist during CASCADE, at which point patients began to see
a dietitian and psychologist at every clinic. Two other intervention sites referred patients to the UCLH
diabetes team to access psychology services.
Team working
In most sites all members of the MDT were in an acute setting; however, there were a number of sites
where the PDSN was based in the children’s community nursing team – working alongside generic
community nurse colleagues.
We’ve no longer got a Band 7 [Nurse] so we’ve been incorporated into the Children’s Community
Nursing team. It does mean that we don’t have anybody leading diabetes and keeping us as one
team which we’re meant to be. A lot of things that are challenges to us at the moment are due to
the fact that we don’t have a Band 7 because the Children’s Community Nursing team leader who is
currently our team leader has no concept how diabetes as a specialism works really and doesn’t really
understand how we work.
Nurse/site educator I3
TABLE 37 Paediatric diabetes consultant and PDSN numbers at baseline by site
Baseline levels Intervention sites (n = 14) Control sites (n = 14)
No. of paediatric diabetes consultants
1 11 10
2 2 4
3 1 0
No. of PDSNs in clinic
1 6 4
2 6 6
3 2 3
4 0 1
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Provision of 24-hour service
Twenty-four-hour advice was an area described as inadequate and needed improving. For the majority
sites patients were directed to the on-call registrar out of hours, except for newly diagnosed patients or
new pump starts for whom 24-hour contact with the PDSN for a short period was the norm.
Diabetes team . . . no, we don’t . . . we used to and it’s something that I do believe in but again due
to resources, you need more people who are able to give the right advice available for a 24/7 service
and that’s what we haven’t got but we will always . . . we give out a contact sheet to all our families
that says . . . ring this number at this time, this number at this time . . . and that’s essentially just
Monday to Friday 9 to 5 . . . outside of hours we tell them to ring the ward.
Nurse C7
The PDSNs offered training to ward staff – but this was either not taken up or the ward staff did not
have time.
[Nurse A] and I are on 9 to 5 and then any other times after that or weekends it will be done by the
children’s ward, from hopefully a designated nurse which is what we want on the ward which
we’re working towards.
Researcher: But that’s not currently available?
No . . . and they speak to doctors and the doctors are not always that well informed.
Site educator/nurse I12
Outpatient services
Paediatric diabetes clinics
Most sites ran a consultant-led clinic at least once a week. At least two-thirds of control sites ran
additional regular nurse-led clinics. Fewer intervention sites ran nurse-led clinics. Nurse-led clinics aimed to
be more ﬂexible and informal than consultant-led clinics and were primarily a key source of support for
patients with persistently poor control and their parents/carers. In most sites nurses also attended
consultant-led clinics. This meant attending 8–10 clinics per month in addition to home visits, school visits
and telephone contact. Sites without nurse-led clinics recognised the need for them and had plans to start
running them. Some nurse-led clinics were held in community venues.
Frequency of nursing contacts from 2008 to 2012 was obtained from a detailed CNR. The mean length of
time data were collected was 49.7 months (range 44–54 months). There was huge variability in how
contact information was recorded. Nurse contacts included home visits, nurse-led clinics, telephone calls,
school visits and ward visits excluding routine clinic visits with the consultant. Data were obtained for
164 control and 162 intervention patients. The average number of nurse contacts per patient per year in
control sites was 5.08 (range 1–121) compared with 7.12 (range 1–168) in intervention sites.
Clinic ‘did not attend’ rates
Clinic staff were asked to estimate the average number of young people who ‘did not attend’ (DNA) clinic
appointments. The rate reported was 5–42% for controls (with most around 15%) and 5–20% for
intervention clinics (with most around 10%).
All clinics reported higher DNA rates for adolescents and young adults (20–50%). One nurse had offered
nurse-led clinics to encourage clinic attendance, which had no impact on attendance. One nurse said it was ‘a
regular few’ who usually did not turn up. In one clinic, a nurse felt the low rate of 5% was because clinics
were scheduled in the afternoon so young people did not miss too much school. Some staff mentioned
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working towards a policy on how to deal with DNAs as part of the preparation for the Best Practice Tariff
(www.diabetes.nhs.uk/networks/paediatric_network/best_practice_tariff_for_paediatric_diabetes/).
Annual review clinics
All clinics carried out annual reviews – the number of clinics reporting what was offered (at the end of the
intervention period) is listed in Table 38.
TABLE 38 Clinical assessments completed at annual reviews
Clinical assessments
Intervention:
n = 14
Control:
n = 14 Notes
Height and weight 12 12 Some sites measured these at all clinics
HbA1c 13 11 Some sites measured this at all clinics. Some asked for a
blood sample in advance of the annual review, so
results could be discussed at clinic
Nearly all sites collected venous samples for the annual
review and all collected capillary samples at 3 monthly
clinic appointments
Urine samples (> 12 years)
(checking for
microalbuminuria)
13 13 Patients often forget to bring a sample. ‘We try
desperately, they’re so averse to peeing some of the
older ones’ (C6)
Thyroid check (> 5 years) 14 11
Eye examinations with a
digital camera
6 0 Inconsistent and often done independently by retinal
screening service via GP referral or less often by the GP.
Some sites will check patients had been to the opticians
for retinal screening and if not refer to the consultant
ophthalmologist. Some examinations were done but not
with a digital camera. Many felt eye examinations apply
only to young people aged > 12 years, as it is unlikely
they will have complications before that. An exception
to this might be if they had been diagnosed for some
years then staff might think about it earlier
Coeliac screen 11 9 NICE guidelines originally said to complete on diagnosis
and every 3 years thereafter, unless young people were
displaying symptoms. Some staff said consultants
screening at every annual review or at least every
3 or 5 years
Foot examination 11 10 Some done at clinic; some sites do not do foot
examinations even at annual review ‘No . . . we don’t, if
there were problems with feet . . . refer to podiatry’ – others
just said ‘probably not’ or ‘not always’
Injection site checks 14 13 Most done at every clinic as well
Blood pressure 12 13 Some at clinic for those aged > 12 years but might be
sooner if patients diagnosed > 5 years
Lipids 3 0 One clinic measures lipids, liver function, urea and
electrolytes
One site measures cholesterol in those aged > 12 years
Food intake review Undertaken in a small number of clinics but, owing to limited dietetic support, often
completed by the PDSN
Psychological review A number of sites said that team available for discussion of parents’ and young people’s
worries and realistic targets following annual review or on an ongoing basis
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Pump therapy
At the start of CASCADE one intervention and three control sites had no patients on pumps.
Seven intervention and four control sites had fewer than 5% of patients on pump therapy. The remaining
four intervention and six control sites had 6–20% of their case load on pumps. Most clinics saw a small
increase in the number of patients on pumps over the time of the study. Data were not available for
three clinics.
Transition to adult services
In general young people were transitioned between 15 and 19 years of age. Nurses managed the
transition process in all clinics. Young people transferred to the adult diabetic service in the same trust in
27 clinics. One discharged patients back to the GP, with a request to refer to adult services. Flexibility in
transition and preparing young people beforehand was common; however, there was no clear transition
policy for the majority of clinics. Individual factors that drove transition included personality of the young
person, cognitive maturity, the need to ease pressure on overcrowded paediatric clinic, ﬁtting in with
examinations and negotiating with young people on an ad hoc basis. Some young people remained in
paediatric clinics even although it was felt appropriate for them to move. Reasons included:
l no pump services locally
l a young person was autistic so was kept in the paediatric clinic
l no spare capacity in the young adult clinic to accommodate them
l insufﬁcient clinic appointments/dates available.
The care pathway from the paediatric to adult diabetic clinic occurred via interim clinics with a number
of stages:
1. Handover clinic/transition clinic
2. Joint adolescent clinic
3. Young adult clinic
4. Adult clinic.
Staff and young people noted the stark differences between paediatric and adult service.
They have to work harder and I do warn them . . . you know, for the last couple of years that they’re
sort of with me, I do warn them that once you move to adult services, there will not be somebody
ringing you up saying ‘is everything alright?’, there will not be someone popping round the house to
make sure everything’s okay, it will be down to you to ring and say ‘I need some help’.
Site educator/nurse I4
They’re a lot nicer . . . the children’s service . . . They’re just nicer, they seem like they have time for
you, it’s not always about facts and figures, it’s more about how you’re feeling and what you’re
doing . . . Yeah, I suppose I’ve grown up with them, like they all know me and I’ve grown up with
them for 15 years, so . . . you know, it’s nice. I think the adult one is just very rushed, it’s like . . . right,
you’re not dying, fine okay.
YP male I11
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Diabetes education
Education at diagnosis
All sites provided initial diabetes education at diagnosis on the ward. PDSNs were primarily responsible for
education with contributions from other members of the team, including consultants and dietitians and
ward staff.
Well, I do [the initial education] myself . . . obviously the parents are seen by the consultant within the
24 hours and he tells them a little bit, and then I have a package that I work through . . . that’s all we
do really before they get home but they do see a dietitian as well for a brief description.
Nurse C6
Consultants had a minimal role in education beyond a brief description of the diagnosis. One intervention
site offered an appointment with an Emotional Wellbeing Practitioner based in the primary care service,
whereas another referred to a psychologist at diagnosis to assist families with adjustment and
problem-solving.
Initial education at diagnosis usually followed a checklist. It was generally regarded as important to deliver
information in manageable ‘chunks’ so as not to overwhelm families who were dealing with the initial
shock and implications of the new diagnosis. The checklist covered the ‘basics’ about diabetes including
a general overview, managing BG levels, living with diabetes at home and MDI. One clinic uses a DVD
from DUK for families, as well as books and leaﬂets.
It’s quite intensive really . . . how to do an injection, how to prepare it . . . We like them to have a
decent understanding of hypoglycaemia because that’s the biggest emergency . . . high blood sugar
levels and DKA . . . We call those the initial survival skills.
Nurse C7
Dietitians covered topics related to food and CHO. Only one control site introduced CHO counting from
the beginning.
We try and do that right from the start so they’ve got a good idea of adjusting their own doses
because it’s much harder to change once they’re doing something different.
Nurse C1
Nurses kept in close contact with families after their return home, giving them further information,
supporting them through home visits and telephone contact before their ﬁrst clinic visit. Families were
encouraged to telephone nurses with queries or concerns. Some patients had their ﬁrst hospital
appointment 1 week after diagnosis, but for others ﬁrst appointments could be up to 6 weeks later.
Contact between nurses and families with a newly diagnosed child varied depending on the perceived
individual needs, as well as available resources. Many nurses offered several home visits to deliver more
information about managing diabetes. Other nurses offered telephone support, often daily, in the ﬁrst
week. Following that, telephone contact was on an as-needed basis for ‘trouble-shooting’.
It’s very much on an individual basis because I say to the families, ‘I’m here to support you’, and some
families will need daily visits for maybe the first 4 or 5 days . . . I’m very much guided by what the
families want cause some need more support than others.
Site educator/nurse I4
Usually go and do education on the ward, follow them up with a home visit and then do an evening
session for their family and friends and then do as much education (as required) for their swimming
teachers, scouts, brownies, community education . . . I usually follow them up once a week initially
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and then once a month until they feel confident but I phone them every day and we talk about what
the day is like and then put into place anything we need to for the following 24 hours.
Nurse C2
Nurses also visited schools to deliver training to staff often within a week after diagnosis and before the
child returned to school. This could involve several visits to implement a health-care plan and to train
staff, including ﬁrst aiders and school nurses. One nurse mentioned training ‘whole school employees’
including receptionists. This could be more intensive for primary school children who were more
dependent on staff.
I go into the schools when they’re newly diagnosed if they want me to educate the staff and (help
with) health care plans. If they change to different teachers, then I’ll go in and see the new teacher to
educate them. I’ll go into whole schools like the training days if they let me and just educate all the
staff for that and like if they change to Basal Bolus or a pump, then again I’d go in and help support
the staff.
Nurse C3
A minority of sites were less involved with schools. In one intervention site, the nurse acted in an advisory
capacity but considered the care plan to be a contract between school nurses and parents. A nurse at
one control site said they were having difﬁculty implementing comprehensive care plans because schools
were reluctant to take responsibility for administering injections and blood tests.
Most staff rated education provided for newly diagnosed families as ‘sufﬁcient’, ‘good’ or ‘very good’. The
majority of staff had developed education programmes over time using teaching methods that they felt
worked best for them and their patients. This was rarely formally evaluated. In contrast one site was
infuriated by the impact of lack of dietetic time.
What are the key challenges for your service at the moment, would you say?
Nurse C7: Not enough dietetic time.
What do you have in the way of that?
Nurse C7: 8 hours a month.
Is that a change?
Nurse C7: No . . . it’s been the same for quite a few years but it’s not changing, there’s no
development, there’s no improvement, there’s no strategy, there’s no money so that’s the biggest
challenge that we face at the moment.
How do you get round it?
Nurse C7: We don’t, we can’t offer services that we should be offering so the children get no CHO
counting sessions, they don’t have individual one to one after diagnosis, they don’t have any
follow-up after diagnosis, they get one appointment a year with the dietitian which is half an hour
per child per year and if they don’t turn up to their appointment, they don’t get seen that year by a
dietitian so I think the service is . . . that’s particularly where we’re particularly lacking at the moment
and then it’s very difficult when they’re handed over to the adult service cause they’ve had no dietetic
input and then all of a sudden the dietitians in the young adult service can offer a service.
So is that a better service?
Nurse C7: Which is great but we’ve neglected them until they’re 17 and I think that that’s appalling.
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Ongoing diabetes education
The majority of ongoing education was delivered by PDSNs with some input from dietitians and
consultants. Dietitians were particularly involved in teaching CHO counting. When nurses felt that children
and families had grasped ‘the basics’ further information would be discussed depending on individual
need. Education was delivered on an informal basis in consultant-led and nurse-led clinics, during home
and school visits. Clinic appointments were time limited and were regarded by some as not the best venue
for delivering education, which tended to be unstructured and ad hoc.
I would say if you’re attending a clinic appointment we do try and fit in education around that but it’s
very, very limited.
Nurse C4
I think we cover everything, it’s pretty comprehensive, there’s no time limit to do it, some do it all in
6 months, some do it in 6 weeks. We do an awful lot of . . . we do training for members of the family
as well.
Nurse C6
Most clinic staff went into schools on an annual basis, or on request, to update schools. Although parents
were the ﬁrst port of call for schools in emergencies, PDSNs had ongoing contact with schools by
telephone, fax and e-mail and through school visits. A nurse at a control site was frequently called to visit
schools that did not have school nurses. In one intervention site staff went into schools four times at the
beginning of a school year to train staff in giving injections, to explain regimens, to offer advice on school
trips and managing hypoglycaemic attacks and to make sure they had adequate supplies. In another
intervention site the nurse had also taught other school children about diabetes.
I’ll go in and do education sessions to the other children so that they know what little J’s having to go
through and if there’s issues of teasing or bullying I’ve been into schools as well to talk about insulin
and . . . it’s not fun.
Nurse/site educator I13
Two sites offered training for health-care and education professionals. One site had organised a group
session for up to 40 teachers; however, schools were reluctant to pay the £5 the clinic was charging to
cover costs.
Group education for patients
Many sites had run groups at some point. These tended to be occasional and ad hoc rather than a formal
or regular programme. A few sites had run more formal programmes with a planned curriculum that
generally focused on CHO counting. One intervention site nurse and dietitian ran a series of 3-hour
sessions for a group of 4–6 people on CHO counting over a period of 3 years prior to CASCADE.
Limited resources were seen as a barrier to the development of group work. Although some site staff
reported positive experiences with good attendance and good feedback from attendees, others had found
them difﬁcult to organise with poor attendance.
[Organising groups has been] a bit ad hoc. It’s always taken ages; different languages (spoken by
families) and times that people can make it are so different.
Nurse C9
One nurse said she had run groups in the past but felt they did not work as well as one-to-one training
where individual needs, abilities and stages could be catered for.
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About half of the control sites ran some kind of education groups during the trial, which were described
as informal, loosely structured and ‘ad hoc’. A few had attempted to use a theoretical base and
a curriculum.
Examples of groups offered in control sites during the trial are listed below.
1. One PDSN organised educational and social events, afﬁliated to DUK, for children and families to meet
and gain support in living with diabetes. Age-banded events were held including a meal at a restaurant
for the teenagers, a party for the younger ones and an activity day for 7- to 17-year-olds. A parents
workshop was facilitated by an experienced counsellor. A Healthy Eating family workshop was
facilitated by a dietitian. The PDSN also organised a ‘boys-only night’ for boys aged 11 years and their
Dad, brother or best friend (male). A few adults with diabetes share their experiences of life with
diabetes – from leaving home to getting a job and what happens when things go wrong. Boys with
diabetes who attended got a £10 voucher.
2. A group has been run by a dietitian for the past ﬁve years on CHO and insulin adjustment based
on DAFNE.145
3. ‘If it’s about CHO counting, you know, the grandparents are struggling, then we get the scales out and
the food and start weighing so they understand and it’s much easier with practical sessions’ (Nurse C2).
4. A series of 10 education sessions over 12 months (in 2010) was offered through a quarterly newsletter.
Topics included ‘What is diabetes and what does it mean for me?’; CHO counting; exercise and travel;
sick day management; pumps; insulin dependent devices; sex, drugs and alcohol; and transition to
adult services. Attendance at sessions was poor.
Almost all group sessions were run by nurses and dietitians with minimal involvement of consultants at
three control sites. Two control sites mentioned the involvement of employees from companies that
provide pumps in CHO counting training.
We also have a rep that comes from his company . . . helps with the carb counting so that’s why he’s
been involved and he’s offered financial help as well.
Nurse C13
Education groups were primarily run on hospital premises. The majority took place outside school hours in
the late afternoon, evening or during the school holidays, and occasionally during weekends.
Certainly every main holiday and often every half term as well, it depends how many youngsters have
expressed an interest and obviously the availability of the dietitian as well but certainly every Easter,
summer, Christmas holiday we would do one session and often we would do one in between at
half term.
Nurse C8
In the majority of cases, attendance was a patient’s choice. Sessions were open to those who ‘expressed
an interest’ or who wanted to come along to a particular session. Families were invited to group education
on the basis of their ‘stage’ in the clinical pathway.
We have an ongoing list so that’s decided as we get to know the patients and their families and we
know what the next stage is for them or if they’re going to be going on to an insulin pump that’s
part of pump (pathway).
Nurse C10
Groups varied by site according to type of education offered and whether it was targeted to a speciﬁc
group or the entire caseload. PDSNs were aware that mixed age groups did not work well so organised
groups on the basis of age or gender with age regarded as more important than gender. Parents were
involved in some groups.
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Rather than doing a group of 12, it’s probably better to do a group of 6 so we’re looking at splitting
that one but when we actually came to it we discovered the older teenagers weren’t particularly
impressed, so we’ve actually had to split the very young from moderately young.
Nurse C8
A lot of stuff around sport and exercise . . . I would say one of the best attended ones because we’ve
had an outside speaker and she’s excellent and we’ve had two or three sessions on that. I would say
we’ve had 60 people there at those sessions. Yeah, it makes it worthwhile for her coming as well
Nurse C4
Group attendance varied from two to three individuals up to groups of 60. The percentage of invited
people who attended was generally quite low and was often difﬁcult to predict.
Challenges to the service
A lack of administrative support was a key challenge.
We have the consultants’ secretaries who are very good and will do the odd one but the majority . . .
yeah, the clerical stuff is down to us . . . you know, clinic letter, filing and all that sort of thing.
Site educator/nurse I2
Stafﬁng levels were also considered a challenge by many although a few felt the level of stafﬁng
was acceptable.
Not enough manpower . . . there’s too many patients126 and only me . . . and I feel we can’t meet the
needs of our patients really, there’s only so many pump (starts) we can do and we’re jiggling clinics all
the time to try and fit all our patients in so very over-stretched.
Site educator/nurse I7
From a nursing point view we feel very fortunate . . . yeah, it’s probably not quite within the (RCN)
guidance of one nurse to 70 cause we’ve got about 120 but I think compared typically it’s not far off,
it’s not too bad.
Nurse C11
Views about continuing professional development varied.
All study leave’s been cancelled . . . for the moment, they’ve cancelled it from January to the end of
March and then we were meant to get a message at the end of March to let us know whether
they’ve lifted the ban and at the moment we haven’t been given the all-clear.
Nurse C8
We feel we have enough training which is lovely . . . Yeah, nice to be able to say that we attend
conferences when we feel we need to. We, we do it as a team. And everybody in diabetes [has had]
pump training, that’s all been offered to us, so we’re very fortunate . . .
Nurse C11
Increases in referrals and referring to CAMHS were seen by some as a challenge:
Referrals are going up. It’s a little bit of a challenge because we have had . . . I think it’s nearly
40 children since November, obviously new children take priority over everything and they
take longer.
Site educator/nurse I5
STANDARD CARE IN NHS CLINICS
98
NIHR Journals Library www.journalslibrary.nihr.ac.uk
I think the CAMHS . . . the referring into CAMHS, I think that’s something I would . . . you know, we
can’t always guarantee that the child will be seen . . . yeah, that’s an area really.
Site educator/nurse I2
In contrast, some felt referrals were not a problem:
We haven’t had many new ones to be fair, until very recently we’ve had these three but even that
that’s absolutely fine . . . no problem with that, if we need to refer them on like I said to CAMHS for
example, got the psychologist, she comes to all the clinics, she sees everybody anyway and then
follows them up outside of that so we’re quite fortunate that we’ve got that service and the dietitian
attached to the clinic . . .
Site educator/nurse I3
Other key challenges mentioned by staff at control sites included providing education, the demand for
insulin pumps, teaching requests, social problems, standardisation of services and management issues.
Answers from intervention site staff covered issues such as providing managing transition, preparation
for best practice tariff and management and divisional changes.
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Chapter 7 Cost-effectiveness analysis
In this chapter the cost-effectiveness of CASCADE compared with current NHS practice is assessed.Given ﬁndings from the PE a scenario analysis is undertaken of a hypothetical Enhanced
CASCADE intervention.
Methods
The economic evaluation compares CASCADE with current NHS practice. Education on diet, insulin
dosage, regimen and exercise are delivered in a non-standard and irregular way during diabetes clinics
(see Chapter 6). To assess the cost-effectiveness of CASCADE with respect to current NHS practice, the
analysis focuses on the relative success in controlling HbA1c level and predicted impact on diabetic
complications over time. Good control (HbA1c value of < 7.5%) is associated with a reduction in the risk of
diabetic complications.175
The cost-effectiveness model considered long-term costs and beneﬁt implications of delaying the onset of
microvascular and macrovascular complications of diabetes by comparing HbA1c levels in the intervention
and control groups. A series of MCMC submodels simulated the progression of microvascular
complications (kidney diseases, neuropathy – foot ulcer and risk of amputation, and retinopathy) and
cardiovascular complication (infarction). These predicted future treatment cost of patients receiving the
CASCADE intervention or routine NHS care. This is a similar approach to that adopted in the DAFNE
study.145,176–178,186
The proportion of children starting in each health state was based on baseline data from the CASCADE
study and the literature (Table 39).
The model simulates the progression of diabetes through a number of mutually exclusive health states.
At the end of each cycle, the person can move from one stage to another. The same model is used for
both current NHS practice and CASCADE. The only elements allowed to vary between arms are the extent
to which patients achieve improved metabolic control. Transition probabilities are assumed to depend on
HbA1c levels. For instance, consider the MCMC assessment for kidney diseases (Figure 6). Those without
kidney disease continue without developing kidney disease, die, develop uncomplicated kidney disease or
end-stage kidney disease (ESKD) in the next time period. Those with diabetic complications could continue
with complications, return to the without-complications state or die in the next period. For each model,
health states and transition probabilities were determined, based on study data and from the literature.
The transition probabilities for diabetes complications did not consider whether patients move to a more or
less severe stage of disease (for instance, from a kidney disease to a cardiovascular infarction) in a given
year. This was because these probabilities depend on a series of parameters that were either incomplete or
unavailable in our database. The sub-MCMC models use HbA1c level (low or high) to predict if patients will
or will not develop diabetes complications. The present MCMC submodels contain different health states
depending on diabetic complications. The lifetime costs associated with each complication were estimated
and incorporated in the model. Table 40 shows the transition probabilities owing to intensive HbA1c
control between health states for different diabetes complications. Mortality rates were assigned to all the
diabetes outcomes.
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TABLE 39 Initial probabilities for the MCMC
Complications Probabilities (%) Source
High HbA1c value (> 7.5%) 81 CASCADE
Uncomplicated kidney disease 0.92
ESKD 0a
Retinopathy 2.75
Uncomplicated foot ulcer 0.61
Foot amputation 0a
Myocardial infarction 0a
ESKD, end-stage kidney disease.
a Near to zero.
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See subtree below for 
kidney disease CASCADE
Low HbA1c level
Markov
information
Term rwd:
_STAGE = 120
High HbA1c level
Control of
T1D
Enhanced
CASCADE
NHS current
practices
No kidney disease
No kidney disease
No kidney disease
Uncomplicated
kidney disease
Uncomplicated
kidney disease
Uncomplicated
kidney disease
ESKD
ESKD
Uncomplicated kidney disease
ESKD
ESKD
ESKD
Death
Death
Death
Death
Death
Death
Death
Uncomplicated kidney disease
ESKD
ESKD
Markov
Low HbA1c level
Markov
information
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
Markov
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
Term rwd:
 _STAGE = 70
M
Markov
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
Markov
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
FIGURE 6 A MCMC for kidney disease. incr rwd, incremental reward; init rwd, initial reward; term rwd, final reward.
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TABLE 40 Transition probabilities
Transitions
Low HbA1c
(< 7.5%)
High HbA1c
(> 7.5%) Source
Kidney disease
No kidney disease No kidney disease 0.989945 0.989428
Uncomplicated
kidney disease
0.009090 0.009200 CASCADE
ESKD 0.000965 0.001372 Roze et al. 2005;187 Burke 2011188
Death 0 0 Assumption
Uncomplicated
kidney disease
Uncomplicated
kidney disease
0.906235 0.905828
ESKD 0.000965 0.001372 Assumed same as no kidney
disease to ESKD
Death 0.0928 0.0928 Assumed same as ESKD to death
minus 20%
ESKD ESKD 0.884 0.884
Death 0.116 0.116 Diabetes UK 2010186
Retinopathy
No retinopathy No retinopathy 0.9028275 0.901671
Retinopathy 0.0043725 0.005529 Roze et al. 2005;187 Burke 2011188
Death 0.0928 0.0928 Assumption
Retinopathy Retinopathy 0.884 0.884
Death 0.116 0.116 DUK 2010186
Foot ulcer
No foot ulcer No foot ulcer 0.9874482 0.891589
Uncomplicated
foot ulcer
0.0015a 0.097a Tennvall et al. 2001189
Foot amputation 0.0040518 0.004411 Roze et al. 2005;187 Burke 2011188
Death 0.007b 0.007b Tennvall et al. 2001189
Uncomplicated
foot ulcer
Uncomplicated
foot ulcer
0.896 0.896
Foot amputation 0.097 0.097 Tennvall et al. 2001189
Death 0.007b 0.007b Tennvall et al. 2001189
Foot amputation Foot amputation 0.884 0.884
Death 0.116 0.116 DUK, 2010186
Myocardial infarction
No MI No MI 0.995578 0.995001
MI 0.004422 0.004999 Roze et al., 2005;187 Burke, 2011188
Death 0 0 Assumption
MI MI 0.884 0.884
Death 0.116 0.116 DUK, 2010186
a Assumed as Risk 1 and Risk 4 from Tennvall and Apelqvist, 2001189 classiﬁcation.
b Assumed as equivalent.
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Markov chain Monte Carlo for diabetes complications are presented in Appendix 9 (see Figures 9–11).
The DCCT study showed the risk reduction owing to intensive HbA1c control for kidney disease is 50%, for
nerve disease 60%, for eye disease 76% and for any cardiovascular disease event 42%.190,191 CASCADE
was modelled as a one-off intervention (for any particular child), through which any improvement in HbA1c
level control achieved is assumed to be sustained. The model is run with an annual cycle for 70 years.
An individual is either in the health state with or without diabetic complications until they exit the model
(at death), and the next patient selected from the hypothetical sample. This process is repeated for a
sample of 10,000 patients of ≥ 13 years. At the end of the simulation, the time spent in each of the
treatments and health states, and the time spent alive are calculated in terms of lifetime costs and lifetime
health beneﬁts comparing current NHS practice to CASCADE.
The analysis was undertaken from the perspective of the NHS and thus only considered directly incurred
NHS costs. Future costs were discounted at 3%. The model captures the direct costs of CASCADE and the
direct NHS costs in the treatment of diabetes (inpatient treatment and diabetes complications). Direct costs
for CASCADE included start-up costs for planning, reviewing and producing the educational material
and training workshop costs. Recurrent costs associated with module delivery included (1) planning,
administration and setting-up each session; (2) supporting the site educators during module delivery;
and (3) staff time to deliver sessions. Start-up and recurrent costs were collected by the CASCADE team.
As start-up costs are not incurred every time CASCADE is offered at a particular site it is assumed
(arbitrarily) that groups are offered on average twice a year for 3 years.
Costs for CASCADE were estimated using standard methods where the mean use of resource was
multiplied by the unit cost of that resource to produce the estimated direct mean cost incurred by the
intervention.192 The resources involved in the development and delivery of CASCADE are shown
in Table 41.
The salaries of the UCLH team responsible for developing the educational material, running workshops
and supporting site educators were PDSN (Band 7), clinical psychologist (Band 8d), assistant psychologist
(Band 4) and dietitian (Band 6). Consultants and registrars were assumed to be paid average salaries for
their scales (http://careers.bmj.com/careers/static/advice-salary-scales.html). The same salary points were
used to cost the Enhanced CASCADE scenario. The site PDSNs and dietitians were allocated at Band 6.
Salaries were downloaded from the NHS pay rates website: www.nhscareers.nhs.uk/details/default.aspx?
id = 766 (accessed 30 May 2012).
An additional 20% was added to all salary costs to allow for pension costs and National Insurance
contributions incurred by the NHS. A unit cost per day was estimated by dividing the annual cost by 220.
Direct costs incurred by the NHS for the treatment of diabetes were also estimated using standard
methodology.192 Frequency of use of NHS resources by patients enrolled in intervention and control groups
were collected by the CASCADE team. NHS costs were related hospital admissions to manage the diabetes
(Table 42). The costs of diabetes complications (kidney disease, neuropathy – foot ulcer and the risk of
amputation, retinopathies and cardiovascular infarction) are based on 2010/2011 NHS reference costs
ﬁgures, as the estimates for the 2011/2012 period are not yet available.193
A one-off treatment cost is included for patients experiencing \eskd, cardiovascular infarction and foot
amputation. No costs associated with dialysis and cardiovascular complications have been included. Costs
for hospital admissions to treat general glycaemic disorders were entered for all health states. The average
hospital length of stay was assumed as 1.4 days for no complications and retinopathy, 3.2 days for
uncomplicated kidney diseases and uncomplicated foot ulcer, 5.4 days for myocardial infarction, 23 days
for ESKD and 23.7 days for foot amputation.20
Health gains from improved HbA1c level are estimated by predicting the quality-adjusted life-years (QALYs)
experienced by CASCADE patients and comparing them to those predicted for current practice patients.
These QALYs were estimated by combining the years spent in each health state predicted by the model
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TABLE 41 Resources necessary to develop and deliver the CASCADE educational intervention
Activity CASCADE (actual resource use)
Start-up Type of resource (quantity; time in days)
Developing, reviewing and producing the educational
material
Nurse (1; 49)
Psychologist (1; 24)
Assistant psychologist (1, 48)
Dietitian (1; 5)
Stationery and equipment
Training the site educators Nurse (1; 12)
Psychologist (1; 12)
Assistant psychologist (1, 14)
Clinic staff being trained (43;a 86)
Stationery, venue and equipment
Recurrent (per clinic) Type of resource (quantity; time in hours – per clinic)
Planning activities Nurse (2; 1)
Administrative tasks Nurse (2; 2)
Setting up the education sessions Nurse (2; 1)
Delivering education sessions Nurse (varied; varied)
Stationery, transport, materials, venues and equipment
Supporting the site educators during delivery of the modules Nurse (1; 6.5)
Psychologist (1; 6.5)
Nurse for support (1; 7)
1-day refresher workshop
a Attended 2 days’ training: 28 nurses, 10 dietitians, 1 consultant and 1 registrar. Attended 1 day’s training: 1 consultant.
TABLE 42 NHS costs for the treatment of diabetes complications (2010/2011 prices)
Cost item Unit cost (£)
Hospital admission 2485
General renal disorder (kidney diseases) 2688
ESKD (haemodialysis and transplant)a 18,560
Uncomplicated foot ulcer (without major cardiovascular problems) 2236
Foot amputation (without major cardiovascular problems) 8726
Retinopathy (eye diseases) 1187
Cardiovascular infarction 1410
a Assuming 50% of each treatment.
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with health-state values from the literature.194 These health-state values are not directly related to
educational programmes to control T1D, but rather to the use of insulin and are presented in
Table 43. QALYs were discounted at 1.5% since for this patient group they potentially arise over a long
time horizon.195
A probabilistic sensitivity analysis was performed using Monte Carlo simulation whereby input parameters
were varied simultaneously over speciﬁed ranges to capture uncertainty in the model. The simulation drew
values for each input parameter and calculated expected cost and effectiveness for each arm of the model
by repeating the simulation process 10,000 times to give a distribution of expected cost and clinical
effectiveness values. Gamma distributions were speciﬁed for the cost parameters and beta distributions
were speciﬁed for the probabilities, utilities and risk reduction parameters. The distributions assumed for
these parameters are reported in Appendix 10. In addition a one-way sensitivity analysis was conducted to
identify the variables that had the largest impact on the model results. For this analysis all parameters were
varied by ± 20%. The parameters that had the largest impact on the model are presented in a tornado
diagram (a bar chart where cost categories are ordered so the largest impact is presented on the top of
the chart followed by the next largest impact categories).
TABLE 43 Utility values per health states
Health state Utility Reference
No kidney disease 0.814 Clarke et al., 2002;196 Cummins et al., 2010194
Uncomplicated kidney disease 0.720 Assumed to be average of values for ESKD and no kidney disease; Clarke et al.,
2002;196 Cummins et al., 2010194
ESKD 0.626 Assumed as an average of values for haemodialysis (0.490) and kidney transplant
(0.762); Tengs et al., 2000;197 Cummins et al., 2010194
No retinopathy 0.814 Clarke et al., 2002;196 Cummins et al., 2010194
Retinopathy 0.774 Assumed as an average of values for macular oedema (0.794), severe vision loss/
blindness (0.734) and cataract (0.794); AIHW, 2003;198 Brown et al., 2004;199
Cummins et al., 2010194
No foot ulcer 0.814 Clarke et al., 2002;196 Cummins et al., 2010194
Uncomplicated foot ulcer 0.549 Assumed as an average of values for foot amputation and no foot ulcer;
Clarke et al., 2002;196 Cummins et al., 2010194
Foot amputation 0.285 Assumed as an average of utilities values for amputation, year of event (–0.109)
and amputation, 2 years after the event (0.680); Clarke et al., 2002;196
Cummins et al., 2010194
No MI 0.814 Clarke et al., 2002;196 Cummins et al., 2010194
MI 0.710 Assumed as an average of values for recent MI (0.685) and remote MI (0.736);
Clarke et al., 2002196
Death 0 Assumption
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Results
The costs incurred in the development and delivery of CASCADE are reported in Table 44. As can be seen,
the bulk of costs is recurrent and will be incurred each time the education programme is offered.
Lifetime costs and QALYs predicted under current NHS practice and with CASCADE are reported in
Table 45. Current NHS practice dominates CASCADE in that it achieves the same number of QALYs at a
lower cost. This follows directly from the failure of CASCADE patients to demonstrate improved
metabolic control.
TABLE 45 Base-case scenario comparing CASCADE and current NHS practice
Type of practice
Cost
(discounted)
QALY
(discounted)
Incremental
cost
Incremental
QALY ICER
Current NHS practice 247,551 14.4293
CASCADE 247,973 14.4293 422 0 Dominated
ICER, incremental cost-effectiveness ratio.
TABLE 44 Cost of CASCADE delivered in 13 clinics with 97 children, 2012 prices (£)
Activity CASCADE
Start-up
Developing, reviewing and producing the educational material 4485
Training the site educators 3963
Total start-up cost 8448 (21%)
Recurrent
Planning activities 2378
Administrative tasks 4755
Setting-up the education sessions 2378
Delivering education sessions 12,308
Supporting the site educators during delivery of the modules 5334
Other resources 5291
Total recurrent cost 32,444 (79%)
TOTAL COST 40,892 (100%)
COST PER SITE 3145
COST PER CHILD 422
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Scenario analysis
The PE identiﬁed a lack of (1) support setting up groups, (2) knowledge and (3) difﬁculty maintaining the
SFBT/MI behaviour change approaches by some of the site educators. There was, however, highly positive
feedback from parents and young people who attended the groups. They reported changes in behaviours
that were not detected in either the primary or secondary outcome measures. As a consequence of these
delivery issues, an Enhanced CASCADE scenario was modelled, which addressed the reported difﬁculties
with delivery and uptake. To estimate the costs of the enhanced scenario, the clinical team identiﬁed areas
that could be improved using a different combination of resources and/or the inclusion/exclusion of a
speciﬁc resource. Delivery to a different group of patients and earlier in time after diagnosis would have no
cost implications for the model. The Enhanced CASCADE involves more intensive training and support for
those delivering the intervention and increasing the proportion of site educators who are psychologists
(Table 46). The amount of training was modelled on the current DAFNE training course shown to be
widely acceptable to clinical teams (www.dafne.uk.com/downloads/04_fact_sheet_four.pdf).
TABLE 46 A comparison of the training requirements of current and Enhanced CASCADE
Training component
No. of hours
NotesCASCADE Enhanced CASCADE
Staff required PDSN plus any
other team
member
PDSN plus team psychologist The use of a psychologist will
improve the delivery of the
behaviour change techniques
Other team members None required 15 hours training (2-day
workshop) for consultant/clinic
lead and other team members
Similar to DAFNE training so team
can support delivery of
programme
Orientation 0.5 1
Background reading Not compulsory 5 Educational knowledge will be
assessed
Educators observe
CASCADE modules 1–4
delivered by trainer
0 8 Could be live or video
Workshops 15 30
Preparation (training
provided for ﬁrst group
run)
0 10 Educators required to keep
portfolio of preparation activity
that is reviewed by trainers
Educators ﬁrst group
observed by peer
reviewer
0 8 Peer reviewer will be PDSN or
psychologist that has successfully
completed training
Follow-up workshop 0.5 8 To reinforce skills and sort any
issues
Total 16 85
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The anticipated resource use is reported in Table 47 (in comparison with Table 41) and estimated cost in
Table 48. As can be seen by comparing Tables 45 and 48, for a fourfold increase in training there is only a
doubling of the estimated cost per child.
The cost-effectiveness of the Enhanced CASCADE scenario was explored by assuming that risk reductions in
the prevalence of complications would be similar to those observed in the DCCT study at 12 months.190,191
These reductions in complications are arbitrary and illustrative as there is no evidence as to what an
Enhanced CASCADE intervention could achieve.
The lifetime costs and QALYs predicted under current NHS practice and for the Enhanced CASCADE
intervention are reported in Table 49. Current NHS practice is therefore assumed to be less costly and less
effective (in terms of QALYs) compared with Enhanced CASCADE. Enhanced CASCADE is estimated to
have a cost per QALY gained of £15,920 compared with current NHS practice. This is less than the
cost-effectiveness threshold of £20,000 to £30,000 currently speciﬁed by NICE.
TABLE 47 Resources necessary to develop and deliver Enhanced CASCADE educational intervention
Activity Enhanced CASCADE (hypothetical resource use)
Start-up Type of resource (quantity; days)
Developing, reviewing and producing the educational material Nurse (1; 49)
Psychologist (1; 24)
Assistant psychologist (1, 48)
Dietitian (1; 5)
Stationery and equipment
Training the site educators Nurse (1; 43)
Psychologist (1; 43)
Assistant psychologist (1, 30)
Nurses being trained (13;104)
Psychologists being trained (13; 104)
Nurse to observe the training (1; 4.67)
Psychologist to observe the training (1; 4.67)
Stationery, venue and equipment
Recurrent Type of resource (quantity; hours per clinic)
Planning activities Nurse (2; 5)
Administrative tasks Nurse (2; 2)
Setting up education sessions Nurse (2; 1)
Delivering education sessions Nurse (1; 8)
Psychologist (1; 8)
Stationery, transport materials, venues and equipment
Supporting site educators during module delivery (UCLH staff) Nurse (1; 1)
Psychologist (1; 1)
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The 95% credible ranges for the costs and QALYs based on 10,000 simulations are reported in
Appendix 11. Figure 7 illustrates the cost-effectiveness acceptability curves that indicate the probability
that an intervention is cost-effective for a range of willingness-to-pay thresholds. The probability that
Enhanced CASCADE is cost-effective compared with CASCADE and current NHS practice increases as the
threshold increases. For a threshold between £20,000 and £30,000 per QALY, the Enhanced CASCADE
scenario would have a probability of 42–45% of being cost-effective. However, the difference between
the Enhanced CASCADE scenario and the CASCADE scenario is small for the £20,000–30,000 threshold.
The univariate sensitivity analysis results are shown in the tornado diagram (Figure 8). The diagram reports
the possible net monetary beneﬁt of Enhanced CASCADE compared with current NHS practice for the
10 variables that have the largest impact on the model results. Net monetary beneﬁt is calculated by
taking the difference in clinical effectiveness and multiplying by society’s willingness to pay less the
difference in costs. A positive net monetary beneﬁt indicates a scenario where Enhanced CASCADE may
be cost-effective relative to current NHS practice, whereas a negative net monetary beneﬁt indicates that
current NHS practice may be cost-effective compared with Enhanced CASCADE. The variables that had the
largest impact on the model results were the cost of hospitalisation, the utility of diabetes with no
complications, the utility of uncomplicated foot ulcer, and the transition probability from uncomplicated
foot ulcer to uncomplicated foot ulcer.
TABLE 48 Cost of Enhanced CASCADE 2012 prices (£)
Activity Enhanced CASCADE
Start-up
Developing, reviewing and producing educational material 4485
Training site educators 12,097
Total start-up cost 16,582 (14%)
Recurrent
Planning activities 11,888
Administrative tasks 30,304
Setting up education sessions 2378
Delivering education sessions 43,602
Supporting site educators during module delivery 7619
Other resources 9260
Total recurrent cost 105,052 (86%)
TOTAL COST 121,634 (100%)
COST PER SITE 9356
COST PER CHILD 1254
TABLE 49 Enhanced CASCADE compared with current NHS practice
Type of practice
Cost
(discounted)
QALY
(discounted)
Incremental
cost (£)
Incremental
QALY ICER
Current NHS
practice
247,551 14.4293
Enhanced CASCADE 252,053 14.7121 4502 0.2828 15,920
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FIGURE 7 Cost-effectiveness acceptability curves for CASCADE, Enhanced CASCADE and current NHS practice.
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Tornado analysis (net benefits)
pHTFAFA (0.7072 to 1.0)
cTreatment (1988.0 to 2982.0)
uNocomplications (0.651 to 0.977)
uUfootulcer (0.106 to 0.659)
pHTUFUHb (0.0776 to 0.1164)
pHTRetinoRetino (0.7072 to 1.0)
pLowHbA1c (0.152 to 0.228)
pHTUFUFA (0.0776 to 0.1164)
uFootamputation (0.228 to 0.342)
uUkidneydisease (0.576 to 0.864)
Net monetary benefit (£)
FIGURE 8 Tornado diagram showing the 10 variables with the largest impact. pHTFAFA, probability of remaining in
the foot amputated state; cTreatment, refers to the cost of the treatment for diabetes, in this case, the cost of
hospitalisation; uNocomplications, utility for no complications of diabetes; uUfootulcer, utility for uncomplicated
foot ulcer; pHTUFUHb, probability of remaining in the uncomplicated foot ulcer state; pHTRetinoRetino, probability
of remaining in the retinopathy state; pLowHbA1c, probability of low HbA1c level; pHTUFUFA, transition probability
from uncomplicated foot ulcer to foot amputation; uFootamputation, utility for foot amputation; uUkidnedisease,
utility for uncomplicated kidney disease.
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Discussion
A number of fundamental challenges are faced when estimating the cost-effectiveness of an educational
intervention such as CASCADE. The most signiﬁcant is that the costs of delivering the intervention are
largely incurred in the near future, whereas many consequences for patient health and utilisation of
health-care resources (should the intervention be effective and improved metabolic control be sustained)
are experienced in the more distant future, some more than 30 years hence. Thus, although many costs
can be captured as part of the trial, most of the consequences in terms of health effects and future
treatment costs must be modelled rather than observed. The reduction in risk of diabetic complications
owing to improved glycaemic control is at the heart of the assessment of the cost-effectiveness
of CASCADE.
These future consequences were modelled by specifying a relationship between the likelihood of diabetic
complications and relatively short-run changes in HbA1c. In the modelling it was assumed that any change
in the successful management of diabetes taking place as a consequence of CASCADE would be
adequately captured in the HbA1c level. Because of limited follow-up it is not possible to be sure that
changes in HbA1c level will be sustained in the longer term. Moreover, the model assumes that the
signiﬁcant change in HbA1c is from ≥ 7.5% to < 7.5%, and that the relationship between HbA1c level and
annual risk of different complications can be speciﬁed. The DCCT trial, conducted from 1983 to 1993 in
the USA and Canada, involved 1441 volunteers, ages 13–39 years, with T1D and showed that keeping
HbA1c level as close to 7.5% as possible slows the onset and progression of eye, kidney and nerve damage
caused by diabetes.200 However, neither the DAFNE nor DCCT studies, nor even the UKPDS study for
T2D,201,202 provide evidence that good metabolic control reduces chronic complications. In other words, no
deﬁnitive assessment shows a causal relationship between speciﬁc levels of glycaemic exposure and the
risk of complications, as confounding is possible from a number of sources (DAFNE Study Group.
Clinical and cost effectiveness for education people with type 1 diabetes mellitus in diabetes
self-management. 2002, unpublished).
Data show that those of Afro-Caribbean, African and South Asian ethnicity are more likely to develop
diabetes, as well as the complications associated with the disease, than other ethnic groups.186 These
differences have not been explored because the CASCADE intervention and control groups were,
respectively, 91% and 81% white British or other white people.
The CASCADE intervention and NHS current practice might have also been compared in terms of daily
insulin dose; however, as recognised by the DAFNE UK study, and as shown in our data, the number of
insulin injections varies widely across both study arms and many of the data on insulin dose were
incomplete in our database145,183 (also DAFNE Study Group. Clinical and cost effectiveness for education
people with type 1 diabetes mellitus in diabetes self-management. 2002, unpublished).
The cost of treating future diabetic complications and the consequence of these for the patient’s health
state must necessarily be based on literature rather than on trial data. Although the costs of delivering the
intervention are ﬁrmly rooted in data from the trial, even here assumptions must be made. In particular,
if CASCADE were to be introduced into routine clinical practice only some of the costs would be incurred
each time the programme was delivered, whereas other costs with respect to training educators would
not. Thus assumptions must be made regarding on how many occasions educators will deliver
the programme.
Despite the lack of impact of CASCADE as delivered on HbA1c level, the considerable support from the PE
for the intervention introduced the question of whether an Enhanced CASCADE compared with current
practice might be cost-effective. Although a reasonable estimate of the costs of an Enhanced CASCADE
can be made, any estimate of cost-effectiveness is highly speculative given there is no evidence regarding
the likely success of an Enhanced CASCADE programme. As is highlighted by the probabilistic sensitivity
analysis, there is great uncertainty regarding the cost-effectiveness of the different interventions.
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Chapter 8 Discussion
In the following discussion, we highlight the strengths and weaknesses of the study and discuss thegeneralisability of the ﬁndings. Interpretation of the study results will be considered, taking into account
the study hypothesis. Considerations for future delivery of clinical services and research are addressed.
Key ﬁndings
Training PDSNs and other members of diabetes teams to deliver CASCADE structured education groups
using behaviour change methods was not shown to impact beneﬁcially on glycaemic control as measured
by HbA1c levels.
Both parents and young people reported an increase in young people’s responsibility for diabetes
self-management, although young people’s self-reported happiness with body weight decreased.
At 12 months’ follow-up, 87.5% of children in the intervention arm were on ≥ 4 injections per day
compared with 80% in the control arm. At both 12 and 24 months’ follow-up, there was a tendency for
young people in the intervention group to use higher doses of slow- and quick-acting insulin. This is
potentially consistent with those receiving the intervention being more likely to take more insulin to correct
high BG readings.
The majority of parents who attended the intervention groups described improved knowledge and
understanding of diabetes. They also described positive impacts on lifestyle, for example shopping
habits, managing BG and exercise, as well as greater conﬁdence managing diabetes, motivation and
decision-making in their son/daughter and improved family relationships. Positive impacts reported by
children and teenagers included improved understanding of diabetes, greater motivation in managing
diabetes and increased conﬁdence and changes in attitude, for example in discussing their diabetes and
improved relationships with parents and peers. Twenty-four months after the intervention, nearly half of
the young people who had attended CASCADE reported that the sessions had made them want to try
harder to control BG levels and that they had carried on trying. Interviews with young people suggested
less perceived impact by teenagers than younger children.
The CASCADE study shows that a high-quality, complex, pragmatic trial of structured education can be
successfully conducted alongside standard care in NHS diabetes clinics with a number of provisos discussed
below. Despite challenging circumstances we were able to recruit teams and patients from clinical services
reﬂecting a wide range of philosophies and research experience throughout London, south-east England
and the Midlands. The pragmatic components of a NICE-compliant structured education programme can
be successfully delivered following a relatively brief 2-day training workshop, whereas paediatric
health-care professionals beneﬁt from training in behaviour change skills.
The workshop component of the training represented 12.5% of the overall costs of the intervention.
CASCADE was not found to be cost-effective. However, in the economic model cost-effectiveness could
be achieved only by improving metabolic control, and no value is being assigned to increased competence,
or any changes in behaviour, if they do not translate into better metabolic control.
Strengths and limitations
Design strengths
A randomised cluster design was used to good effect in this study. An appropriate number of clinics and
additional participants were recruited to allow for dropout without compromising statistical power.
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We achieved a sample size that allowed adequate power to test our hypotheses. All centres recruited and
randomised into the study completed the structural and training elements of the study.
Delivery by a large number of practitioners minimised the inﬂuence of individual practitioners’ skills and
personality. Secondary outcomes used included several shown to perform well in measuring QoL in
children with diabetes in a range of contexts.203 Assessment of practitioner ﬁdelity used extensive
observation of a large sample of workshops delivered at different time points, as well as self-assessment
by practitioners after delivery of every group.204
Data loss
Many young people had issues with providing the blood samples, which was a major barrier to both
recruitment and subsequent collection of HbA1c data after consent. Considerable negotiation was often
required as to how and when the sample would be collected. Clinics often struggled to ﬁnd an
appropriate HCP to collect the blood samples. Primary (HbA1c) and secondary (questionnaire) measures
were sometimes collected on separate occasions at both follow-up points. Trying to organise telephone
questionnaires, when they could not be completed in the clinic, was a key contributor to data loss.
Internal validity
Measurement bias was minimised by the use of a central laboratory for all HbA1c assays. The two trial arms
were well balanced at baseline. One limitation of pragmatic cluster trials is possible bias due to trial arm
allocation knowledge. Allocation was concealed until after clinics had consented and a ﬁrst participant
recruited to minimise selection biases at entry of clusters to the trial. Checks for bias revealed no obvious
imbalances in demographic data. It is unlikely that allocation knowledge bias affected recruitment rates as
there was no difference between trial arms in number of eligible patients or ﬁnal recruitment rates.
Intervention development
A strength of the CASCADE trial was incorporation of recommendations from previous systematic reviews
of psychoeducational interventions in childhood diabetes.91 The intervention had a ﬁrm theoretical basis
that drew signiﬁcantly on principles of MI and SFBT previously shown to have potential in childhood
diabetes117,121 and incorporated key components of structured education programmes following
NICE guidelines.4
Educational content
The study highlighted different levels of knowledge in practitioners for aspects of key diabetes content.
Problematic topics were related to food groups, matching food and insulin, CHO counting and insulin
sensitivity ratios. A small number of secondary site educators did not have a thorough grounding in
diabetes knowledge. In interviews only half of the parents and young people said they had been familiar
with the content of the groups even though the majority of the content should have been covered in the
average 5 years since diagnosis. This conﬁrms a lack of consistent and effective structured education
currently being offered as part of standard care by the majority of diabetes teams.
Lay and professional stakeholder perspectives
The CASCADE trial involved the views of both lay and professional stakeholders at many levels. A parent of
a young child, a young person and two adults with diabetes were members of the initial study design team
and reviewed the structure and content of the length, general tone and speciﬁc items on the questionnaire.
Two adults with diabetes were members of the study management team. Comments on the content and
tone of questionnaires by the parent and a staff member with research responsibilities for a diabetes charity
raise questions about how to involve lay perspectives in designing data collection instruments. In particular,
the content and language of some tools were better suited to the cultural norms for health and illness in
their country of origin (USA) than the UK context of this trial. This challenge is heightened where changes
to research instruments have implications for their validation or copyright status.
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A parent and young person from the UCLH diabetes service reviewed the content and delivery of the
intervention, and an independent group of PDSNs reviewed and trialled the training workshop content
and delivery. The extensive integral PE can be used to inform interpretation of the results and ensure that
parents and young people can make a valid contribution to future research programme, such as
CASCADE, to ensure that further developments are likely to be feasible and practical in an NHS paediatric
diabetes context.
Serious adverse effects
The CNR highlighted the difﬁculties involved in attempting to set up a formal reporting system in this
context. The data from the CNR showed that the actual number of SAEs was in line with expected levels.
Overall number of DKA episodes found in the CNR matches data from the recent UK NPDA and Hospital
Episode Statistics data, which is 200–400 per 1000 for 0- to 20-year-olds, and highest in teenagers. There
was also a lower number of cases of hypoglycaemia reported than might be expected, reﬂecting the fact
that we chose a population with higher HbA1c levels. However, the CNR highlighted that the clinical teams
involved were very poor at reporting SAEs.
Feasibility and training exposure
Training to deliver CASCADE
Overall the training programme was positively evaluated although motivation to attend the workshops
varied, often depending on how site educators had become involved. Training (from the same two
trainers) took place over 2 days, primarily at UCLH. The majority of site educators regarded 2 days of
training as feasible and acceptable, although some felt there was too much to take in. All site educators
received substantially the same or very similar training, with some variation depending on group dynamics
and types of questions and discussion. Site educators generally thought that the training was very good
and were initially excited and motivated.
Running groups
Despite the post-training enthusiasm of the site educators, only 30 out of a possible 44 groups were run
(68%). One site did not manage to run a full set of sessions and one site failed to run any groups owing
to lack of staff.
Experience of setting up and running groups by site educators was often minimal. Most sites found
organising the groups very difﬁcult and time-consuming, with little use of electronic media to facilitate this
process. Some found it very difﬁcult and time-consuming to agree dates and times with families. Practical
issues, such as ﬁnding appropriate rooms to house the groups and identifying time for nursing staff to
deliver the group, were also barriers to delivery. Some thought that more time could have been spent on
this in the training, despite 25% of the training being focused on getting clinics to think about how to get
the groups up and running as well as practical issues like arranging rooms. Site educators suggested that
more administrative support would have been helpful. Key barriers to running groups included lack of
administrative support for organisation of groups, low use electronic media for communication with
patients, competing priorities for potential participants and factors speciﬁc to being part of a research study.
The research context
Highly variable turnaround times obtaining necessary governance approvals at sites led to signiﬁcant delays
in patient recruitment, which had an impact on clinics’ ability to organise groups soon after completion of
training. Site educators felt that momentum was lost because of the time lag between training and the
setting up of the CASCADE groups.
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The Research Passport system (www.nihr.ac.uk/systems/Pages/systems_research_passports.aspx) and
Integrated Research Application System were introduced as the CASCADE study started. This meant that
R&D processes were very slow and in some cases stopped for protracted periods while staff drew up new
local policies and procedures. (e.g. one trust refused the research team access for 6 months). A strength of
CASCADE was the quality of the study processes, capacity and continuity between collection of all data by
the research team. However, there were signiﬁcant delays obtaining honorary contracts/letters of access
for research staff. All R&D departments requested additional supporting documentation, resulting in long
delays, and Criminal Record Bureau checks taking up to 6 months. A pragmatic decision was taken to
arrange contracts for selected research staff to work in selected clinics rather than across all sites as
originally intended. Although this ultimately sped up the recruitment process it complicated the
management of ﬁeldwork. The negative impact of negotiating these regulatory procedures on recruitment
has been reported by others.205
Where possible the research team liaised closely with secretarial, clerical and path laboratory staff to check
clinic dates, demographic details, etc. as noted in the extensive acknowledgement list; however, staff
reported feeling pressured by additional trial-related tasks (such as organising for research blood samples
to be taken and liaison with research staff over clinic dates, etc.).
Restricting the groups to a subset of patients who were recruited to the trial, instead of being able to offer
the groups to the entire clinic list was perceived as making the organisation of the groups more
challenging. This was particularly the case in sites where small numbers of recruits and/or where a hospital
served a large geographical area making travel arrangements complex. It also meant that natural
groupings of patients (by age, or geographical area, etc.) were more difﬁcult (and at times not possible).
Age-appropriate groups
The educators found it difﬁcult to keep the young people focused when more challenging topics were
introduced. This may have been because the language used by the educator was not age appropriate and
was particularly challenging in groups with mixed ages. The UCLH training team emphasised the need to
have similar age groups. However, for pragmatic reasons compromises were sometimes made in terms of
the CASCADE model for optimum group composition. Rather than grouping by age, groups were often
mixed. Educators found it difﬁcult to keep mixed age groups focused on activities and to engage the
entire group at once. Additionally, the age mix of the groups was felt to be problematic by some
young people.
Delivery
The intervention appears to be deliverable within the context of routine care without major impacts on
service structure with some provisos. Although at least two practitioners from each study site attended
both workshops, there was a failure to use trained educators in a few sites in the delivery of some groups,
which compromised the integrity of the programme. Two sites that swapped site educators across the
modules started with higher ﬁdelity scores in the ﬁrst two modules, which tailed off in modules 3 and 4.
Fidelity of delivery of activities was generally high across all sites. Site educators delivered activities as
described in the manual and used aspects of the approaches demonstrated in the training sessions.
However, less time than was recommended was often spent on some activities. Some of the key exercises
that would have had the greatest impact on HbA1c level were the ones on which less time was spent. Key
factors that inﬂuenced effective delivery included having an appropriate venue and having planned breaks.
In addition, advance preparation for sessions by both site educators and skilled group management using
the psychological approaches with conﬁdence made the groups run smoothly.
Although ﬁdelity of CASCADE techniques was good, it was not as high as desired. Site educators were
aware that they needed to use CASCADE approaches more often (e.g. evoking knowledge by asking
‘What else?’) but found it difﬁcult to do in larger or small groups or where there were group dynamics
they found difﬁcult to manage. Educators found it challenging at times to work with parents and children
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and keep both of them focused on the task and would have beneﬁted from more training in how to
manage the group when there was a dominant member of the group, usually a parent. Some site
educators found it difﬁcult to move away from didactic teaching and struggled with ‘avoiding giving a
choice or giving people the answer’ and asking ‘how come?’. They said it was ‘impossible’ to keep asking
‘what ifs’ if only one family attended a session. The frequency with which groups would comprise single
families had not been anticipated in the training, hence this was not prepared for. The training workshops
seemed to have ‘deskilled’ the PDSNs, as in normal practice they are more used to working with single
families than groups. As PDSNs reported lacking conﬁdence delivering the CASCADE groups to a single
family this would have to be addressed in future training.
Generalisability
The trial was conducted in NHS paediatric diabetes clinics spread throughout London, SE England and the
Midlands. Eligible list size varied but was well balanced across trial arms although the number of eligible
patients reported by clinics was surprisingly low. Exclusion criteria were kept to a minimum and the
heterogeneity of the paediatric diabetes population is well reﬂected by trial participants.
Uptake
Staff thought that many of the young people who were eligible for CASCADE were the least motivated in
terms of their diabetes, and that these remained the least motivated to attend groups, even if recruited.
Of the 180 families recruited, 66 (37%) failed to attend any of the groups offered, but were happy to
provide baseline and follow-up data. The majority of reasons for opting out of groups were a desire not to
miss school (young people) and not missing work (parents). Older teenagers and young people with higher
baseline HbA1c levels were signiﬁcantly less likely to attend than those with lower baseline HbA1c levels.
The mean HbA1c value of the patients at baseline was higher than the population average as reported by
the NPDA. This was because the study selected young people with a higher HbA1c level. The data suggest
that the intervention does not appeal to young people with baseline HbA1c levels of ≥ 10.4 mmol/l and an
alternative, more personalised and/or intensive, intervention may be required for this subgroup of patients.
Stafﬁng problems and difﬁculties organising groups prevented 14 of the expected 44 groups being
offered. The most suitable timing for when groups are best offered and which speciﬁc age groups should
be targeted remain unclear. Some staff felt that CASCADE would have been more effective if offered
during ﬁrst 12 months after diagnosis when young people and families are more likely to take on
information and are more in ‘the right frame of mind’ (site educator, I14). Children (8–12 years) were
signiﬁcantly more likely to attend CASCADE than teenagers (13–16 years), which would suggest that
parents found it easier to ‘bring’ younger children to the session. In addition, reported perceived impact
was signiﬁcantly higher for younger children than teenagers.
We contend that the generalisability of these results is high for diabetes patients in the UK aged
8–16 years and their carers with participation of a large number of diverse clinics, serving diverse
populations and suggest it is feasible to set up and run structured education with adequate support. A low
dropout rate and good attendance for the subgroup that attended the intervention, as well as reported
impact by this group, strengthens the ﬁndings of the study; however, it suggests that uptake and
effectiveness might be improved if offered to younger individuals with lower HbA1c levels.
Although the start-up cost associated with the intervention could be spread over more patients were
CASCADE to become routine clinical practice, about four-ﬁfths of the costs of the intervention are closely
related to the number of patients. Thus, the costs will differ by number of patients and will be lower for
larger clinics. However, these differences will not be large.
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Pragmatic RCTs tend to demonstrate high external validity and assess effectiveness rather than efﬁcacy.
The intervention has been evaluated in ‘real-life’ and representative settings, with all the challenges that
this presents, ultimately providing invaluable information on barriers and opportunities regarding future
similar interventions.
Changing the clinic culture
In hindsight it might have been helpful to have trained the whole clinical team in the CASCADE
philosophy to create a clinic environment that supported the delivery of the structured education groups.
It is possible that children, young people and families attending groups that effectively encouraged
behaviour change may have then been faced by didactic appointments with other clinicians. This approach
can create resistance and may have cancelled out a positive effect of the groups, particularly in older
teenagers with higher HbA1c.
Sites that remained most faithful to the delivery of activities and used the techniques most effectively
generally came from relatively well-resourced teams. They were able to take time to prepare before the
modules were run and had suitable venues available. The site educators were enthusiastic about
CASCADE, had experience in delivering groups, had worked together in the clinic for some years and
had good knowledge of the participants.
The failure of the study to demonstrate an effect on HbA1c level is disappointing, given the inﬂuence of MI
and SFBT on its design and previous evidence that behaviour change approaches can have beneﬁcial
effects on glycaemic control. Positive results have been reported in studies that used trained psychologists
with more extensive training and skills in MI and SFBT. The interventions had a much greater emphasis on
the psychological components without needing to teach new educational content.117,121
Many site educators made real attempts to adhere to the approach, but there were instances when they
found this difﬁcult or unachievable. It is possible that the approach was not delivered consistently. Site
educators were less able to deliver content that conﬂicted with their standard practice or reported
knowledge of a topic, for example testing urine for ketones. Less adherence to the manual was reported
in exercises involving CHO (e.g. CHO counting and use of CHO to keep BG stable and exercise
management), as well as identifying how insulin works, matching insulin to food and making permanent
insulin changes, and identifying hypoglycaemia. Encouraging all of these behaviours is critical to good
diabetes management.
In addition, some educators struggled to complete aspects of the delivery that are key to the theory of
change. Limited time was spent on the introduction (module 1) and reviews (modules 2, 3 and 4) designed
to ‘bring forth’ positive events and activities to build participants’ sense of knowledge, skills and abilities.
These activities were identiﬁed as challenging. Some site educators also misunderstood the intention of the
‘looking to the future’ activity and struggled to deliver it effectively. Key behaviour change techniques that
address ambivalence (e.g. the pros and cons of BG testing and when to seek help) were also not delivered
consistently. Ambivalence and discrepancy between knowledge and action is a key target for approaches
delivering MI effectively. The importance of using these key techniques to address ambivalence towards
behaviours is highlighted by data that showed that, although nearly all parents (93%) reported a greater
desire to stop their child’s BG going too high or low, less than half (43%) reported wanting to test their
child’s BG level more often.
The PE showed that some nurses lacked basic knowledge, some did not adopt the CASCADE approach
and some struggled to adhere to the approach consistently. However, it is unclear whether failure to
deliver the content and approach with adequate ﬁdelity or organisational issues and the capacity to set up
groups are the critical components for the failure to demonstrate effectiveness in improving
glycaemic control.
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Change in patient and family behaviour
Just over half (53%) of young people in the intervention sites attended one or more CASCADE education
sessions, with the majority attending three or four modules. However, the per-protocol analysis showed no
effect of the intervention in those who attended. School and parental work commitments, holidays and
forgetting were the most common reasons to miss a group. Young people and parents liked being in the
sessions together. Staff also found it helpful to include parents (albeit ﬁnding it challenging at times).
The majority of participants considered sessions to be the right length with appropriate content level.
Nearly all would recommend CASCADE to other families. Parents and young people who attended at least
one CASCADE group reported positive changes. Some nurses reported signiﬁcant changes in speciﬁc
challenging individual patients but this was not conﬁned to sites where delivery was rated highly.
Glycaemic control is crucial to the short- and long-term well-being of patients with T1D. The primary trial
outcome established in the research commissioning brief was levels of HbA1c. Effective glycaemic control
is consequent upon several contributing factors. It is therefore important to also focus attention on the
secondary outcomes, given their potential position as potential mediators or moderators; however, the
small number of signiﬁcant secondary outcomes consistent with change described by parents were in line
with what would have been expected by chance.
Impact on standard care
The challenge of delivering standard NHS care identiﬁed by staff interviewed at the end of the 4-year
study period showed some differences in control and intervention sites. Control sites identiﬁed their main
challenges under the theme of ‘providing education’. This included; how to provide education, the
demand for insulin pumps, requests for more teaching, help managing social problems, the need for
standardisation of services and management issues. Several control sites expressed disappointment that
they were not offered the training for the CASCADE groups at the end of the trial, even although they
were aware that the intervention was not effective in changing glycaemic control.
Intervention sites identiﬁed key issues that fell under a theme of ‘teaching requests’ related to topics that
included managing transition, preparation for best practice tariff and management and divisional changes.
Six of the 12 intervention sites that offered groups continued to use the CASCADE material as part of their
clinic structured education programme (before the trial results were reported).
Changes for future delivery
Site educators want (and need) more supervision and support to ensure that the key techniques and
activities are completed according to the intention of the CASCADE philosophy. The pragmatic nature of
this intervention did not allow us to speciﬁcally assess whether or not these techniques would have been
more effective if combined with other efforts to intensify diabetes management. It is also possible that
failure to address the entire clinic culture (as DEPICTED tried to) may have had better overall impact,
although the DEPICTED trial similarly did not have a signiﬁcant effect on HbA1c level.
Interpretation of results
The training and programme delivered in the CASCADE trial was not effective in changing glycaemic
control over a 1- and 2-year follow-up period post intervention.
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This disappointing outcome may be due to one or more of the following inﬂuences:
1. The level of support for the intervention was inconsistent across teams. The impact may be greater if
the whole diabetes team value the importance of the approach. This would require practitioners to
adopt a holistic approach to behaviour change in routine consultations with families alongside
structured education sessions.
2. Support for delivery would require involvement by commissioners and trust management to facilitate
the process of integrating structured education into routine clinic systems.
3. The level of diabetes speciﬁc education of site educators was inconsistent and, therefore, insufﬁcient
to improve patient knowledge
4. The level of training provided did not provide the skills required to facilitate behaviour change in
the patient.
5. The level of support for site educators was insufﬁcient for them to achieve the sustained
ﬁdelity required.
6. The timing of delivery was not optimal. Staff have suggested that they would have found it more
useful for young people diagnosed more recently.
7. Mixed age groups did not work well for staff, as some of the older age group reported that they held
back asking for speciﬁc issues to be addressed in deference to the younger age group being present
(issues such as drugs, sex and alcohol consumption).
8. It would have been better to have focused the intervention only on the younger age group.
9. The intervention should have been a universal one rather than a targeted one. Focusing on a higher
HbA1c group made it more difﬁcult to recruit a population who, by deﬁnition, were less likely to
attend groups and are also more resistant to change.
10. On the basis of the results, the training as deﬁned in the CASCADE trial cannot be recommended to
produce clinically signiﬁcant changes in children with diabetes, although the PE suggests it was
beneﬁcial for some children and young people with questions regarding timing, readiness to change
in some groups, and the need to value small steps in the right direction.
11. There were high levels of initial exposure to the training with good levels of attendance of workshops
and high levels of enthusiasm to participate. There were problems with the timing of training delivery
and group delivery which resulted in a loss of skill and conﬁdence.
Recommendations and reﬂections
On the basis of the results, the training as deﬁned in the CASCADE trial cannot be recommended to
produce clinically signiﬁcant changes in children with diabetes. However, HbA1c levels – the primary trial
outcome – is dependent upon several intervening steps. The intention of the session delivery style is to
invite young people to think about change as much as actively change behaviours. Increase in insulin in
the intervention group may suggest small changes in attitude that have not yet impacted on HbA1c level.
Changes in knowledge, attitude and family relationships were reported in the PE. There was some
evidence of an impact on patients’ and carers’ appraisal of their own self-management, although, as two
of many secondary outcomes, these may be signiﬁcant by chance. It is possible therefore that we did not
choose the best secondary outcome measures in this trial, or that instruments used chosen were not
sensitive enough to identify reported change. Changes between groups in insulin dosage at 12 and
24 months are similar at both time points. However, without baseline data this is difﬁcult to interpret
and there is no suggestion of a continuing effect.
The MRC guidance on complex interventions recommends that the results are interpreted within two
domains. In CASCADE the ﬁrst was the effort of the study to change the behaviour of practitioners
through provision of training workshops. The second was subsequent efforts to change the behaviour
of patients (children and parents) through development of the structured education programme.
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The research team assumed a level of basic knowledge missing in some cases and variable in many. It is
suggested that educational knowledge must be assessed and addressed in any training workshop prior to
attempting to change the behaviour of practitioners. Currently the Nursing and Midwifery Council (NMC)
sets standards of education, training, conduct and performance so nurses can deliver high-quality health
care consistently throughout their careers. The need to develop and implement a standardised national
competency framework for diabetes specialist nurses is being addressed by SWEET.185 NHS England now
oversees and shapes the development of the health and care workforce and promotes high-quality
education and training responsive to the changing needs of patients and local communities.
It has been suggested that more extensive training with attendant allocated resources to address
organisational, administrative and clinical support would have been beneﬁcial in delivery of the CASCADE
groups. Despite the majority of site educators saying 2 days’ training was adequate, there was some
concern expressed at a later date at the scale of the task ahead considering the relative briefness of
the training.
Because of unfamiliarity with the psychological approaches, some felt that conﬁdence using the new style
of teaching and techniques would have increased if there had been a middle step between being told how
to do it and actually doing it with families. Research has shown that nurses can ﬁnd it difﬁcult to adjust to
using a non-didactic approach compared with how they have been trained.131
Limited training, such as the half-day described in DEPICTED,123 or 2-day courses, such as provided in the
CASCADE study, may not be enough. Programmes need to provide ongoing supervision and skill
development. Having more of the clinical team attend the training could help change the team culture
with the added beneﬁt of reducing the risk of staff turnover or absence, which was a major problem.
Providing training locally may also improve attendance.
A more extended training is used by the successful DAFNE programme.145 The ‘ideal’ training programme
(based on DAFNE) would include (1) extended training with more role play and assessment of educational
knowledge; (2) more support and training in preparation for organising and running groups; (3) site
educators having an opportunity to observe a peer trainer deliver sessions to patients; (4) peer trainers
observing site educators delivering their ﬁrst groups; and (5) increased support and supervision throughout
the delivery of the ﬁrst group.
An enhanced intervention involving more intensive training and support for those delivering the
intervention and increasing the proportion of educators who are psychologists was costed. Current NHS
practice is less costly and less effective (in terms of QALYs) than this Enhanced CASCADE were it to
be effective. Enhanced CASCADE is estimated to have a cost per QALY gained of £28,100 compared
with current NHS practice. This lies within the cost-effectiveness threshold range of £20,000–30,000
currently speciﬁed by NICE.
Change in practice behaviour
There are mixed results in the use of the techniques in group delivery. The PE sheds doubt about the
ability and willingness staff who attended training (and those who did not) wanting to use the approach
or deliver the groups. There was therefore a limited embrace of the shift in style, attitude and skills. The
unavoidable delay before groups were delivered that impacted on skill and conﬁdence may be avoidable
if sessions were delivered as part of usual service.
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Conclusions
Determining the effective elements of complex interventions is a signiﬁcant challenge.
Members of paediatric diabetes services trained to deliver the CASCADE structured education package
using behaviour change techniques did not improve glycaemic control in patients compared with control
subjects 1 and 2 years after the intervention.
The training workshops for practitioners were well evaluated; however, more intensive training was
needed. Maintaining skills following training was a particular challenge.
The cost of the intervention was £683 per patient but it was not cost-effective because it did not improve
metabolic control. Although a reasonable estimate of the costs of an Enhanced CASCADE can be made,
any estimate of cost-effectiveness is highly speculative given that there is no evidence regarding the likely
success of an Enhanced CASCADE programme. Investment of signiﬁcantly greater resources in training,
ongoing supervision of the techniques and administrative support is required. As is highlighted by the
probabilistic sensitivity analysis, there is great uncertainty regarding the cost-effectiveness of the
different interventions.
Practitioners can be trained to use a range of MI and SFBT techniques in the delivery of structured
education, although some aspects were more difﬁcult to maintain than others were. Limited use and
adoption of speciﬁc activities and/or techniques by site educators suggested a lack of adequate education.
Skill levels in the use of behaviour change techniques were insufﬁcient to impact on glycaemic control,
unlike the outcomes of trials using intensive MI.
There was a failure to effect changes in the whole team approach owing to training only part of the
clinical team. Greater involvement by consultants could have made them (1) more likely to use the
techniques themselves when working with patients; (2) more engaged with the project and thus more
sympathetic for site educators need for time to prepare sessions; and (3) have a better understanding of
the problems with organising groups/uptake.
A complex, pragmatic intervention is deliverable and the integral PE has provided extensive data to identify
necessary improvements in training and programme content. Key factors that inﬂuenced effective delivery
included preparation in advance of delivering modules; conﬁdence using the psychological approaches,
having at least two site educators, site educators who could manage groups effectively and team having
adequate resources to be able to offer comfortable, quiet venues with planned breaks. Factors that made
delivery more challenging included delays between training and delivery of modules, small numbers or
mixed age groups, not preparing or practising sessions in advance and a lack of experience or conﬁdence
in site educators.
Key messages that emerged from the PE that are important for the development of future psychosocial
interventions include:
l creating a sense of ownership in whole teams adopting the approach
l creating solutions to the practical logistical challenges to organising the groups and making them
accessible and attractive to those with the poorest glycaemic management
l ensuring resources are available to provide clerical support to set up and organise the sending of
invitations, making appropriate appointments, communicating with young people/parents/carers and
reminding them of appointments, changing and rescheduling appointments, room hire and
organising refreshments
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l offering better training in group working and management of group dynamics; clinicians are often
poor at involving children in group conversations or managing ‘difﬁcult individuals;206,207 children resent
being ‘left out’ of discussions about their medical care208
l a collaborative approach to who should be invited to the intervention in order to address the needs of
different patient subgroups
l training on how to engage families and young people in the process and recognition of the difﬁculties
integrating diabetes into everyday life and embedding CASCADE philosophy in standard
clinical education.
Implications for clinical services
Structured education packages, which are NICE compliant, are urgently needed, as well as effective
communication skills training. It is essential that regulatory bodies emphasise the need for effective
communication underlying high-quality clinical care for children with diabetes.4,209 These skills need to be
learned early on in professionals careers and/or as they enter the ﬁeld of paediatric diabetes. Evidence for
the effectiveness in changing difﬁcult behaviour is provided in MI and SFBT research.210
Consideration needs to be given to the practical organisation of structured education and alternative
approaches alongside clinical appointments. Our experience suggests that additional voluntary
appointments will not be taken up by those who are in the greatest need and are the most difﬁcult
to engage.
Resource implications for delivery of an effective structured
education programme
The failure of CASCADE to impact on metabolic control suggests that alternative educational approaches
should be pursued. Additional training is required to standardise both the educational level of PDSNs and
behaviour change techniques and communication sills. Teams must ensure that they are adherent to
evidence-based international guidelines in preference to preferred local delivery. Future training would
demand that education was a key component of training to ensure adequate knowledge levels as well
as providing training in communication and behaviour change skills with support in reinforcing and
maintaining skills as suggested in the Enhanced CASCADE model.
Future developments
There is a demand for acceptable, deliverable and effective structured education in paediatric diabetes. The
CASCADE study has provided an evidence base from which to develop future programmes. As highlighted
by previous studies,123 a key consideration will be where responsibility lies for provision and regulation of
such programmes (e.g. with NHS trusts or professional bodies, such as the Royal Colleges, the NMC or
General Medical Council).
Additional support for practising delivery and reduced time lag between training and delivery were
identiﬁed as key improvements. Some trainees thought they already used the skills taught. Many thought
that professionally they should be practising in this manner. Clinicians often complain that the pressure of
time in clinic demands a directive approach. However, they are also aware that this is not satisfactory,
which is an important message and challenge for future researchers.180,211
The challenge is to help practitioners see behaviour change and communication skills as a way of
working differently rather than as tasks that need to be imposed on top of what is already done.
Non-threatening ways to evaluate and feedback to clinicians on consultation skills are required ensuring
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that parents and children also participate in this process. The RCPCH is currently evaluating a patient-
reported experience measure in all paediatric diabetes clinics in England and Wales. It is hoped this will
enable the 29,000 children and young people living with diabetes to let clinicians know their thoughts
about their clinic visits.212
Some practitioners demonstrated particular determination in trying to apply and retain skills and it is
essential to explore how to maintain skills in routine clinical practice in a cost-effective manner. Ongoing
training of nurses (who provide the majority of day-to-day care in diabetes services) should be invested in
with adequate administrative support provided to deliver the latest evidence-based service to their patients.
Implications for future research
There is widespread evidence for effectiveness of psychosocial interventions in diabetes.97 The particular
utility of MI/SFBT in diabetes has been highlighted although it is not effective in every setting.213 Process
research points to the central value of using reﬂective listening to evoke change talk, which, in turn,
predicts behaviour change.214 Researchers in paediatric diabetes might respond to this by following the
approaches described by Channon et al. and/or Christie.123
A better understanding of the cost-effectiveness of an educational intervention for this patient group will
require data on the extent to which any resulting improvements in metabolic control are sustained in the
future, and on the relationship between improvements in metabolic control and changes in the number
and timing of diabetic complications.
The dilemma is whether we should be using counsellors or psychologists to deliver MI-linked
evidence-based therapy with selected patients at a more individual level or persevering in our attempts to
train different team members to deliver group interventions to the required standard. Perhaps the answer
is that we need both.
The CASCADE groups were based on a programme delivered at UCLH by a psychologist and senior PDSN
with training in MI in the context of a whole team practising the CASCADE philosophy. The creation of
a deliverable manual and training programme to enable the trial to take place therefore by deﬁnition
required a degree of dilution of the approach. There is a need to address how to help teams work
effectively as part of the delivery of structured education programmes. The lack of consistent educational
knowledge by practitioners must be addressed.
Pragmatic RCTs tend to demonstrate high external validity and assess effectiveness rather than efﬁcacy.
The intervention has been evaluated in ‘real-life’ and representative settings, with all of the challenges that
this presents. Thus, it provides invaluable information on barriers and opportunities regarding future,
similar interventions. A low dropout rate and good attendance for the subgroup that attended the
intervention, as well as reported impact by this group, strengthens the ﬁndings of the study but, however,
suggests there might be improved uptake if offered to young people with lower HbA1c level.
Understanding why 37% chose not to attend is another important area.
Although acquiring mastery and maintaining skills is a focus of training, it is important to ensure that
teams ‘sign up’ to the approach and are given adequate supervision to ensure that they continue to use
the approach when things get difﬁcult. Testing whether this approach can be more successful with
a robust ongoing supervisory element should be a target of further research.
Finally, follow-up of HbA1c levels within the current trial cohort at 4 years may help to address whether
reported changes in psychosocial outcomes and self-management behaviours have resolved into
subsequent differences in glycaemic control.
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Appendix 2 Curriculum for Education programmes
Type 1 Education network: agreed learning methods and core
content for programmes
Method
Goal setting
Time for patients own agenda
Group interaction
Problem-solving
Experiential learning
Patient feedback and reﬂecting
Content
CHO counting
Insulin dose adjustment
How insulin works
Hypoglycaemia
How to manage exercise
Lifestyle issues
Complications
Other self-management skills
American Diabetes Association National standards
recommended curriculum for Diabetes
Self-Management Education
Describing the diabetes disease process and treatment options
Incorporating nutritional management into lifestyle
Incorporating physical activity into lifestyle
Using medication(s) safely and for maximum therapeutic effectiveness
Monitoring BG and other parameters and interpreting and using the results for self-management decision-making
Preventing, detecting and treating acute complications
Preventing detecting and treating chronic complications
Developing personal strategies to address psychosocial issues and concerns
Developing personal strategies to promote health and behaviour change
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Appendix 3 Record of reported changes in HTA
project protocol
Changes to protocol reported in 6-monthly progress reports.
Change to protocol Progress report Date Approved by
Recruitment and consent taken by clinical staff with
appropriate expertise in addition to research staff
1 30 October 2008 Simon Bevan
Use of a DVD to assist with recruitment 2 30 April 2009
Timing of primary and secondary outcomes 2 30 April 2009
Questionnaires to be carried out over the telephone
where required
3 14 December 2009
Revision of recruitment target (non-substantial
amendment)
3 14 December 2009
Participants to be offered £10 reward for completing
follow-up
5 2 November 2010
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Appendix 4 PDF file of letter of favourable intent
from ethics
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Appendix 5 Trial Steering Committee and Data
Monitoring and Ethics Committee membership details
Trial Steering Committee members
Professor David Dunger, Professor of Paediatrics
Department of Paediatrics
University of Cambridge
Box 116, Level 8
Addenbrooke’s Hospital
Hills Road
Cambridge
CB2 0QQ
Professor Jacqueline Barnes, Professor of Psychology
Department of Psychological Sciences
Institute for the Study of Children, Families and Social Issues
Birkbeck
Malet Street
London
WC1E 7HX
Professor Tim Cole, Professor of Medical Statistics
Centre for Paediatric Epidemiology and Biostatistics
University College Institute of Child Health
30 Guilford Street
London
WC1N 1EH
Data Monitoring and Ethics Committee members
Professor Christopher JH Kelnar, Honorary Professor of Paediatric
Endocrinology
University of Edinburgh
9 Easter Belmont Road
Edinburgh
EH12 6EX
Professor Darren Ashcroft, Professor of Pharmacoepidemiology
University of Manchester
School of Pharmacy and Pharmaceutical Sciences
1st Floor, Stopford Building
Oxford Road
Manchester
M13 9PT
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Professor Robert Coe, Professor of Education
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Durham University
School of Education
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Centre for Public Health
Queen’s University Belfast
Room 3.014, ICS Block B,
Royal Victoria Hospital
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Appendix 6 Per-protocol analyses tables for young
people and parent/carers
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Appendix 7 Process evaluation tables
TABLE 52 CASCADE Activity completion: ratings by site educators and research observers (scores: 1 = not completed;
7 = completed)
Module contents
Site educator
self-ratings:a median
scores (range)
Research observer
rating:b median
scores (range)
n = 35 modules n = 10 modules
Module 1
1 Introductions 7 (1–7) 6 (4–7)
2a and 2b Identifying strengths and abilities and
looking at the future
Focusing on the future and scaling
7 (4–7) 6 (4–7)
3a/3b ‘All food is good!’ and ‘What is a
healthy diet?’
7 (5–7) 1 missing 6 (5–7)
4 What is CHO? 7 (5–7) 5 (3–7)
5 How insulin works 7 (5–7) 1 missing 5.5 (4–7)
6a and 6b How insulin works in somebody
without diabetes How your insulin
injections work
7 (5–7) 1 missing 5 (4–7)
7 Matching insulin to food (ambivalence
task)
7 (4–7) 6 (5–7)
n = 30 modules n = 10 modules
Module 2
1 Review of previous session 7 (4–7) 6 (4–7)
2 HbA1c 7 (5–7) 6 (4–7)
3 Factors that inﬂuence insulin
requirements
7 (5–7) 6 (5–7)
4 Identifying hypoglycaemia 7 (6–7) 6 (4–7)
5 Treating hypoglycaemia 7 (5–7) 6 (5–7)
6 Pros and cons of BG testing 7 (5–7) 5 (4–7)
n = 33 modules n = 10 modules
Module 3
1 Review of previous session 7 (5–7) 2 missing 6 (4–7)
2 and 2b Identifying hyperglycaemia
Identifying hyperglycaemia + ketones
7 (5–7) 1 missing 6 (4–7)
3 When to get help: Treat at home vs.
contact a health-care professional
7 (5–7) 1 missing 5 (5–7)
4a and 4b Managing high BG levels – temporary
insulin changes, calculating a
correction dose
7 (3–7) 5.5 (3–7)
5 Managing high BG levels – permanent
insulin changes
7 (5–7) 5 (4–7)
6a and 6b CHO counting: What is it?
CHO counting: Addressing
ambivalence
7 (4–7) 1 missing 6 (4–7)
continued
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TABLE 52 CASCADE Activity completion: ratings by site educators and research observers (scores: 1 = not completed;
7 = completed) (continued )
Module contents
Site educator
self-ratings:a median
scores (range)
Research observer
rating:b median
scores (range)
n = 35 modules n = 10 modules
n = 28 modules n = 10 modules
Module 4
1 Review of previous session 7 (4–7) 1 missing 5.5 (4–7)
2a, 2b and 2c Low BG levels before activity
High BG levels before activity
BG levels before activity
7 (5–7) 6 (4–7)
3a and 3b Activities that affect the BG level 7 (4–7) 6 (4–7)
4 Timing of insulin injections in relation
to activity
7 (4–7) 6 (4–7)
5 Using CHO to keep your BG stable 7 (4–7) 5.5 (2–7)
a Completion of objectives on a scale from 1 (not completed) to 7 (completed) with 4 (partly completed).
b Observer scores scale:1 = not completed, 2 = between not completed and partly completed, 3 = nearly partly completed,
4 = partly completed, 5 = just more than partly completed, 6 = not quite completed, 7 = completed.
Module contents
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TABLE 53 Time taken for speciﬁc activities in observed CASCADE modules
Module contents
Suggested
minutes
Mean minutes
spent Range
Module 1 (nine observed groups)
Activity
1 Introductions 10 8 3–15
2a and 2b Focusing on the future and scaling
Identifying strengths and abilities and looking
at the future
15 18 10–30
3a and 3b What is a healthy diet?
All food is good!
10 21 13–35
4 CHO 15 11 3–17
5 How insulin works 20 10 3–20
6a and 6b How insulin works in somebody without diabetes
How your insulin injections work
20 17 10–25
7 Matching insulin to food (ambivalence task) 10 12 5–23
Module 2 (11 observed groups)
1 Review of previous session 15 11 3–20
2 HbA1c 5 5 3–7
3 Factors that inﬂuence insulin requirements 15 17 13–22
4 Identifying hypoglycaemia 20 16 4–29
5 Treating hypoglycaemia 20 18 9–32
6 Pros and cons of BG testing 30 26 15–37
Module 3 (nine observed groups)
1 Review of previous session 10 10 4–20
2a and 2b Identifying hyperglycaemia
Identifying hyperglycaemia + ketones
20 18 10–33
3 When to get help: treat at home vs. contact a
health care professional
15 18 10–30
4a and 4b Managing high BG levels – temporary insulin
changes
Calculating a correction dose
30 28 15–52
5 Managing high BG levels – permanent insulin
changes
10 5 3–8
6a and 6b CHO counting – What is it?
CHO counting – addressing ambivalence
15 22 7- 33
Module 4 (11 observed groups)
1 Review of previous session 10 6 3–13
2a and 2b Low BG levels before activity
High BG levels before activity
10 20 11–28
3a and 3b BG levels before activity
Activities that affect the BG level
40 29 15–41
4 Timing of insulin injections in relation to activity 10 11 2–33
5 Using CHO to keep your BG stable 15 10 5–19
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TABLE 54 Use of CASCADE techniques (1 = not used, 5 = used ‘extensively’): site educator and observer scores
Scores
Module 1 Module 2 Module 3 Module 4
Median
(range)
Median
(range)
Median
(range)
Median
(range)
n = 35 n = 30 n = 33 n = 28
Site educators’ self-scoring
Asking open questions 4 (4–5) 4 (4–5) 4 (3–5) 4 (4–5)
Focusing on positive solutions 4 (3–5) 4 (3–5) 4 (3–5) 4 (3–5)
Avoiding giving a choice or answer 4a (2–5) 4 (2–5) 4 (2–5) 4 (3–5)
Encouraging families and children to identify
previous successes
4 (2–5) 4 (3–5) 4 (3–5) 4 (3–5)
Asking ‘how come?’ 4 (1–5) 4 (3–5) 4 (3–5) 4 (3–5)a
Asking ‘what else?’ 4b (3–5) 4 (3–5) 4 (3–5) 4 (3–5)
n = 10 n = 11 n = 10 n = 12
Observer scoresc
Asking open questions 4 (3–4) 4 (3–5) 4 (3–5) 4 3–5)
Focusing on positive solutions 4 (2–5)a 4 (2–5) 4 (2–5) 4 (3–5)
Avoiding giving a choice or the answer 3 (2–4) 4 (3–5) 3 (2–4) 4 (2–5)
Encouraging families and children to identify
previous successes
4 (2–5) 3 (2–5) 4 (2–5) 4 (2–5)
Asking ‘how come?’ 3 (2–4) 3 (2–5) 3 (2–4) 3 (2–4)
Asking ‘what else?’ 4 (3–5) 4 (3–5) 4 (2–5) 3.5 (2–5)
a One missing.
b Two missing.
c Observer techniques scores scale:1 = techniques not at all used, 2 = a bit used, 3 = somewhat used, 4 = used quite a bit,
5 = used extensively.
TABLE 55 Reasons given by young people for not attending at all (follow-up 1 questionnaire)
Reasons (multiple allowed) No. (N = 36)
Didn’t want to/couldn’t miss school 10
Wasn’t told when the modules were 6
Ill on the day 5
Wasn’t interested/didn’t want to go 5
Clashed with other out of school activities/work 4
No one to attend with them/parent work 4
Didn’t think they would help 3
Couldn’t get to the place where they were being organised 2
Forgot to attend 2
Was away/on holiday 2
Felt too shy/scared to attend group sessions 1
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TABLE 56 Who accompanied young people at CASCADE modules
Accompanied by: No. of modules attended (N = 297)
Mother 203 (68%)
Father 34 (11%)
Mother and father (or stepfather) 41 (14%)
Parent(s) and sibling 7 (2%)
Sibling 4 (1%)
Other family member (grandmother, aunt) 3 (1%)
Mother and grandmother 1 (0%)
Girlfriend 1 (0%)
No child, just family members (2 ×mother; 1 × father and grandmother) 3 (1%)
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Appendix 8 Case example of exemplary
CASCADE session
The team of site educators were well prepared and organised – they had done ‘dummy runs’ of eachmodule beforehand. They worked well together and each had a role. The site educators were
authoritative, positive and caring. They appeared conﬁdent and relaxed. The team were very respectful
of the families. They thanked them for their thoughts/contributions. They listened well and used MI
techniques consistently and appropriately.
A site educator explained activities clearly so patients and carers knew what was required of them. They
reiterated key points at different stages of the activity. There was consistent use of the ﬂipchart so key
points and outcomes of discussion were recorded and visible to everyone.
Site educators were inclusive in discussions; they asked for feedback from everyone without ‘picking on’
individual people. They went into discussions in depth, facilitating this in a way that seemed to invite
families to contribute quite openly. They asked people to think about the possibility of doing things
differently in managing their diabetes. They asked them if they might be willing to try to do
things differently without telling them what they should do and got feedback from families to
their open questions.
Site educators gave families concrete examples to illustrate points made so they could use the information
in their everyday life. More time was spent on some sections of module 4 than was noted in other sites,
for example they spent over 30 minutes on the subject of the timing of insulin injections in relation to
exercise. This was because they explained the topic in depth, as it had particularly relevance to some of
the group attendees.
Ideas, questions and experiences raised by families were followed through by site educators either in the
group as a whole or on a one-to-one basis so nothing was left uncertain or unexplored.
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Appendix 9 Markov chain Monte Carlo submodels
for retinopathy, foot ulcer and myocardial infarction
No retinopathy Retinopathy
Retinopathy
Retinopathy
Retinopathy
Retinopathy
No retinopathy
No retinopathy
Death
Death
Death
Death
Death
Low HbA1c
M
Markov
information
Term rwd:
_STAGE = 120
Markov
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
Markov
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
Markov
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
FIGURE 9 Markov chain Monte Carlo submodel for retinopathy. incr rwd, incremental reward; init rwd,
initial reward; term rwd, final reward.
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No foot ulcer
No foot ulcer
No foot ulcer
Foot amputation
Foot amputation
Foot amputation
Foot amputation
Foot amputation
Foot amputation
Foot amputation
Death
Death
Death
Death
Death
Death
Death
Uncomplicated foot ulcer
Uncomplicated foot ulcer
Uncomplicated
foot ulcer
Uncomplicated
foot ulcer
Uncomplicated
foot ulcer
Markov
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
Markov
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
Markov
Markov
information
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
Markov
information
Init rwd: 0
Incr rwd: 0
Final rwd: 0
Low HbA1c
Term rwd:
STAGE = 120
M
FIGURE 10 Markov chain Monte Carlo submodel for foot ulcer. incr rwd, incremental reward; init rwd,
initial reward; term rwd, final reward.
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No myocardial
infarction
No myocardial
infarction
No myocardial infarction
Myocardial infarction
Myocardial infarction
Death
Death
Death
Death
Death
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infarction
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infarction
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infarction
Low HbA1c
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Incr rwd: 0
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Incr rwd: 0
Final rwd: 0
Init rwd: 0
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Final rwd: 0
M
FIGURE 11 Markov chain Monte Carlo submodel for infarction. incr rwd, incremental reward; init rwd,
initial reward; term rwd, final reward.
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Appendix 10 Statistical distribution of parameters
used in the model
Description of distributions Type of distributiona Parameters
Cost ESKD γ
β
α: (185602)/(23202),
λ: 18,560/(23202)
Cost enhanced CASCADE α: (1253.962)/(156.742),
λ: 1253.96/(156.742)
Cost uncomplicated foot ulcer α: (22362)/(279.502),
λ: 2236/(279.502)
Cost treatment (hospitalisations) α: (24852)/(310.622),
λ: 2485/(310.622)
Cost myocardial infarction α: (14102)/(176.252),
λ: 1410/(176.252)
Cost CASCADE α: (421.572)/(52.702),
λ: 421.57/(52.702)
Cost uncomplicated kidney disease α: (26882)/(3362),
λ: 2688/(3362)
Cost foot amputation α: (87262)/(1090.752),
λ: 8726/(1090.752)
Cost retinopathy α: (11872)/(148.372),
λ: 1187/(148.372)
Initial probability for no complications Subtype: 2, α: 0.2724,
β: 0.01218
Initial probability for retinopathy Subtype: 2, α: 15.5325,
β: 549.2857
Initial probability for uncomplicated foot ulcer Subtype: 2, α: 15.8963,
β: 2590.055
Initial probability for uncomplicated kidney disease Subtype: 2, α: 15.8436,
β: 1706.287
Probability of remaining in the no complication stage in the low
HbA1c level
Subtype: 2, α: 0.81534,
β: 0.00895
Probability of remaining in the no complication stage in the high
HbA1c level
Subtype: 2, α: 1.082687,
β: 0.15116
Probability of moving from no complications to uncomplicated
kidney disease in the low HbA1c level
Subtype: 2, α: 15.92274,
β: 3487.829
Probability of moving from no complications to uncomplicated
kidney disease in the high HbA1c level
Subtype: 2, α: 0.600924,
β: 0.062473
Probability of moving from no complication to ESKD in the low
HbA1c level
Subtype: 2, α: 15.9918,
β: 33127.63
Probability of moving from no complication to ESKD in the high
HbA1c level
Subtype: 2, α: 15.9836,
β: 16547.33
Probability of moving from no complication to retinopathy in the
low HbA1c level
Subtype: 2, α: 15.98216,
β: 15213.83
Probability of moving from no complication to retinopathy in the
high HbA1c level
Subtype: 2, α: 15.92567,
β: 3626.308
continued
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Description of distributions Type of distributiona Parameters
Probability of moving from no complication to uncomplicated
foot ulcer in the low HbA1c level
Subtype: 2, α: 15.9898,
β: 26633.68
Probability of moving from no complication to uncomplicated
foot ulcer in the high HbA1c level
Subtype: 2, α: 15.9745,
β: 10633.69
Probability of moving from no complication to foot amputation in
the low HbA1c level
Subtype: 2, α: 15.97245,
β: 9839.183
Probability of moving from no complication to foot amputation in
the high HbA1c level
Subtype: 2, α: 15.92501,
β: 3594.37
Probability of moving from no complication to myocardial
infraction in the low HbA1c level
Subtype: 2, α: 15.9564,
β: 6205.444
Probability of moving from no complication to myocardial
infraction in the high HbA1c level
Subtype: 2, α: 15.91502,
β: 3167.725
Probability of remaining in the uncomplicated kidney disease in
the low HbA1c level
Subtype: 2, α: 0.203,
β: 0.00999
Probability of remaining in the uncomplicated kidney disease in
the high HbA1c level
Subtype: 2, α: 0.18876,
β: 0.00946
Probability of moving from the uncomplicated kidney disease to
ESKD in the low HbA1c level
Subtype: 2, α: 15.9918,
β: 33127.63
Probability of moving from the uncomplicated kidney disease to
ESKD in the high HbA1c level
Subtype: 2, α: 15.97668,
β: 11628.83
Probability of moving from uncomplicated kidney disease to
death in the low HbA1c level
Subtype: 2, α: 15.2112,
β: 312.6164
Probability of moving from uncomplicated kidney disease to
death in the high HbA1c level
Subtype: 2, α: 14.4224,
β: 140.9914
Probability of remaining in the ESKD state in the low
HbA1c level
Subtype: 2, α: 8.486,
β: 10.7131
Probability of remaining in the ESKD state in the high HbA1c level Subtype: 2, α: 14.028,
β: 106.903
Probability of moving from ESKD to death in the low
HbA1c level
Subtype: 2, α: 6.514,
β: 5.160
Probability of moving from ESKD to death in the high HbA1c level Subtype: 2, α: 14.028,
β: 106.903
Probability of remaing in the retinopathy stage in the low
HbA1c level
Subtype: 2, α: 12.39328,
β: 46.0215
Probability of remaining in the retinopathy stage in the high
HbA1c level
Subtype: 2, α: 14.028,
β: 106.903
Probability of moving from retinopathy to death in the low
HbA1c level
Subtype: 2, α: 2.60572,
β: 0.701972
Probability of moving from retinopathy to death in the high
HbA1c level
Subtype: 2, α: 14.028,
β: 106.903
Probability of remaining in the uncomplicated foot ulcer stage in
the low HbA1c level
Subtype: 2, α: 0.2928,
β: 0.01271
Probability of remaining in the uncomplicated foot ulcer stage in
the high HbA1c level
Subtype: 2, α: 0.768,
β: 0.089143
Probability of moving from uncomplicated foot ulcer to foot
amputation in the low HbA1c level
Subtype: 2, α: 15.3404,
β: 380.0307
Probability of moving from uncomplicated foot ulcer to foot
amputation in the high HbA1c level
Subtype: 2, α: 14.351,
β: 133.5975
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Description of distributions Type of distributiona Parameters
Probability of moving from uncomplicated foot ulcer to death in
the low HbA1c level
Subtype: 2, α: 15.9524,
β: 5681.333
Probability of moving from uncomplicated foot ulcer to death in
the high HbA1c level
Subtype: 2, α: 15.881,
β: 2252.833
Probability of remaining in the foot amputation stage in the low
HbA1c level
Subtype: 2, α: 9.9888,
β: 18.26007
Probability of remaining in the foot amputation stage in the high
HbA1c level
Subtype: 2, α: 14.028,
β: 106.903
Probability of moving from foot amputation to death in the low
HbA1c level
Subtype: 2, α: 5.0112,
β: 2.741275
Probability of moving from foot amputation to death in the high
HbA1c level
Subtype: 2, α: 14.028,
β: 106.903
Probability of remaining in the myocardial infraction stage in the
low HbA1c level
Subtype: 2, α: 7.28376,
β: 6.922356
Probability of remaining in the myocardial infraction stage in the
low HbA1c level
Subtype: 2, α: 0.972,
β: 0.127548
Probability of moving from the myocardial infraction stage to
death in the low HbA1c level
Subtype: 2, α: 7.71624,
β: 8.119091
Probability of moving from the myocardial infraction stage to
death in the high HbA1c level
Subtype: 2, α: 14.028,
β: 106.903
Probability of utility for no complication Subtype: 2, α: 2.162,
β: 0.49402
Probability of utility for uncomplicated kidney disease Subtype: 2, α: 3.76,
β: 1.46222
Probability of utility for uncomplicated foot ulcer Subtype: 2, α: 6.667,
β: 5.476898
Probability of utility for retinopathy Subtype: 2, α: 2.842,
β: 0.829835
Probability of utility for foot amputation Subtype: 2, α: 11.155,
β: 27.98535
Probability of utility for myocardial infarction Subtype: 2, α: 3.93,
β: 1.605211
Probability of utility for ESKD Subtype: 2, α: 5.358,
β: 3.201105
Probability of low HbA1c level Subtype: 2, α: 12.77,
β: 54.44053
Probability of high HbA1c level Subtype: 2, α: 2.23,
β: 0.523086
a Estimated using TreeAge Pro HealthCare module.
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Appendix 11 Expected costs and effectiveness for
the control of diabetes type 1 interventions with
95% credible ranges based on the results from the
10,000 Monte Carlo simulations
Practices Cost, £ (range) QALY (range)
Current NHS practice 247,551 (209,080–289,642) 14.4293 (13.48–15.59)
Enhanced CASCADE 252,053 (211,590–290,023) 14.7121 (13.78–15.80)
CASCADE 247,972 (205,852–293,964) 14.4293(13.48–15.59)
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Appendix 12 Follow-up questionnaire (parent of
young person > 12 years)
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